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 I 
Abstract 
Necrotising enterocolitis (NEC) is an inflammatory intestinal disorder affecting premature infants. Despite the worldwide 
improvement of health care practices and facilities raising the survival rates of neonatal premature infants, there has not 
been any improvement in treatment options or mortality rates for NEC. There has been an extensive volume of research 
into NEC, though to date there has not been any evidence to directly associate a causal agent to this devastating disease, 
nor have there been any conclusive observations of NEC prior to birth. The only key prognostic signal for NEC is that 
onset and severity of the disease are significantly associated with the prematurity of the neonatal infant.  
During the process of birth, the infant transitions from the near sterile conditions of the womb to the outside 
environment teeming with bacteria. Only then does the infant develop a symbiotic relationship as a host to beneficial 
bacteria. Upon this transition the community of gut microbes develops and aids in a range of host functions, namely 
digestion and absorption of nutrients, as well as the immune response. It is also at this time that NEC can begin to develop 
in the lower gastrointestinal tract. This coinciding of factors implicates the colonisation of the gut with bacteria in the 
development of NEC, however studies to date have failed to provide consistent reports of a causative pathogen or a 
characteristic gut microbiome structure associated with NEC.  
The purpose of this study was to characterise the structure of the bacterial community in the gastrointestinal tract 
of infants with and without NEC in order to identify a community distinctive to infants with NEC. This was addressed 
using non-invasive faecal sampling of premature infants in a large, prospectively enrolled cohort from across England, 
sampled over a twenty-day window spanning ten days prior to and ten days following the onset of NEC.  
Using established V4 16S rRNA protocols, bacterial taxa within environmental samples could be characterised 
without relying on classic culture dependent methods. With this amplification technique it was possible to utilise small 
amounts of bacterial DNA isolated from infant faecal samples while at the same time mitigating the selection bias 
associated with culture-based techniques. 
Short read sequencing (illumina MiSeq) was performed on a total of 656 faecal samples from 132 infants 
spanning eight neonatal intensive care units across England. All infants had gestational durations of less than 35 weeks. 
44 infants had NEC (225 samples) and 88 were assigned as controls (431 samples) according to key risk factors defined 
by medical practitioners. Taxonomic abundances assigned with the QIIME informatics pipeline were normalised using 
non-reductive negative binomial normalisation. Local contributions to beta-diversity (LCBD) scores were used to 
quantify taxonomic changes in the community structure through subset regression. Non-metric multidimensional scaling 
(NMDS) was used to establish risk factors that best described NEC and control samples. The Random Forest machine 
learning algorithm was used to establish taxa that best discriminated between NEC and control infants, as well as to 
identify any conserved pathogens. 
Subset regression identified feeding regime, mode of delivery and age at sampling as significant discriminating 
factors for the NEC status of infants based on sample LCBD values. However, NMDS plots of sample LCBD values 
showed no clear clustering of samples according to NEC status. Canonical correlation analysis (CCA) indicated that this 
variability was due to inter-individual differences. Of the risk factors that could be accounted for, feeding regime was 
the most effective in differentiating community structures of NEC and control infant samples. There was also evidence 
that initial communities were influenced by delivery method. Three subgroups of infants based on these influential risk 
factors and with sufficient sampling depth were established and analysed separately in addition to collective, population-
scale analysis. 
Random Forest analysis demonstrated that reduced abundance of the genus Bifidobacterium was significantly 
associated with NEC across all sub-groups of infants. Additionally, this method of analysis indicated no clear pathogenic 
taxa that consistently spanned the population. For infants with NEC that were delivered by caesarean section and fed 
both formula and breast milk, there was increased abundance of the genus Dialister when sampled shortly after birth. 
Infants that did not develop NEC, who were delivered vaginally and fed both formula and breast milk were seen to have 
a significantly greater abundance of the genus Veillonella over time, relative to NEC subjects. There were no additional 
taxonomic differences that could be ascertained in the sub-group of infants who were vaginally delivered and fed breast 
milk exclusively. 
Overall, the unique nature of the microbiome and the high degree of inter-individual variation within the 
community made direct comparisons between NEC and non-NEC subjects difficult. However, by accounting for factors 
that were significantly associated with NEC status it was possible to observe consistent association of increased 
bifidobacterial abundance in infants that did not develop NEC. This highlights the importance of large scale studies and 
case-control assignment when analysing complex community structures such as that of the human gastrointestinal tract, 
as well as the powerful, deep analytical analysis provided by machine learning algorithms. Further work should look to 
establish the impact and role of Bifidobacteria in the human gut community to inform early interventions in healthcare 
settings for infants at risk of NEC, focussing specifically on encouraging the development of a community structure 
reflective of that observed in premature infants that do not develop NEC.  
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  1 
1 Introduction 
Necrotising enterocolitis (NEC) is the most common life threatening gastrointestinal (GI) 
disorder found to affect premature infants, and remains a major cause of morbidity and 
mortality in survivors1,2.  
 
NEC is an acute inflammatory disease that occurs in the intestinal tract of newborn infants, 
predominantly infants born prematurely. NEC is characterised by haemorrhagic necrosis of the 
intestinal tissue which may lead to perforation and destruction of the gut. Symptoms include 
abdominal distension, bilious vomiting, and bloody stools, which if not alleviated can lead to 
septic shock, disseminated vascular coagulation, peritonitis and intestinal perforation.  
 
The function of the gut has been associated with the presence and structure of a microbial 
community referred to as the gut microbiome3. The community structure fluctuates through 
childhood4 before stabilising in early adulthood. These changes have been shown to be 
influenced by different environmental factors5,6.  
 
There have been numerous small and large scale experiments designed to understand if there is 
an association between NEC and altered gut microbiota development7,8, beneficial bacterial 
taxa9 or if there are strains of bacteria associated with increased risk of NEC10. In general there 
has been an increased interest into research on the gut microbiota and gastrointestinal 
diseases,11 such as irritable bowel syndrome12 and Crohn’s disease13.  
 
Despite many years of research into the pathogenesis and treatment of NEC, relatively little 
progress has been made towards improving the outcomes of affected infants. In light of recent 
  2 
advances in understanding the association between the gut microbiome and host health, there 
has been reason to further investigate potential associations with NEC, especially within large 
scale, population cohorts.  
 
The dramatic decline in the cost of DNA sequencing and the development of techniques which 
allow for the quantification of diversity within bacterial communities, without the need for 
invasive or time intensive techniques, have enabled large, population level cohort studies into 
diseases associated with metabolic, intestinal disorders within fragile hosts. 
1.1 Necrotising Enterocolitis 
1.1.1 History of Necrotising Enterocolitis 
The first recorded instance of NEC was considered to be that of Caroline Jossey, who was 9 
days old. This case was observed by Charles Billard in 1826 but the book in which it was 
described was not published until 1928, wherein he termed the disease ‘gangrenous 
enterocolitis’14. Following a post mortem, he described the same features used today in the 
diagnosis of NEC; a swollen abdomen, bloody stools, and the terminal ileum being intensely 
red and swollen with a friable and bloody mucosa. Inspection of the membrane found that the 
surface was furrowed by numerous wrinkles with black lines within. Additionally, a large 
number of spots associated with bleeding underneath the surface tissue were observed, these 
spots being seen in different regions of the colon.  
 
The first reporting and labelling of an NEC case was by Genersich in 1891. He described the 
classical NEC symptoms including septic shock, gastric retention, bile stained vomitus, 
abdominal distention with ileus, and bloody stools15. The pathology was first defined and 
articulated only in 1952 by Schmidt and Quaiser, who named it as enterocolitis ulcerosa 
necroticans16,17 - 126 years after its original description14. After the early 20th century there 
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appears to have been an increase in the number of NEC cases around the world, in parallel with 
the development of neonatal intensive care units (NICU). It is likely that this was linked to the 
increased number of premature infants surviving birth due to advances in protocols associated 
with infant care18,19,20,21.  
 
NEC was brought to public awareness by Dr Touloukian in the 1960s, who suggested that 
many of the poorly defined reports relating to functional ileus, intra-abdominal abscesses, 
spontaneous perforations of the ileum, appendicitis, and colitis with perforation in newborn 
infants appear to represent the same entity. The purpose of his report was to suggest the 
surgical management of such diseases and how they have evolved between 1955 and 196622. In 
his review, Dr Touloukian identified the first instance of infant survival after NEC related 
surgery (attributed to Agerty et al in 194323). 25 cases were described in this report (18 female, 
7 male) between 1955 and 1966 in which the incidence of prematurity (22-39 weeks gestation) 
was high and birthweight low, (only 7 patients weighed over 2500 grams at birth). His primary 
findings included:  
 
“(1) An extremely high incidence of fetal or neonatal hypoxia, (2) a latent period 
prior to onset of clinical signs, (3) a variability in the length of necrotic intestine 
and (4) mucosal necrosis as the constant pathologic finding.” 
 
It was postulated that a decreased blood flow to the intestine of a hypoxic infant could induce 
ischaemia, leading to a diminished mucin production and degenerative alteration of the 
intestinal tissue. Touloukian et al suggested that this may be linked to the infant microbiome. It 
was stated that “gas forming organisms” became more abundant in the lower intestinal tract 
after 24 hours of life and invaded the mucosa, thereby suggesting that these were responsible 
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for forming the gas pockets located in the submucosa and subserosa. The large number of 
patients could help define the radiological and clinical presentations of the disease. Following 
this publication, the interest and research into NEC has risen over the years (Figure 1). 
 
Figure 1 Number of articles relating to NEC published each year 1952-2016 
 
By 1975, detailed analysis of survival rates for NEC patients treated with gastric 
decompression, antibiotics, intensive support therapy, and intravenous hyperalimentation 
suggested a significant drop in platelet counts could be used to identify gangrenous bowels. 
This was considered a predictor of NEC onset and infants should be considered for surgical 
intervention when this was observed24.  
 
In 1978 M. J. Bell devised a grading system on which to base therapeutic decisions. He defined 
NEC as two polar forms with a spectrum existing between25 the fulminant form, which 
progresses to intestinal necrosis in 12-24 hours, and the more slowly evolving and benign 
form. The latter was first observed by Richmond, in 1975, who focused on seven infants with 
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comparatively mild clinical signs and clear radiographic findings of NEC but without 
pneumoperitoneum26.  
 
In 1982 R. Wilson et al indicated that the age at onset of NEC was primarily determined by the 
maturity of the gastrointestinal tract. It was suggested that as birthweight increased, the risk of 
NEC declined. These observations correlated with the gestational age for each birth weight 
group, with a sharply declining risk for infants between 35 and 36 weeks’ gestation being 
observed27. 
 
By 1985, research on pathogenic bacteria and the occurrence of NEC had begun. Initial studies 
focused on species of Clostridium28,29 and Escherichia coli30. One of the first descriptions 
indicating an association with the gut microbiota was suggested by J. Blakey et al, who 
described a decrease in the presence of Bacteroides and Lactobacilli species in infants with 
NEC compared to controls31. 
 
In 1986, Walsh was one of the first authors to suggest multiple factors associated with the 
development of NEC and further expanded on the staging criteria proposed by Bell in 197832. 
This was followed through the 90’s with further reviews of multifactorial theories in the 
prevention of NEC33,34. A. Kosloke suggested that ischemic episodes, bacterial interference, 
and mucosal immaturity had to be treated in order to prevent the onset of NEC35. This was 
built upon with studies into the influence of feeding regimes and the onset NEC,36 as well as 
intestinal maturation37,38. 
 
In 1991 the PCR amplification of the 16S subunit of ribosomal ribonucleic acid (rRNA) was 
identified as a method that could be used in the characterisation of bacterial strain phylogeny39. 
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The advent of high throughput sequencing technology40 along with multiplexing of samples41  
has enabled researchers to explore the community structure of the gut microbiota in detail for 
relatively little cost and time when compared to culture based techniques. 
 
This led to greater understanding of environmental factors associated with the development of 
the gut microbiota in early infancy,42,43,44 as well as the exploration of potentially beneficial 
bacterial taxa9 and strains associated with increased risk of NEC10. However, these studies 
were predominantly small scale and many were contradictory45. Only recently have studies 
aimed to elucidate the microbiota’s influence in the development of NEC in large scale cohort 
analysis46. 
 
1.1.2 Definition of Necrotising Enterocolitis 
From a clinical perspective it is clear that NEC symptoms vary among infants, therefore it is 
important to define a clinical spectrum from which medical staff can gauge the extent of the 
disease, and the level of treatment required to mitigate the symptoms. The disease ranges from 
rapid onset and extremely dangerous,25 to slow and benign26. Systemic, intestinal, and 
radiologic signs are all important in the diagnosis, but these can variable. 
 
Prior to the development of a standardised method by M. J. Bell in 1978 clinicians would 
primarily rely on stool observation. If the stool was bloody it could be indicative of NEC when 
presented alongside abdominal distention in the form of air pockets around the intestines and 
pneumatosis. However, these symptoms could be associated with various other diseases such 
as focal intestinal perforation47,48, septicaemia with ileus23, and neonatal pseudomembranous 
colitis49 . 
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Table 1 defines how Bell described three key stages of NEC25. Infants considered to be in 
Stage I (‘Suspected’ NEC) were seen to have minor symptoms relating to poor feeding, 
distention, lethargy, and a high temperature. Stage II (‘Definitive’ NEC) built upon the same 
symptoms as Stage I but with the addition of gastrointestinal bleeding, marked abdominal 
distention, rigid bowel loops, pneumatosis intestinalis, and portal vein gas. These would have 
been observable clinically and by radiographic evaluation. Other disorders such as malrotation 
and Hirschsprung’s disease must, however, be excluded. Stage III is classed as ‘Advanced’ 
NEC, and patients display bowel necrosis, peritonitis, perforation, and septic shock. It has also 
been noted that a small group of infants with NEC can have less severe symptoms but 
radiographic evaluation shows pneumoperitoneum. 
Table 1 Bell’s NEC grading system based on historical, clinical and radiographic data25. 
Stage I (Suspected)  
a Any one or more historical factors producing perinatal stress. 
b Systemic manifestations - temperature instabili ty, lethargy, 
apnoea, bradycardia.  
c Gastrointestinal manifestations - poor feeding, increasing 
pregavage residuals, emesis (may be bilious or test positive for 
occult blood) mild abdominal distension, occult blood may be 
present in stool (no fissure) 
d Abdominal radiographs show distension with mild ileus. 
Stage II (Definite) 
 
a Any one or more historical factors.  
b Above signs and symptoms plus persistent occult or gross 
gastrointestinal bleeding; marked abdominal distension. 
c Abdominal radiographs show significant intestinal distension 
with ileus; small bowel separation (edema in bowel wall or 
peritoneal fluid), unchanging or persistent "rigid" bowel loops, 
pneumatosis intestinalis, portal vein gas. 
Stage III (Advanced) 
 
a Any one or more historical factors.  
b Above signs and symptoms plus deterioration of vital signs, 
evidence of septic shock or marked gastrointestinal haemorrhage.  
c Abdominal radiographs may show pneumoperitoneum in addition 
to others listed in II c. 
 
Further refinement of the diagnosis of NEC was proposed by Walsh et al in 1986. They 
suggested that not all infants who develop NEC have observable risk signs associated with 
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Bell’s Grading. For example, two studies identified infants with no obvious signs of NEC were 
seen to have symptoms following a more thorough investigation; five infants in a sample of 
fifty in the paper published by O’Neil et al50 and six infants in forty-four in another report by 
Yu and Tudehope32. Walsh et al suggested that there are two distinct epidemiologic 
classifications of NEC, endemic and epidemic32.   
 
Walsh suggested that there was an endemic (sporadic) incidence of NEC in all nurseries 
studied, ranging between 0 and 2 cases per month. In addition to these there are epidemics of 
NEC, in which a large number of cases are clustered in space and time51,52. It was reported that 
during epidemics, patients tended to have higher birthweights and Apgar scores as well as later 
onset of the symptoms than those occurring in endemic cases of NEC53.  
 
Based on these findings, Walsh proposed modifying Bell’s staging criteria to include systemic, 
intestinal, and radiographic signs, and he suggested that treatment should be based on the 
added stages and the severity of the illness (Table 2). Progression from Stage I to Stage II 
usually occurs within 24-48 hours. The progression from Stage II or IIIA to Stage IIIB could 
be delayed for 5-7 days.
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Table 2 Walsh’s Suggested Modified Bell’s staging Criteria for NEC 32 
 
Bell's 
Stage 
Sub-stage 
Proposed 
Description Systemic Signs Intestinal Signs Radiological Signs Treatment Options 
I A Suspected 
NEC 
Temperature instability, 
apnoea, 
Bradycardia, 
lethargy. 
Elevated pre-gavage 
residuals, 
mild abdominal distention 
emesis, 
guaiac-positive stool. 
Normal or intestinal 
dilation, 
mild ileus. 
Nil-by-mouth and 
antibiotics for three days 
pending culture. 
 
B Suspected 
NEC 
Same as previous sub-
stage. 
Bright red blood from 
rectum. 
Same as previous sub-
stage. 
Same as previous sub-
stage. 
II A Definitive 
NEC 
Same as I-A. Same as previous stage, 
plus;  
absent bowel sounds, 
+/- abdominal tenderness. 
Intestinal dilation, 
ileus pneumatosis 
intestinalis. 
Nil-by-mouth and 
antibiotics for seven to 
ten days, if examination 
is normal in 24-48 hours 
  B Definitive 
NEC 
Same as I-A, plus; 
mild metabolic acidosis, 
mild thrombocytopenia. 
Same as previous sub-
stage, plus;  
abdominal tenderness, 
+/- abdominal cellulitis or 
right lower quadrant mass. 
Same as previous sub-
stage, plus; 
portal vein gas, 
+/- ascites. 
Nil-by-mouth and 
antibiotics for 14 days, 
NaHCO3 for acidosis 
III A Advanced 
NEC 
Same as previous sub-
stage, plus; 
hypotension, 
severe apnoea, 
combined respiratory and 
metabolic acidosis, 
disseminated intravascular 
coagulation. 
Same as previous sub-
stage, plus; 
signs of generalised 
peritonitis, 
marked tenderness, 
distention of abdomen. 
Same as previous sub-
stage, plus; 
definite ascites. 
Same as previous subs-
stage, plus; 
200+ ml/kg fluids, 
inotropic agents, 
ventilation therapy, 
paracentesis. 
 
B Advanced 
NEC 
Same as previous sub-
stage. 
Same as previous sub-
stage. 
Same as previous sub-
stage, plus; 
pneumoperitoneum. 
Same as previous sub-
stage, plus; 
surgical intervention. 
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1.2 Affected individuals & Rate of Incidence 
The primary group affected by NEC are premature infants, with 90% of cases occurring in 
infants born at less than 34 weeks gestation54,55,56,57. Additionally, it has a much greater 
prevalence in infants at very low birth weight (VLBW); 14% of those born at less than 1000g 
are observed to have NEC. This rate of occurrence decreases significantly in association with 
increasing gestation and birthweight58. NEC predominantly affects infants in NICU units 
with evidence of individual, sporadic, and nosocomial NEC outbreaks59 
 
The average incidence rate of NEC has been shown to be approximately 1 in 1000 live births, 
however there is considerable variation observed both among and within institutes56. 
Incidence rates vary globally; within the UK the overall rate of occurrence in 2010 for infants 
in NICUs was approximately 2%58. For comparison, the rates in other high income countries 
were as follows: Australia and New Zealand 1% to 3.5%, Canada 2.5% to 8.7%, Finland 
22%, Germany 2.9%, Italy 1% to 13.1%, Japan 0.1% to 5.7%,  Korea 6.8%, Poland 8.7%, 
Spain 2.8% to 10.9%, Sweden 0.1% to 4.6%, Switzerland 0.7% to 11.1% and the USA 2.1% 
to 9.8%60.  Data obtained from the UK National Neonatal Research Database61 between 
December 2011 and September 2014 described a 23% incidence rate for NEC in all 163 
neonatal units across England, from a total of 3,866 infants admitted62. 
 
When compared to infants born full term, VLBW infants at risk of NEC have abnormal 
faecal colonisation63. They demonstrate a relatively small population of normal enteric 
bacterial species in addition to a delayed colonisation pattern that would be observed in 
healthy preterm or term infants64,65. Relative to term infants it has been shown that premature 
infant microbiotas have a limited, non-stable presence of Bifidobacterium, a high prevalence 
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of Staphylococcus, Enterobacteriaceae, Enterococcaceae as well as other lactic acid bacteria 
such as Lactobacillus in a low diversity microbiota66,66,67.  
1.3  Pathology & Pathogenesis of Necrotising Enterocolitis 
Despite the extensive depth of research since 1965, the key frustration of NEC is the lack of 
understanding of its aetiology. Even within the great wealth of carefully planned and 
designed experiments utilising the latest models and technology, there is still no clear 
understanding of NEC development.  
 
1.3.1 Pathology 
The current hypothesis for the pathology of NEC is, primarily, the coinciding of two or three 
pathogenic characteristics; coagulation (ischaemic) necrosis; excess protein substrate in the 
intestinal lumen; and bacterial overgrowth within the intestine33. It is characterised by bowel 
wall necrosis of various lengths and depth, with bowel perforation affecting one in three 
infants68. NEC is most commonly referred to as a multifactorial disease, with a complex 
interaction of factors leading to mucosal injury34. Critically, bacterial colonisation is believed 
to be necessary for its occurrence35,69. 
 
1.3.1.1 Prematurity with impaired host defence - Epithelial Barrier 
The most consistently associated risk factor of NEC is prematurity. This inherently has 
multiple implications in the host’s physiology and responses70,71. In the context of NEC, the 
primary region of interest is the intestinal mucosa. This is where necrosis occurs initially in 
neonates and it appears to be in a constant equilibrium of injury and repair. This may depend 
on a variety of conditions associated with prematurity including hypoxia72, perinatal infection 
(primarily indicated by the presence of interleukin-6)73,74,75, and starvation76 (a common 
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approach to mitigate respiratory distress syndrome, immaturity of gastrointestinal function, 
and systemic hypoxia77). Additionally, microcirculatory dysfunction also contributes to 
epithelial damage78. 
 
Under normal physiological conditions, repair of the epithelium begins immediately after 
injury when mature enterocytes migrate into the affected area79. This is followed by 
proliferation of new enterocytes within the crypts of Lieberkühn to complete the repair 
process80. Recent literature has suggested that infants with NEC have both enterocyte 
migration and proliferation inhibition, resulting in the host being susceptible to further injury. 
The potential loss of the epithelial barrier could facilitate the translocation of microbial 
pathogens from the intestinal lumen into the mucosa81. The loss of the epithelial barrier 
allows for the translocation of bacteria from the intestinal lumen into the mucosa layer. 
 
1.3.1.2 Innate Immunity 
Innate immunity relates to the host’s nonspecific defence mechanisms that become activated 
immediately or within hours of a pathogen appearance in the body. These mechanisms 
include physical barriers such as skin and gastric acid, as well as the immune system that 
attacks foreign cells in the body. Inflammation is one of the first responses of the immune 
system to infection. This process is stimulated by chemical factors released by injured cells, 
with the purpose of establishing a physical barrier against the spread of infection, in addition 
to promoting the healing of the damaged tissue. 
 
Key components of the innate immune system are located on the epithelial surface; these play 
a major role in tissue repair and the recognition of microorganisms. In particular toll-like 
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receptors (TLRs) are known to be some of the primary cell-surface sensors of bacterial 
components and key to the induction of the proinflammatory responses82.  
 
TLRs are evolutionarily conserved pattern recognition receptors which recognise highly 
conserved structural motifs known as pathogen-associated microbial patterns83. Pathogen-
associated motifs include components such as mannans on the yeast cell wall, formylated 
peptides, and various bacterial cell wall components such as lipopeptides, peptidoglycans, 
teichoic acids, and lipopolysaccharides (LPS).  
 
TLR4 appears to have a crucial role in NEC development84,85,86. Cynthia Leapheart et al 
demonstrated a clear association in human and mouse models of NEC and increased 
expression of TLR4 within the intestinal mucosa. Physiological stressors, such as LPS and 
hypoxia, were associated with NEC development by sensitizing the murine intestinal 
epithelium to LPS through upregulation of TLR4. It was shown that TLR4-mutant mice were 
protected from the development of NEC when compared with wild-type mice.  
 
Ward Richardson et al showed TLR4 activation causes apoptosis of the small intestine or 
colon in newborn mice but not in adults. Its activation was influenced by nucleotide-binding-
oligomerization domain-2 (NOD2)85. NOD2 activation inhibited TLR4 in enterocytes, but 
not macrophages, and reversed the effects of TLR4 on intestinal mucosal injury and repair. 
The protection by NOD2 utilised a novel pathway linking NOD2 with second mitochondria-
derived activator of caspases (SMAC)-diablo, wherein NOD2 reduced SMAC-diablo 
expression, attenuated the extent of enterocyte apoptosis, and reduced the severity of NEC. 
This was further supported by the work of Sodhi et al who were also able to show that TLR4 
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activation significantly impaired enterocyte proliferation in the ileum, but not the colon, of 
newborn mice; this was not observed in adult mice86.  
 
Developing foetuses express elevated levels of TLR4 until the end of gestation; this could be 
linked to the importance of TLR4 in the proliferation and differentiation of the intestinal 
epithelium tissue during the embryogenic period. When observed in TLR4 knockout mice 
there was an increase in the frequency of goblet-like cells and these appeared to be more 
apparent along the duodenum-jejunum ileum axis87.  
 
These cells are modified, simple, columnar epithelial cells whose function is to secrete gel-
forming mucus, thereby protecting the mucous membranes. In this study, it was shown that 
both the mice with TLR4 knockout isolated within the intestinal tissue, and those with 
complete TLR4 knockout were observed to have significantly reduced levels of bile acids in 
the ileal lumen and stool relative to wild-type strains. 
 
The evidence that bile acid concentration in the newborn gut has been linked to the regulation 
of goblet cells88 raises the possibility that bile acids could play a role in the increased level of 
goblet cells observed within TLR4-deficient mice. However, when treated with four 
antibiotics neither knockout mouse strain showed a difference in the level of goblet cells. 
This would suggest that bile acid concentrations have a greater influence on the levels of 
goblet cells than exposure to bacteria. 
 
Expression of TLR4 in preterm babies is very high relative to full term infants. When 
combined with the introduction of environmental bacteria, relative to the developing foetuses 
which remain in a quasi-sterile environment, the TLR4 signal could be over activated. This, 
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in turn, decreases the host’s ability to repair the epithelium after injury. This results in gut 
barrier failure, bacterial translocation into the mucosa, intestinal inflammation and activation 
of systemic inflammatory responses84.  
 
However, there appear to be additional factors that result in most premature infants not 
developing NEC, despite the observation that TLR4 activation is significantly increased in 
preterm infants. This would suggest that mechanisms are involved that limit the 
consequences of TLR4 activation within the newborn intestinal epithelium. These 
mechanisms are likely to be influenced or based on intra- and extracellular factors and are 
probably affected by the microbiota composition. 
 
1.3.1.3 Intra- /Extracellular Mechanisms 
1.3.1.3.1 Hsp70 
Heat shock proteins (Hsp) are a family of intracellular proteins activated by a variety of 
stressors and which contribute to the delivery of proteins into a degradation pathway 
involving the ubiquitin-proteasome. Hsp70 is the predominant member of this family and 
chaperones molecules, specifically, the carboxyl terminus of Hsp70-interacting protein 
(CHIP)89.  
 
Hsp70 has been shown to have a protective role in CHIP-mediated ubiquitination and 
associated degradation of TLR4, with intracellular Hsp70 induction in enterocytes being 
linked to dramatically reduced TLR4 signalling. This was assessed by LPS-induced nuclear 
factor kappa-light-chain-enhancer of activated B cells (NFκB) translocation, cytokine 
expression, and apoptosis.  
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Expression of Hsp70 in the intestinal epithelium was significantly decreased in murine and 
human NEC compared with healthy controls, suggesting protective effects were imparted by 
Hsp70 on TLR4 and could be critical in the prevention of NEC90. 
 
1.3.1.3.2 Amniotic Fluid/EGF 
The epidermal growth factor (EGF) has been observed to influence the TLR4 signal. EGF is 
an extracellular factor that is extremely rich within the amniotic fluid. It inhibits the TLR4 
signalling by the peroxisome proliferator-activated receptor gamma and NFκB pathway.  
 
During gestation, the foetus takes in high quantities of amniotic fluid which limits the 
amplification of TLR4 signalling in the intestinal mucosa, this is also apparent in cultured 
enterocytes exposed to bacterial products. These associations were further confirmed with 
amniotic fluid-mediated TLR4 inhibition, which reduced the severity of NEC in mice through 
EGF receptor activation91.  
 
It was observed that NEC development in both mice and humans was associated with 
reduced EGF receptor expression, which was subsequently restored by the administration of 
amniotic fluid-mediated EGF signalling. 
 
1.3.1.3.3 PAF 
TLR4 signalling has also been shown to upregulate platelet-activating factor (PAF) 
expression. PAF has been demonstrated to increase the risk of injury in experimental models 
of NEC92. It is an endogenous phospholipid mediator that is synthesised and secreted by 
many cell types with relevance in a variety of pathophysiological processes. It has been 
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shown that LPS and PAF act synergistically to induce bowel necrosis, in addition to other 
systemic changes such as hypotension, haemoconcentration, and leukopenia92.  
 
1.3.1.4 Gut microbiota  
NEC is associated with changes in the abundance of bacteria in many studies, but no single 
species has been consistently identified as a causative pathogen. Research has suggested that 
NEC may be a consequence of prematurity, enteral feeding and bacterial colonisation, where 
feeding results in inappropriate colonisation and an exacerbated inflammatory response. As 
such, it has been hypothesised that altered colonisation patterns of the premature intestine 
could cause NEC93.  
 
A community established from naturally occurring bacterial, known to be members of the gut 
microbiome and found in stable proportions (equilibrated), have been shown to have an 
essential role in nutrient digestion and metabolism94, vitamin synthesis95, immune tolerance,96 
and maturation of the intestinal mucosa97. The composition of this community varies widely 
along the different regions of the gastrointestinal tract according to factors such as transit 
time, pH, nutrient availability, oxygen tension, host secretions, mucosal surfaces, and 
interactions with the immune system98. 
 
With the introduction of improved sequencing technologies and databases it has been 
possible to perform direct sequencing and interpretation of bacterial deoxyribonucleic acid 
(DNA) from stools. However, even with the utilisation of these methods there have been 
inconsistent reports of the level of association with the gut microbiota and NEC. 
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Some researchers have observed little or no correlation between bacteria and NEC. Raveh-
Sadka et al identified potentially pathogenic bacteria of the same species colonising many 
infants within their cohort. Genome-resolved analysis revealed that strains colonising each 
infant were typically distinct and that no strain was common to all infants who developed 
NEC99.  
 
Erika Claud et al demonstrated a temporal pattern in the faecal samples of control infants 
which converged towards that of a healthy full-term breast-fed infant. In contrast, the 
microbiota development in infants with NEC diverged from that seen in controls three weeks 
prior to diagnosis100.  
 
The majority of differentially abundant genes in the NEC patient were associated with 
members of the family Enterobacteriaceae, but there was no significant differences associated 
with specific taxa100. In addition, Erik Normann et al identified a high relative abundance of 
Bacillales and Enterobacteriaceae in the early time points of patients with NEC but in 
contrast, healthy controls were observed to have a greater dominance of Enterococcus 
relative to NEC subjects. However, neither of these differences was seen to be statistically 
significant101. 
 
Some researchers have identified associated disparate organisms such as Gram-negative 
Bacilli. Morrow et al identified infants with NEC showing community dysbiosis preceding its 
onset in addition to lacking propionibacteria when compared with their controls. Earlier 
communities in the diseased infants appeared to become dominated by Firmicutes, followed 
by Proteobacteria dominance, specifically Enterobacteriaceae. Those NEC diagnoses 
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preceded by Firmicutes dominance were observed to have an earlier onset relative to those 
preceded by Proteobacteria dominance102.  
 
Proteobacteria were also observed to contribute a significantly higher proportion of the 
microbiome in infants with NEC and additionally Actinobacteria at one week prior to 
diagnosis. These were offset by lower numbers of Bifidobacteria and Bacteroidetes. 
Additionally, within this same study a distinct, novel signature most closely resembling 
Klebsiella pnuemoniae was strongly associated with NEC development later in life103.  
 
Further support for blooms of Proteobacteria within NEC subjects was observed in the work 
by Mai Volker et al, observed to be offset by Firmicutes in controls. This group of 
Proteobacteria was not defined in any database but most closely resembled the 
Enterobacteriaceae family104. 
 
Clostridia have also been observed to be in greater abundance in early onset NEC subjects 
compared with their controls, specifically Clostridium sensu stricto. In late onset NEC, 
Escherichia/Shigella in addition to other Gammaproteobacteria were observed to increase in 
relative abundance prior to the onset of NEC105. 
 
Large scale 16S rRNA analysis of faecal samples by Kathleen Sim et al also demonstrated 
that Clostridia were seen to be overabundant in pre-diagnosis samples from infants with 
established NEC. Culture analysis confirmed the presence of Clostridium perfringens type A; 
those NEC infants that did not have C. perfingens prior to diagnosis were seen to have an 
overabundance of Klebsiella106. 
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There is considerable inconsistency between reports on how the gut microbiome of infants 
with NEC differs from those who do not develop the disease and this has largely been 
attributed to small scale studies limited by sampling challenges. These challenges are, in part, 
due to the unpredictable occurrence of NEC throughout the first two months of life107.  
 
One of the symptoms of NEC is reduced defecation at the onset of the disease. This is partly 
attributable to the disease itself but also, in many cases, clinicians treat NEC using nil-by-
mouth feeding regimes, further reducing the likelihood that infants will pass stools. This 
leads to variable frequency of stool production within and between infants of this age and as 
such timed sample sets are often non-uniform. 
 
Another aspect that further complicates the trends and patterns that are observed within NEC-
control cohorts are the sudden population shifts that are inherent to the developing gut 
community which gradually converge into a community more closely shared between 
individuals108. 
 
Recent large-scale analysis has described significant differences emerging after one month of 
age in NEC infant gut microbiomes. Specifically, the time-by-necrotising-enterocolitis 
interaction emerged only after the first month of age. Mixed model analysis described a 
positive association with Gammaproteobacteria and a negative association with strictly 
anaerobic bacteria, in particular, Negativicutes. A more extensive dataset found the 
Clostridia-Negativicutes class were negatively associated with NEC subjects. These 
associations were observed to be strongest for infants born at less than 27 weeks’ gestation46. 
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As described previously, activation of TLR4 on the intestinal epithelial lining by Gram-
negative bacteria leads to a number of deleterious effects, including increased enterocyte 
apoptosis, impaired mucosal healing and enhanced proinflammatory cytokine release109.  
 
Infants with NEC show abnormal and inappropriate colonisation manifested by low 
microbiota diversity110, increased Gram-negative pathogen colonisation, and high levels of 
pathogens in the peritoneal cavities111. The influence of bacteria in the development of NEC 
is somewhat supported by evidence that antibiotic administration in newborn mice87 and 
NEC infants112,113 decreased bacterial load and protect against the onset of NEC.  
 
1.3.1.5 Intestinal Tissue Integrity – Immaturity 
The neonatal intestinal barrier is immature in preterm infants and has been shown to mature 
post-natally114,115,116. Multiple factors can induce postnatal intestinal maturation of this barrier 
including epidermal growth factor117, endogenous glucocorticoids118, diet,119,120,121 and 
commensal bacterial114,122. Commensal bacteria have been shown to induce expression of 
tight junction (TJ) proteins that can tighten the intestinal barrier114,123.  
 
As such, neonates with delayed or dysbiotic colonisation of the gut may be at a greater risk of 
intestinal inflammation and injury due to an immature or defective intestinal barrier, which 
could allow the translocation of microbes, their products or toxins from the gut lumen124. 
This could explain why prolonged antibiotic treatment has been observed to have increased 
risk of late onset sepsis and NEC125, whilst infants administered probiotics were seen to have 
reduced incidence of NEC126. 
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1.3.1.6 Histology 
From a histological perspective, a large, retrospective clinicopathologic 10 year study 
performed by Balance et al33 analysed intestinal specimens from 84 infants with NEC; 64 
surgical and 19 from autopsies. They found that their observations were very similar to other 
bowel diseases known to be ischaemic in origin; diseases such as necrosis after mesenteric 
artery occlusion; embolic infarction; volvulus; and intussusception. They identified that 
coagulation (ischaemic) necrosis, inflammation, and bacterial overgrowth were all present in 
the intestine of nearly all patients. In many cases they were accompanied by idiopathic 
medical complications and variability of symptoms. 
 
TJs are an important component to the structural integrity of the gut barrier. These serve as a 
molecular fence that partitions the cytosolic membrane into apical and basolateral domains, 
which act to preserve the cellular polarity. In combination with transcellular transportation, 
these domains also generate distinct internal environments, function to strengthen the 
epithelial barrier, and prevent translocation of bacteria into the mucosa tissue.  
 
A decreased expression of TJ has been linked to increased intestinal permeability in NEC and 
other inflammatory intestinal diseases127,128. Altered expression and localisation of claudin 
and occluding proteins that form these TJs, have been observed in NEC and are associated 
with increased epithelial permeability127,129. 
 
As previously discussed, failure of the gut barrier function is known to cause systemic 
inflammation from translocation of bacterial products such as LPS. In preterm infants 
multiple stressors associated with prematurity (hypoxia, infections, treatment with 
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indomethacin and glucocorticoids) have been suggested to compromise TJs and therefore 
epithelial integrity107. 
 
Intestinal alkaline phosphatase (IAP) has been shown to detoxify LPS by dephosphorylating 
the lipid. This prevents LPS from binding to the TLR4 complex and replacement or 
supplementation of IAP has been shown to reduce the level of intestinal inflammation and 
endotoxemia130,131,132,133. 
 
1.3.1.7 Translocation 
Under normal conditions, microbes and their molecular products are prevented from moving 
through the epithelial barrier by a complex of tightly regulated cellular and molecular 
processes. However, as discussed, this complex has been shown to be weakened in premature 
infants both intrinsically, with immaturity in the tissue differentiation and low levels of EGF, 
and extrinsically via LPS exposure, TLR4, and PAF over-expression leading to inflammation 
cascades. Therefore, reduced intestinal epithelial integrity encourages the opportunity for 
bacteria, pathogenic or commensal, to translocate through the membrane. 
 
Bacterial translocation through the intestinal barrier subsequently leads to systemic 
inflammatory response, as seen in subjects with NEC. Evidence of the clinical impact of 
bacterial translocation was observed by O’Boyle et al who identified a significant increase in 
the post-operative sepsis of patients, who were observed to have bacterial translocation134 
upon undergoing a laparotomy procedure.  
 
The lack of identification of bacteria and endotoxins in portal blood and the development of 
the systemic inflammatory response system has suggested that bacterial translocation occurs 
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via a lymphatic route135. This response to extreme stress is characterised by an extremely 
large release of cytokines, endothelial cell damage, tissue oedema, increased tissue 
permeability, activation of the coagulation system, platelet aggregation, local tissue hypoxia 
with shunting, and a hypermetabolic state136.  
 
Bacterial translocation could indeed be a major component in the development of systemic 
inflammatory response system, however human studies addressing this question have been 
hindered by methodological issues due to serial cultures from mesenteric lymph nodes not 
being possible in humans. 
1.4 Risk Factors for Necrotising Enterocolitis 
1.4.1 Gestation/Prematurity 
As alluded to in the previous section, NEC has been defined as a multifactorial disease, with 
many potential mechanisms contributing to its occurrence. However, it is consistently 
associated with premature birth.  
 
An estimated 15 million infants are born preterm; this equates to 1 in 10 live births, with rates 
ranging from 5% in some European countries to 18% in some African countries137. The 
number of preterm births is rising; in Canada for example, rates increased from 6.6% to 9.8% 
for births under 36 weeks’ gestation, 1.7% to 2.3% at less than 34 weeks and 1.0 to 1.2% at 
less than 32 weeks138. 
 
This is confounded by the increase in survival rates in high income countries such as the UK 
and USA, which at the beginning of the 20th century had similar infant mortality rates to the 
African nations of 40 per 1000. By 1998 this was reduced to 15 per 1000 live births in the 
USA as neonatal care became more widely available137 and by 2008 in the UK, infant deaths 
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were reduced to 6 per 1000139. The most recent survey from the Office for National Statistics 
in England and Wales showed that this has been reduced to 4 deaths per 1000 by 2016140. 
 
Evidence from the UK and USA has shown that whilst there has been a significant decrease 
in the total infant mortality rate, there has also been a significant increase in the rate of NEC 
cases141. These statistics demonstrate that it is vital for the aetiology of NEC to be understood 
and successful treatments developed. However, if preterm births could be reduced this would 
also be a significant step in reducing the incidence of NEC. 
 
Factors leading to preterm birth can arise from maternal or foetal causes, which lead to 
induced labour, spontaneous preterm labour with intact membranes, and preterm premature 
rupture of the membrane (PPROM)142. The causes of preterm births differ by ethnic group 
with spontaneous preterm birth being associated most commonly with white women whilst 
PPROM is associated most commonly with black women143. 
 
1.4.2 Birthweight 
Shorter gestational durations are unavoidably linked to a lower birthweight. It has been 
commonly reported that NEC has a greater prevalence in infants of lower birthweights56,144,27, 
with the highest risk groups being observed between 750-990g. Infants born below 750g are 
less likely to survive and, therefore, are less likely to be diagnosed with NEC prior to other 
complications. Evidence suggests that risk factors vary with birthweight and gestational age, 
with more immature infants and lower birthweights developing NEC onset at significantly 
later ages. This is potentially due to the delayed development of the intestine and resulting 
microbiome, without which NEC cannot develop. 
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1.4.3  Microbiota 
As discussed previously, it is thought that an inappropriate inflammatory response is likely to 
be a major factor in the occurrence of NEC and therefore factors that contribute to this 
pathology are probable risk factors and should be considered in comparative analysis. Whilst 
immaturity of the gut and immune system are likely to be related to the decreased gestational 
duration, interaction with the gut microbiota is a key factor in many preterm morbidities such 
as NEC145. In the normal microbiota the relationship with the host forms a mutually 
beneficial relationship with the community, supporting important functions in obtaining 
nutrition146, angiogenesis147, and mucosal immunity38,148.  
 
Recent studies using molecular methods to profile the faecal microbiota of infants with NEC 
and infants who develop normally have suggested that the disease is associated with a 
different microbial community structure149,110,104,102,105. The preterm infant is exceptionally 
undeveloped relative to term infants and can be considered foetal in physiology in some 
regards. When considering the intestine, this includes limited contact with bacteria and food 
substrates, because these immaturities increase the likelihood of an exaggerated immune 
response to both commensal and pathogenic bacteria.  
 
This interaction between inappropriate colonisation of premature infant microbiota was 
hypothesised in 2001, and it was suggested that intestinal injury is a consequence of 
prematurity, enteral feeding, and bacterial colonisation93. In addition to the interaction with 
TL4 and Gram-negative bacteria, immature intestinal epithelial cells in rodents were 
observed to have significantly lower levels of I-kappa-B (IκB) genes which have been 
confirmed as key regulators of the NFκB-dependent inflammatory pathways. IκBα 
expression has been shown to inhibit the interleukin-8 (IL-8) response to bacteria in the 
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immature enterocyte cell line and therefore could suggest that the microbiota and the 
immature immune response have implications for the pathogenesis of NEC150. 
 
The preterm infant colonisation pattern differs from that of a healthy term infant because of 
factors associated with neonatal care. Significant contributors to the establishment of the 
microbiota include feeds, birth methods, and antibiotic administration. These should be 
carefully considered when making comparisons of the community structure of the gut 
microbiome. 
 
1.4.4 Mode of Delivery 
Delivery method has been shown to alter multiple factors associated with infants’ health and 
wellbeing. It has been shown that infants delivered vaginally have a greater likelihood of 
being born earlier, smaller, and with a higher prevalence of sepsis151. Early colonisation 
patterns interact with the intestinal mucosa to form an immune response towards homeostasis 
or dysregulation152,153,154 (Section 1.3.1.2). 
  
Neonates born by caesarean delivery have been shown to have different bacterial flora from 
that of those born vaginally. Klebsiella, Enterobacter, and Clostridium were seen to have 
increased abundances in those infants delivered by caesarean section155,156,157,158. This implies 
that the delivery method, which shapes the initial gut microbiota, may contribute to the onset 
of NEC due to an altered response and development pattern in infants delivered by different 
methods. 
 
The microbiota is clearly influenced by the mode of delivery but recent evidence suggests 
that the mode of delivery is not significantly associated with necrotising enterocolitis151. 
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However, infants were seen to be significantly different based on mode of delivery, 
particularly in relation to size and prevalence of sepsis151. It is important to remember that 
infants born by different methods are likely to have different colonisation patterns and that 
these should be considered carefully before conclusions are made. 
 
1.4.5 Feeding Ability & Regimes 
One of the key challenges faced by newborn infants, term or otherwise, is the transition from 
parenteral to enteral nutrition. The foetal gut is not inactive during pregnancy as it swallows 
significant volumes of amniotic fluid which contains proteins that can be digested and 
absorbed159. These peptides, together with the appropriate cell lines, have been identified in 
the human gut from 6 to 16 weeks after conception160. As gestation continues there are 
changes in the spectra of the molecular forms, with an alteration in the peptides present in 
different regions of the gut.  
 
This could imply that cells secreting these regulatory peptides are inducing growth and 
functional development of the foetal intestine. This is particularly apparent in the second 
trimester where the amniotic fluid has been shown to contain substantial concentrations of 
hormones and peptides. Amniotic fluid may therefore provide a vital role in the development 
of the gut in preparation for postnatal feeding. 
 
The foetal gut appears to be prepared for the intake of enteral feeds by the third trimester159, 
however after oral feeding is initiated there is an associated change of the gut both 
physiologically and morphologically.  
 
  29 
Evidence for the immaturity of the gut in preterm infants has been seen in the lower capacity 
for fat absorption (this can be compensated for by using medium-chain triglycerides) and a 
decreased absorptive capacity for carbohydrates161. Therefore, there is likely to be an 
association between issues in feeding and nutrient uptake in preterm infants, the type of feeds 
administered, and the development of a normal gut. 
 
This was aptly shown in a study by Berseth where early feeding of preterm infants enhanced 
the maturation of the small intestinal motor activity and peptide responses to food. 
Additionally, a delay in enteral feeding was shown to prevent normal maturation of the gut37.  
 
Many preterm infants who develop NEC are fed enteral milk feeds. When there is no 
introduction of maternal breast milk and infants are fed artificial formula exclusively, there is 
evidence of an increased risk of NEC36. This is likely to be due to breast milk containing 
many additional non-nutrient factors such as immunoglobulins, which are involved in 
intestinal adaptation, maturation, and improved enteral feed tolerance, and which provide a 
protective influence against infective and inflammatory agents162. 
 
This understanding of the protective effects of maternal breastmilk has been validated  in 
multiple studies163,164. In particular, Lucas and Cole showed evidence that infants who are 
exclusively fed human milk reduced the incidence of NEC prevalence observed from 3.4% in 
the control group down to 1% (Paired T-test; p-value = 9x10-3)165. 
 
Other differences have been observed with feeds and the development of NEC including 
timing of introduction of feeds and the volume of daily increments. Those infants who have 
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had feeds introduced earlier and feeding volumes advanced more quickly have been observed 
to have higher incidences of NEC166. 
 
1.4.6 Infection/Antibiotics 
Infections of premature infants, whether isolated to the intestinal tract or systemic, have been 
shown to spread NEC. It is unclear whether enteric infection is an instigator in the 
development of NEC. Although there is an abundance of bacteria in the premature intestine 
in early life167, which includes the evidence of Gram-negative sepsis, a positive blood culture 
from infants with NEC is uncommon168.  
 
A study by Bizzarro et al found that of 410 infants with NEC, 158 (39%) were diagnosed 
with at least one blood stream infection (BSI). Of these, 69 (43.7%) had infection prior to 
NEC onset (NEC-associated)169. Two thirds of those with NEC-associated infections were 
observed to have Gram-negative bacilli. This would suggest that infection as the precipitating 
factor in NEC is unlikely, although bacteria are clearly associated in the pathogenesis of 
NEC, as can be seen in Table 3 which describes all incidences of NEC with significant 
bacterial, viral or fungal associations. 
 
Although intestinal pathogens may contribute to NEC or NEC-like symptoms in animal 
models, and in some cases clinical outbreaks, there appears to be no evidence of their 
presence in the majority of NEC cases170. 
 
Epidemiological studies have shown a correlation between the duration of antibiotic courses 
and the occurrence of NEC. Prolonged antibiotic regimes immediately after birth may be 
associated with an increased risk of developing NEC171,172.  Though, these studies do not 
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necessarily demonstrate a direct cause and effect between antibiotics and NEC, they do 
suggest an impact on the microbiome composition. When making comparisons antibiotic 
usage should be considered carefully. 
Table 3 Species and references of bacterial infection association with NEC diagnosis. Adapted from 
Infectious Causes of Necrotising Enterocolitis173 
Bacterial 
 
Viral Fungal 
Clostridium spp. Astrovirus174,175,176 Candida spp33,177,178,179,   
Butyricum180,181,182,29  Cytomegalovirus183,184,185   
Difficile186,28,187 Coronavirus188  
Perfringens189,190,191,31 Coxsackievirus B2192,193 
Cronobacter (Enterobacter)  Echovirus194 
 
 
Sakazakii195,196,197,198 Human Immunodeficiency 
virus (maternal 
exposure)199,200,201 
Enterococcus (VRE)202 Norovirus203,204,205,204,206 
Escherichia coli169,207,208,30,209  Rotavirus210,211,211,212 
 
Klebsiella spp.213,214,59,215,207 Torovirus216,217 
 
Pseudomonas aeruginosa218,219,220 
  
Salmonella221,222 
   
Staphylococcus aureus (MRSA)223 
  
Staphylococcus epidermidis224,225 
  
Ureaplasma urealyticum226,227 
  
 
1.4.7 Other Factors 
Additionally there are other potential risk factors that could be considered niche groups, for 
example, prenatal course including maternal drug use (specifically cocaine)228, 
hypoalbuminemia229, hypoxic ischaemic encephalopathy, and respiratory distress 
syndrome230. 
1.5 The Diagnosis of Necrotising Enterocolitis 
NEC diagnosis is based on the presence of abdominal distention and infrequently in rectal 
bleeding (haem-positive or excessively bloody stools). Assessment of the infant is then 
performed by abdominal imaging and sepsis evaluation. Although individually the results of 
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these tests are non-specific findings, such as pneumatosis intestinalis, they are likely to be 
indicative of NEC and should warrant further investigation231.  
 
Radiographic analysis of the abdomen can confirm NEC diagnosis and follow the disease 
progression. NEC radiographic features can be abdominal gas patterns in the dilated loops of 
the bowel. Bubbles of gas in the small bowel wall are representative of pneumatosis 
intestinalis – this is primarily associated with Bell’s grade II or III. 
 
Following bowel perforation, pneumoperitoneum is typically present; this is indicative of 
Bell’s grade IIIB and associated with a substantial amount of intraperitoneal air. Bowels that 
remain in a fixed position, i.e. sentinel loops, are also suggestive of necrotic bowel and/or 
perforation when there is no evidence of pneumatosis intestinalis232.   
 
Portal venous gas was thought to be a predictor of poor prognosis and indicative of the need 
for surgical intervention. However, this no longer appears to be the rule as demonstrated by a 
prospective study of 194 infants with confirmed NEC. In this study, the survival rate of 
infants with portal venous gas treated medically was greater than those who that underwent 
surgery233. The decision to operate should, therefore be based on the severity of the NEC and 
not solely on the presence of portal venous gas. 
 
Abdominal ultrasonography is becoming increasingly popular in the diagnosis of 
NEC234,235,236,237. Ultrasound can identify intermittent gas bubbles in liver parenchyma and 
the portal venous system which is not possible using radiography. More severe NEC 
diagnostic signs include free gas, focal fluid collections, and increased bowel wall thickness 
and echogenicity235,237,238. 
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1.6 Management & Treatment of Necrotising Enterocolitis 
1.6.1 Immediate Supportive Management of Necrotising Enterocolitis 
The initial medical management of NEC includes  stabilisation of the infant and resting the 
intestinal tract, this means the immediate discontinuation of oral feeds for 10 days (nil by 
mouth) and aspiration of gastric contents, decompression of the stomach by nasogastric tube, 
fluid resuscitation, intravenous antibiotics for 7-14 days, and correction of metabolic 
abnormalities239. Broad spectrum antibiotics used are usually dependent on the local policy 
which is informed by the regional microbial flora. Anaerobic cover is used if there is 
evidence of perforation and/or systemic signs that would indicate severe disease240,241. 
 
In a survey on the management of NEC it was seen that two thirds of surgeons (52, 67%) 
kept patients on antibiotics for more than 7 days, whereas the remaining third (23, 34%) kept 
infants on antibiotics up to 7 days. Usually a combination of two, three or more antibiotics 
were administered242. Confirmation of NEC is then established through use of radiographs 
and histopathology (See Section 1.5). 
 
1.6.2 Surgical Treatment of Necrotising Enterocolitis 
Perforated necrotising enterocolitis is a major cause of death and morbidity in infants with 
NEC, between 30% and 50% mortality for those infants243. An appropriate means of 
mitigating this damage is vital in improving the survival rates of those infants with 
perforated, necrotic intestinal tracts.  
 
There are two options regarding the surgical treatment of NEC; peritoneal drainage and 
laparotomy. The standard approach for NEC infants with either a perforated or necrotic 
intestine is the surgical resection of viable intestinal tissue via laparotomy. However, in 
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critically ill infants this carries substantial risks. Peritoneal drainage is considered the less 
risky in providing some form of reduction in the symptoms244.  
 
It has been demonstrated that there is no significant difference between the peritoneal 
drainage and laparotomy and the mortality of infants at 90 days after operation. There were 
no statistical differences between rates of dependence on parenteral nutrition 90 days post-
surgery for those infants that survived245.  
1.7 Prevention of Necrotising Enterocolitis  
1.7.1 Feeding Methods 
Multiple analyses have shown that different feeding regimes have a significant impact on the 
incidence of NEC, these include increased use of human milk instead of formula milk, early 
introduction of feeds, and minimal enteral nutrition for infants with feed intolerance246. 
 
There is little consensus on the exact feeding regimes to use in reducing or treating the 
presence of NEC; most USA NICUs start parenteral nutrition on day one and the first enteral 
feed as soon as possible after birth, either as human milk or formula247. This is partly due to 
the higher nutrient requirement of preterm infants compared with term infants248. However, 
many of these decisions are not evidence-based but are derived from personal experience or 
unit culture. 
 
There is a wealth of data that supports the health benefits of human milk, with evidence 
suggesting that it decreases the incidence rates of sudden infant death syndrome, childhood 
infectious diseases, allergic diseases, food intolerance, inflammatory bowel disease, obesity 
and more249. 
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As described earlier, breast milk is abundant in EGF and amniotic fluid, these are both 
essential for intestinal development as demonstrated in rodent models 250,251,252. Studies using 
exclusive human milk regimes have shown a significant decrease in the date of onset and the 
postmenstrual age of NEC in addition to a significant reduction in NEC incidence165. Meta-
analysis of data from randomised control experiments also indicate that formula milk fed 
infants had higher rates of feed intolerance and NEC compared with those who were fed 
donor breast milk36. 
 
Other feeding treatments are also utilised. Nil by mouth is used by clinical staff to medically 
manage NEC patients in up to 50% of infants242. Additionally, increased incidence of NEC is 
associated with a more rapid rate of feeding in very low-birth-weight infants, and a slower 
feeding rate schedule failed to show an increase in NEC incidence253. 
 
1.7.2 Probiotic Management of the Gastrointestinal Tract 
Some centres try to influence the composition of the intestinal microbiota through probiotics. 
These are bacteria that are introduced into the body because they have beneficial qualities. 
These have been observed to reduce the incidence and mortality of NEC, however, 
determining the safest and most effective cocktail of microorganisms, especially without a 
fundamental understanding of the contribution of bacteria to NEC, is still difficult45. 
 
Probiotics have been shown to increase the quality of the intestinal mucus, improve motility 
of the gut, and control the production of inflammatory cytokines254,255. Probiotics have been 
observed to compete with pathogenic bacteria, limiting their potential overgrowth within the 
intestinal tract. Meta-analysis studies have demonstrated that probiotics can reduce the risk of 
NEC by ~65% and that treating 25 infants could possibly prevent 1 case of NEC45. Most of 
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these studies include a combination of Bifidobacterium with other taxa while those studies 
that contained no Bifidobacteria were not observed to benefit  the host255. 
 
1.7.3 Antibiotic Management of Secondary Sepsis 
Infectious complications of pregnancy, for example chorioamnionitis, increase the risk of 
NEC either by direct colonisation or by anatomical and immunological changes to the 
immature inflammatory cascade of the developing intestine226,256,257,258. However, 
independently proving the association between chorioamnionitis and NEC is a challenge as 
chorioamnionitis associated with prematurity. 
 
Medical management has been suggested to include broad-spectrum antibiotics based on the 
known sensitivities of prevalent pathogens associated with the NICU specifically. These 
should typically be ampicillin plus gentamicin to cover for common intestinal bacteria. The 
addition of a third antibiotic can provide more targeted anaerobic coverage should that be 
considered necessary. Piperacillin-tazobactam can provide an alternative that acts as a broad-
spectrum antibiotic but also includes typical anaerobes found in the intestinal flora173. 
1.8 Unmet Needs  
The association between NEC and the development of the microbiota in premature infants is 
based on the combined evidence that the premature infant immune system exhibits 
inappropriate responses to commensal and pathogenic bacteria7,68, in addition to the 
therapeutic effects of both probiotic259 and antibiotic regimes76, for infants diagnosed with 
NEC. 
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However, the interaction of internal and external factors influencing the microbiota and the 
intestinal tract are not fully understood and are likely to be vital in understanding and treating 
infants with NEC. Therefore, understanding how the preterm microbiota develops and how it 
changes in infants that develop with and without NEC will be crucial in advancing our 
understanding of this deadly disease.  
1.9 The Functions of the Gut Microbiota 
It was estimated that there could be as many as 100,000 genes within the human genome, but 
since the completion of the final chromosome in the Human Genome Project in 2005, it has 
been shown that this was a large overestimation and actually only 20,000 protein-coding 
genes exist260. Research into the human microbiome estimated that there are approximately 
3.8x1013 bacterial cells across the human body, with the majority being found in the gut261. 
Approximately 9 million bacterial genes found the adult human gut262 and evidence suggests 
that this microbiome can contribute a large number of genes to metabolic pathways required 
by the host263. This observation has sparked interest into how these bacterial communities 
found on or in our person, in these many different niches, are complementing the human 
genome264. 
 
It has only recently been possible to estimate the true structure of the microbiome 
communities because of the advent of higher throughput sequencing technologies. Prior to 
this, traditional methods were unable to cultivate the majority of microbial taxa within a 
community and sequencing was cost-prohibitive. However, since the emergence of the new 
sequencing technologies it has been possible to re-assess various diseases265, health issues266 
and agricultural267 challenges using the microbiome perspective. 
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It is widely estimated that between 1013 to 1014 micro-organisms reside in the human 
gastrointestinal (GI) tract, the largest bacterial niche on the human body, which constitutes 
the majority of all bacteria found on the human host. The size and diversity of the gut 
microbiome is directly linked to the multitude of carbon and energy sources available in 
conjunction with substrate availability and colonic transit time268. Therefore, understanding 
how this community develops, grows, and interacts with the host was considered a high 
priority in understanding many dietary related diseases.  
 
The European Commission and China initiated the Metagenomics project of the Human 
Intestinal Tract (MetaHIT)269. From 154 subjects it was possible able to identify 3.3 million 
microbial genes. These appear to be shared between American (>70%) and Japanese (>80%), 
adults, further confirming that the functions of gut micro-organisms are well conserved and 
serve to facilitate the metabolic processes occurring in the GI tract.  
 
1.9.1 Digestion 
One of the primary functions of the human gut microbiota appears to be to aid in the 
absorption of nutrients found in food sources that would otherwise be indigestible for the 
host. Bacteria within the gut provide access to metabolic pathways that have not been 
associated with human cell functions. As such, alterations to the community, both in terms of 
presence/absence and proportional abundances, have been linked to many changes to dietary 
functions and dietary-related diseases. 
 
The predominant phyla of a health gut microbiota are Firmicutes and Bacteroidetes. To a 
lesser extent Actinobacteria and Verrucomicrobia are also important members. Whilst this 
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composition is generally true in health individuals it is known to exhibit temporal and spatial 
differences in the distribution of genera or species270,271. 
 
The gut microbiota derives nutrients primarily from dietary carbohydrates.  One 
characteristic function of the adult microbiota is the fermentation complex carbohydrates that 
escaped proximal digestion into short chain fatty acids (SCFA), which have been observed, 
along with many other metabolites, circulating through the digestive system. The most 
abundant SCFAs in the intestine are acetate, propionate, and butyrate, mainly derived from 
carbohydrates272. Butyrate plays a significant part in regulating the epithelial and immune cell 
growth, in addition to apoptosis273. Evidence suggests propionate is removed by the liver and 
has implications in cholesterol metabolism, and acetate is oxidised in the brain, heart, and 
peripheral tissues274. This process of carbohydrate digestion is predominantly performed by 
colonic organisms such as Bacteroides, Bifidobacterium, Fecalibacterium, Enterobacteria 
and Roseburia275,276. The resulting oxalate in the intestine produced because of this 
carbohydrate fermentation and bacterial metabolism is utilised by organisms such as 
Oxalobacter formigenes, Lactobacillus and Bifidobacterium species277. 
 
The gut microbiota has also been shown to have positive impact on lipid metabolism through 
suppressing the inhibition of lipoprotein lipase activity in adipocytes. In particular 
Bacteroides thetaiotoamicron has been shown improve lipid hydrolysis efficiency by 
regulating expression of a colipase that is required for lipid digestion123. Amino acid 
transporters are found on bacterial cell walls that aid in the absorption of amino acids from 
the intestinal lumen into the bacteria where they are converted into small signalling 
molecules and antimicrobial peptides (bacteroicins). These functions work in tandem with 
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human proteinases and peptidases to increase the overall efficiency of protein 
metabolism278,279. 
 
Bacteroides have been implicated in the synthesis of conjugated linoleic acid. This is known 
to be antidiabetic, antiatherogenic, antibesogenic, hypolipidemic and it is known to have 
immunomodulatory properties280,281,282. Bacteroides intestinali, Bacteroides fragilis and E. 
coli have been shown deconjugate and dehydrate primarily bile acids, converting these into 
deoxycholic and lithocolic acids (secondary bile acids) in the human colon282. A normal gut 
microbiome has been shown to increase the concentration of high energy metabolism 
indicators, e.g. pyruvic acid, citric acid, fumaric acid and malic acid283. 
 
More recently the gut microbiota has been shown to be crucial in the breakdown of 
polyphenols in the diet. Polyphenolic secondary metabolites are present in a variety of plants 
and fruits. These usually remain inactive in the diet until they are biotransformed into active 
compounds after the removal of the sugar moiety, predominantly performed by the gut 
microbiota. Structural specificity of polyphenol and the richness of the microbiota is 
associated with the level of biotransformation that occurs in the intestine. The final products 
of these pathways are absorbed via the portal vein and travel to other tissues and organs, 
wherein they provide antimicrobial and other metabolic actions, including androgenic and 
hypolipidemic actions284. Primarily this has been shown to be performed by members of 
Bacteroides, Enterococcus, Clostridium, Bifidobacterium and Lactobacillus and to a lesser 
extent other genera285. 
 
There are clear implications for the microbiome and its influence on host dietary responses. 
These have been observed in individuals with high starch consumption maintaining a higher 
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copy number of the salivary amylase gene (AMY1) than those with low starch diets286. 
Another prime example of how diet and region can be a major factor in defining the 
community structure was seen in Japanese populations. A marine member of the 
Bacteroidetes, Zobellia galactanivorans, can process porphyrin derived from marine red 
algae from the Porphyra genus. Homologues of the gene from Z. galactanivorans were seen 
to be present in the microbiomes within the genome of Bacteroides plebeius. This gene was 
only found in the microbiome of Japanese citizens and not observed in the American 
microbiota. It has been suggested that this gene was obtained in B. plebeius through 
horizontal gene transfer (HGT)287. 
 
The microbiota has also been linked to health problems associated with diet. For example, 
differences were observed between female monozygotic and dizygotic twins where one twin 
was considered lean and the other obese. It was seen that the human gut microbiome was 
shared among family members, however each host’s microbiome was seen to vary in specific 
bacterial lineages present. Obesity was correlated with phylum-level changes in the 
microbiota, reduced bacterial diversity, and altered representation of bacterial genes and 
metabolic pathways288. 
 
Within term and preterm infants, feed type has been shown to influence the composition of 
the gut microbiome. Increased levels of Bifidobacteria and lactic acid bacteria dominate the 
microbiota of infants fed breastmilk. In contrast, those infants administered formula feeds 
were seen to be more diverse and had higher numbers of facultative anaerobic bacteria such 
as Staphylococci, Streptococci and Enterobacteriaceae289,290,291,292. 
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1.9.2 Immune Response 
The microbiome has been shown to have important roles in priming the immune system as 
the ability to use macronutrients, i.e. dietary nutrients required in large quantities, has been 
seen to be essential in the production and maintenance of a protective effector immune 
response. For example, T-cells are fundamental in recognising antigens presented on 
potential pathogens, and therefore are integral to the recognition and creation of a 
downstream lymphocyte response293. It has been observed that upon stimulation, T-cells 
exhibit an increased uptake of glucose and amino acids and, conversely, a deficiency in 
glucose or amino acid uptake has a negative impact on the T-cell functions294,295.  
 
SCFAs demonstrate the implications of nutrient processing by the microbiota community and 
host diet in the formation of an immune response. SCFAs are bacterial end products from 
macronutrient fermentation, predominantly plant polysaccharides that cannot be digested by 
humans because of the lack of glycoside and polysaccharide hydrolases269. The concentration 
of intestinal SCFAs in the intestinal lumen can be altered depending on the intake of fibre by 
the host, which in turn affects the composition of the microbiota296. In conjunction with 
providing an energy source, SCFAs have been seen to have a clear influence on the host’s 
immune response. Butyrate at low levels is known to modify the cytokine production of the 
T-cells and promote the intestinal epithelial barrier integrity297. 
 
1.9.3 Competitive Inhibition 
The various different microbiotas found on the human body have been implicated in 
competitive inhibition of pathogenic strains. One example of this concerns the notoriously 
persistent gut pathogen Clostridium difficile, which has been shown to be extremely resistant 
to antibiotic treatments298. The infection rates for C. difficile have been observed to increase 
  43 
in both frequency and severity, therefore a treatment option which is not based on antibiotic 
administration is considered ideal.  
 
Faecal microbiota transfer, that is using the faeces of a healthy human host to supplement the 
infected host microbiome, has achieved therapeutic success rates in excess of 90% for 
subjects who had recurrent C. difficile infections299. This was not possible with antibiotic 
administration which could, potentially, have only encouraged the development of highly 
resistant strains within the affected individual’s microbiome and reduced the competitive 
inhibition within the bacterial community300. 
1.10 Establishment and Development of the Gut Microbiome 
The establishment of the gut microbiota is a complex process influenced by microbes with 
external and internal factors of the host. Factors such as the mode of delivery, the type of 
diet, and host immune responses have been shown to influence the establishment, 
development, and stability of the community. It was thought that both term and preterm 
infants were essentially born sterile, however there have been studies disproving this, with 
evidence of bacterial translocation in utero,301 and the presence of microbial life in the 
preterm infants’ meconium302.  
 
More recent studies have started to refute the long held assumption that linked periodontitis 
with the risk of spontaneous preterm birth, abortion or miscarriage, and with bacterial 
colonisation of the placenta. This assumption was based on the hypothesis that circulating 
endotoxin in the maternal blood reaches the foetus through the placenta and initiates an 
inflammatory cascade, triggering preterm labour303. 
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Stout et al demonstrated that 27% of 195 infants were seen to have intracellular bacteria 
found in the placental basal plate304. Within the study, it was shown that this bacterial 
presence occurred in both preterm and full-term gestations. However, there was a greater 
proportion of preterm infants with confirmation of placental microbiota. 
 
Two studies that could be compared were those of Di Giulio et al and Han et al who analysed 
women with spontaneous preterm labour by both culture-based and DNA-based methods 
(Supp. Table 1)305,306. Within term infants Firmicutes, Tenericutes, Proteobacteria, 
Bacteroidetes, and Fusobacteria phyla have all been identified as commensal non-pathogenic 
bacteria from the placental tissue, which were considered to be a metabolically rich 
community307. In preterm infants the species colonising the placenta were observed to have a 
greater association with the oral cavity than with the urogenital tract306. 
 
An important aspect of the development of the normal microbiome is how the maternal 
microbiota is passed on to the infant. This is understandably promoted by close proximity of 
the mother to the child and is primarily initiated upon passing through the birth canal, where 
there is an abundance of bacteria308.  
 
Directly after birth it is possible to detect the prevalence of Lactobacillus, Prevotella or 
Sneathia on the infant’s skin, oral mucosa, and nasopharyngeal aspirate, in addition to the 
first meconium309. Whilst the vaginal microbiome is predominantly Lactobacillus spp.310, it 
has been shown that the Lactobacillus do not actively colonise the infant intestinal tract, but 
rather it is the maternal faecal bacteria, namely the Enterobacteriaceae and Bifidobacteria, 
that initially colonise those infants delivered vaginally156. In contrast, infants born by 
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caesarean section harbour bacterial communities similar to the skin microbiota of the 
mother309. 
 
In a relatively short time frame the vaginally delivered infant develops its first gut 
microbiome, comprising predominantly enteric organisms. In comparison, those infants 
delivered by caesarean section were seen to have reduced richness and diversity within their 
gut microbiome communities up to four months of age42. 
 
Throughout the first year of life, the infant gut is colonised by blooms of microbes, most of 
which are anaerobic or facultative anaerobes; this is due to the lower gastrointestinal tract 
being highly anoxic. Initial colonisation is thought to be predominantly facultative anaerobes 
such as Staphylococcus, Streptococcus, E. coli and Enterobacteria. These consume 
oxygen,311,312 creating an environment suitable for the obligate anaerobes, primarily 
consisting of Actinobacteria and Firmicutes313.  The term infant microbiome reaches maturity 
at approximately three years of age, at which point it becomes relatively stable and resembles 
that of the adult microbiome44,311. 
 
Feed types also influence the composition and development of the microbiome, especially 
during the first six months314. During this time infants are exclusively milk-fed and after six 
months they are given complementary foods315. Increases in the proportion of complementary 
foods in the diet should be made up to 12 months of age, at which age it is expected that 
infants be exclusively fed solids. These changes have been reflected in studies which have 
shown that alterations in the microbiota correspond to key changes in the diet of the host316. 
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Breast milk and formula milk-fed infant gut microbiotas have differences in the bacterial taxa 
identified within their communities and their relative abundances. Breast milk-fed infants 
were observed to have approximately twice as many intestinal bacterial cells, but with lower 
diversity relative to those infants fed formula feeds317.  
 
Breast milk, unlike formula milk, is found to be high in human milk oligosaccharides 
(HMOs), which are broken down into SCFA which promote the growth of Bifidobacteria and 
Lactobacillus. Additionally, breast milk contains maternally generated antibodies, 
immunoactive compounds, growth factors, and antimicrobial enzymes, all of which have a 
beneficial impact on the infant’s health318. The probiotic effect of breast milk results in a 
colonisation pattern that appears to prepare the innate and adaptive mucosal immune 
phenotype by communication between molecular patterns on colonising bacteria and pattern 
recognition receptors such as TLR4319.  
 
In breast milk-fed infants, the dominant Actinobacteria are Bifidobacterium species, 
predominantly B. breve, B. dentium, B. infantis, B. longum and B. pseudocatenulatum292,292. 
The majority of the Firmicutes present are lactic acid bacteria in the form of Lactobacillus, 
Clostridium, and Enterococcus313,320.  
 
One study has shown that infants fed breast milk had twice the number of Bifidobacterium 
compared to formula-fed infants317. Formula feeding has been shown to correlate with greater 
abundances of Atopobium321, which are linked to additional factors such as antibiotics 
administered to the mother and delivery by caesarean section. While there is evidence of 
breast feed infants having a dominance of Bifidobacterium species other conflicting studies 
have demonstrated that formula-fed infants have a dominance of Bifidobacterium spp. 
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compared with breast milk-fed infants292,321,322. These conflicting reports demonstrate how 
difficult it is to attribute species to environmental factors. 
 
Increased abundance of Bacteroides spp. and members of the Enterobacteriaceae were also 
reported in formula fed infants292,322. Despite evidence suggesting the importance of 
Bifidobacterium as an initial coloniser of the gut, it was reported to be absent in significant 
portions of some formula-fed infants’ guts311. This could be due to influences such as 
antibiotic administration, or the mixture of breast and formula feeding regimes within the 
study; however the variability may also be linked to the variation of different formula milks. 
 
Formulas supplemented with prebiotics may account for high levels of Bifidobacterium found 
in many formula-fed infants323,324. A recent report on these prebiotics found that they had 
very similar levels of Bifidobacterium relative to those of infants fed human breast milk, and 
additionally these groups were reported to have ~20% greater relative abundance in relation 
to traditional, formula-fed infants325. The maternal diet may also have an impact on the 
bacterial abundances of infants when they are breast fed326.  
 
Between one to two years of age, the infant gut microbiome alters dramatically for a second 
time as it develops into the stable adult microbiome327,320. It was suggested that, although 
there were clear differences in the microbiome before and after weaning, characteristics of 
earlier colonisation events (e.g. delivery method and feeds) were still present within the 
community321. However, prior to the introduction of solid food diets, breast fed infants from 
different geolocations were seen to cluster together, indicating similar community structures 
irrelevant of location. However, following weaning, infants were seen to cluster into distinct 
geographic groups327. 
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This significant shift was also observed in a cohort of 330 Danish infants, which reported that 
between 9 and 18 months the infants’ microbiomes changed and that this could be correlated 
to the introduction of solid foods. Specifically, Bacteroidetes and Firmicute species were  
seen to increase in abundance, whilst there was a corresponding decline in Bifidobacteria, 
Lactobacillus, and Enterobacteriaceae320. 
  
Butyrate producing taxa were also observed to increase in abundance. These taxa are known 
to be instrumental in the breakdown of indigestible complex plant polysaccharides and 
starches328, which are major constituents of human diets.  
 
The final major change in the gut microbiota community occurs between 18 and 36 months. 
This change results in a stable microbial profile consisting predominantly of Bacteriodetes 
and Firmicutes. This is a temporal change that is representative of the continued variation in 
the solid food diet occurring in the infant’s early life320,321,328.  
 
The proportions of Firmicutes and Bacteroidetes were observed to be strongly influenced by 
diet. This was aptly demonstrated by De Filippo et al where they described the different 
microbiotas of children with very distinct dietary habits. They demonstrated a clear 
dominance of Prevotella in African children, although these taxa were completely absent 
from Italian children327. 
 
This was also detailed in a case study which demonstrated that the introduction of peas, 
formula, and other solid foods resulted in a co-dominance between Firmicutes and 
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Bacteroidetes, with the introduction of plant polysaccharides being linked to increases in the 
abundance of Bacteroidetes328. 
 
The typical adult microbiome usually consists of six or seven bacterial phyla, dominated by 
Bacteroidetes and Firmicutes329, and also includes Proteobacteria, Verrucomicrobiota, 
Actinobacteria, and Euryarchaeota. A five year study of 37 adults suggested that 60-70% of 
the bacterial strains present in the gut microbiome remained unchanged over the duration of 
observation330. This study also suggested that Firmicutes and Proteobacteria were much more 
susceptible to perturbations of the community, whereas Bacteroidetes and Actinobacteria are 
stable. These findings appear to agree with earlier studies using microarray-based 
approaches4. 
 
When health declines with age, so too does the gut microbiome, developing increased 
instability and a decrease in diversity. However, if health remains intact, the microbiota 
maintains the stability and structure of a young, healthy adult331. 
 
The most significant factors associated with age related declines in the microbiota health 
appear to be physiological changes, dietary choices or malnutrition, location (e.g. 
community-dwelling, hospital duration or long-term care) and the use of prescription drugs 
and antibiotics332,333,334,335. 
1.11 Diseases associated with Microbiome Dysbiosis 
Whilst NEC is the subject of this investigation, there are other disorders associated with the 
microbiome of infants and adults that exhibit similar effects on the gastrointestinal tract. 
Many of these appear to be influenced by the recent changes in western diets, which have 
altered the composition of the microbial community and its associated metabolic functions336. 
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These changes in the microbial community are considered to contribute to the increased 
incidence of epidemics in chronic illness throughout the developing world. This includes 
obesity, inflammatory bowel disease, cardiovascular disease, and Clostridium infections6. 
 
In subjects with obesity, it has been observed that the gut microbiome has a greater 
proportion of Firmicutes relative to Bacteroidetes337 compared to lean controls. Models 
suggest that the community in obese subjects has an increased capacity to harvest energy 
from the diet, a trait which appears to be transmissible by faecal transplantation338. 
 
Cardiovascular disease has been linked to an inability to metabolise phosphatidylcholine into 
the proatherosclerotic metabolite trimethylamine-N-oxide (TMAO). This has been shown to 
result in an increase of TMAO in plasma levels and is associated with an increased risk of 
cardiovascular complications in patients at risk339,340. Metabolites of phosphatidylcholine 
were associated with macrophage scavenger receptors linked to atherosclerosis. These studies 
suggested that a potential method to reduce cardiovascular issues in mice could be through 
dietary changes that promote a gut microbiome with a lower rate of phosphatidylcholine 
metabolism. 
 
Irritable bowel syndrome (IBS) has been associated with gut microbiota dysbiosis. 
Treatments directed at the microbiome are sometimes helpful. These include dietary changes, 
probiotics and antibiotics341. 
 
Changes to the diet were observed to decrease the severity of symptoms of IBS when subjects 
avoided fermentable oligosaccharides, disaccharides, monosaccharides, and polyols342. These 
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changes subsequently altered the composition of the gut community by reducing the total 
bacterial abundance along with the structure of the faecal microbiota. This specialised diet 
was associated with specific stimulation of the growth of bacterial groups thought to have 
health benefits12. 
 
Clostridium difficile infection is a well-studied example of how a dysbiotic microbiota can 
result in a devastating human disease. C. difficile is a very resilient opportunistic pathogen, 
which is known to be resistant to antibiotic administration343. The symptoms of the infection 
appear to be related to changes in the human gut microbiome which can be rectified through 
the use of human faecal transplantation344.  
 
Treatment by transplantation of a healthy microbiome into a subject with C. difficile infection 
proved to be effective in treating the infection in 90% of subjects. Analysis after the faecal 
transplantation demonstrated that subjects which previously had C. difficile infection now 
had a microbiota that closely resembled that of the donor. Changes in the microbiome during 
C. difficile infection appeared to promote a metabolome that supported C. difficile 
germination and growth345. 
 
These studies demonstrate that the microbiota impact on the host’s health and wellbeing. 
Many of the factors that influence the establishment and development of the microbiota are 
considered important risk factors in the development of NEC.  
 
Investigations into the microbiota are important in our understanding of the implications it 
may have on the development of NEC. There are clearly many environmental factors that 
result in highly idiosyncratic community structures. An individual’s microbiome appears to 
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be unique and there is a growing interest in the use of metabolomics within the field of 
forensics346.  
 
Therefore, it is important to understand that large scale cohorts will be required to establish 
not only the important factors that influence and shape the premature infant microbiome, but 
also what the impacts of these are on the occurrence of NEC. The development of high 
throughput sequencing technologies has now made it possible to perform these large scale 
comparisons within a reasonable budget. 
1.12 Analysis of the microbiome 
1.12.1 Microbial Culturing 
Originally, the only means of establishing which bacteria were present within an environment 
involved the culturing of organisms from samples. This is a particularly difficult means of 
profiling the gut community for two reasons, the first being that after initial colonisation of 
the gut, it is primarily populated by obligate anaerobes which require sophisticated equipment 
to cultivate. Secondly, the exact culturing requirements for many bacteria species within the 
community are unknown and would need to be established through substantial trial and error 
experiments. 
 
It has been shown that culture-dependent techniques are able to successfully identify the 
dominant microbes present in the instances of acute infection, but there is evidence that these 
techniques fail to identify pathogens due to a lack of growth or because pathogen growth was 
misclassified as oral flora347. This is also exacerbated in metagenomic analysis of 
taxonomically rich samples as those species that grow readily on cultures, such as E. coli, 
will be easily detected and cultured. In the past this led to E. coli being considered a 
significant member of the gut microbiome, however only since the introduction of culture-
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independent techniques was it known that Gammaproteobacteria, of which E. coli is a 
member, represent less than 1% of the community348. This reduction in E. coli is due to the 
reduction in oxygen that results from their metabolism favouring their replacement by strict 
anaerobes349. 
 
The use of culturing techniques to profile communities is both ineffective and inefficient 
compared with modern culture-independent methods, but these techniques still represent an 
important and cost effective role in diagnostics. Primarily, this is when the phylogeny of the 
bacteria is known along with its particular nutrient and culturing requirements. However, 
culture based approaches are confirmatory techniques as they assume that the investigator 
knows either what bacteria they are looking for or growth conditions suitable for the bacteria 
and as such are not a hypothesis free approach that are likely to introduce biases. 
 
1.12.2 High throughput Sequencing 
High throughput sequencing became particularly prevalent in the second generation of DNA 
sequencing technologies, at which point parallel sequencing methods were developed, 
initially by 454 (later purchased by Roche). In particular, the sequencing by synthesis method 
designed by Solexa and subsequently acquired by Illumina40 was the one of the most 
successful means of sequencing designed in this generation. 
 
The fundamental mechanism was the use of adaptor-annealed DNA molecules and, by 
binding them to a lawn of complementary oligonucleotides, it was possible to then perform 
solid phase polymerase chain reaction (PCR) to produce neighbouring clusters of clonal 
populations from each of the individual DNA strands350,351 (Figure 2). In this manner the 
process could be parallelised, greatly increasing the amount of DNA that could be sequenced 
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in one run352. This process was called ‘bridge amplification’ due to the replicating DNA 
strands arching over in order to prime the next round of polymerisation. This method uses 
fluorescent ‘reversible-terminator’ deoxynucleotides (dNTPs) which prevent the binding of 
further nucleotides until the fluorophore is cleaved away, meaning that sequencing occurs in 
a synchronous manner353. After each cycle the identity of the nucleotide is established by 
exciting the fluorophore using lasers and monitored by a charge-coupled device. After this 
enzymatic cleavage of the blocking fluorophore, further synthesis is performed. 
 
Figure 2 Diagram of illumina flow cell bridge amplification of DNA sequences used in illumina high throughput sequencing 
Subsequent generations of this technology and the chemistry underpinning it have produced 
greater read lengths and depths, as well as lower costs both in terms of running the machines 
and the machines themselves. In particular, the Illumina MiSeq provided a very low point of 
entry for inexpensive rapid sequencing of samples354. These technologies, in conjunction with 
culture-independent techniques for microbial profiling, have enabled previously 
unapproachable, large scale, metagenomic analyses.  
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1.12.3 16S rRNA Gene Sequencing 
Identifying a universal consensus genomic sequence within bacteria that maintained enough 
variability to categorise specific operational taxonomic units (OTUs) was also pivotal in the 
creation of assays that could profile a metagenomic community from a sample. The use of the 
16S rRNA gene in this context was first established by Carl Woese in the 1980s, when he 
demonstrated the use of this gene in the identification of bacterial taxa355.  
 
Using universal primers on conserved regions of the 16S rRNA gene it is possible to amplify 
the nine hypervariable regions within this subunit356 (Figure 3). These sequences 
demonstrated a high degree of interspecies variability that could be compared with known 
references within a database. In this manner, it was possible to provide taxonomic 
identification of sequences amplified from a sample39. 
 
Analysis of 16S rRNA gene sequences within faecal samples has become the main means of 
generating non-culture based taxonomic data relating to the composition of the gut 
microbiota94,329,357,358,359. These techniques have enabled scientists to estimate the microbial 
diversity and dominance within the community and identify specific differences in the GI 
tract of subjects both in healthy, normal development as well as in diseased states.  
 
Whilst these nine hypervariable regions allow for large scale taxonomic identification of 
bacteria from environmental samples, they differ in length, position, and taxonomic 
discrimination360.  Selection of which region to analyse on the 16S subunit ultimately 
influences the experimental approach, costs and taxonomic bias,361,361 and resolution362. 
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Figure 3 Diagram of the process for taxonomic identification of bacterial taxa (OTUs) from a single 
sample. (1) Bacterial cell extraction is initially performed on the environmental sample, resulting in a 
mix of bacterial species. (2) Bacterial cells are lysed and DNA, chromosomal and ribosomal, is 
purified. (3) PCR Primers designed to anneal to the neighbouring conserved sequences of RNA 
amplify across the variable region, V4 in this project, producing V4 amplicons that can be used to 
identify bacterial OTUs when compared against known databases. 
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1.12.4 16S V4 Amplicons: Strengths & Weaknesses 
The V4 region in particular has benefits over the other eight hypervariable regions of the 16S 
subunit. Specifically relating to large scale projects, the V4 amplicons are short enough in 
length (~395bp) for the Illumina MiSeq machine through the use of paired-end read 
sequencing (2x250bp), resulting in an overlapped sequence length of 500bp (including 
adaptors, barcodes, and a known overlap region). It was shown that the topology of trees 
using the V4 region were seen to have the least geodesic difference to trees constructed using 
all the sub-regions. Overall these results supported the use of the V4-5-6 regions as the 
optimal combination363.This same study also demonstrated that the V4 region tree topology 
was the most closely related to the tree topology from all sub-regions of the 16S sequence 
when estimated by their relationship in agglomerative hierarchical clustering. In contrast the 
V2 and V3 sub-regions were seen to be outliers in this same analysis. V4 rRNA sequence has 
also been shown to be extremely effective at resolving enteric bacteria such as Firmicutes and 
Bacteroidetes364.  
 
By annealing known sequences onto the amplicon it is possible to tag samples with specific 
DNA barcodes, a method termed multiplexing41. This enables the loading of multiple 
samples onto a single sequence run and dramatically reduces the cost of large scale 
sequencing projects.  
 
It has been shown that the V4 region of the 16S subunit can provide minimal taxonomic bias 
when amplified but still fails to annotate many species when compared to a mock community 
(Supp. Table 2)362. However, on a large scale, within a reasonable time frame and cost, this 
region was shown to ascertain the majority of species likely to be present with the human gut 
microbiome.  
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1.13 Prospective Cohort Design 
One of the most popular means of establishing factors that influence the outcome of diseases 
or disorders are cohort studies365. These involve longitudinal study sampling of a cohort, with 
a cohort being defined as a group of people sharing a defining characteristic. This 
characteristic is usually a common event in a selected period, e.g. birth or puberty.  
 
Cohort studies are a form of panel study. These panel studies are a specific design of 
longitudinal analysis in which the unit of interest is distributed over intervals of time. Within 
these studies all participants must be at risk of developing the outcome being investigated. 
This outcome needs to be clearly and unambiguously defined prior to the start of the 
investigation. 
 
Cases will be defined from the outset of the investigation and usually under highly stringent 
diagnostic criteria used in the medical diagnosis of the disease. Controls are more 
complicated in cohort studies, these should closely resemble cases in all important respects, 
often termed ‘risk factors’, without actually developing the disease. Ideally controls are 
internal and sourced from subjects from the same time and/or place. 
 
Cohort studies should define the outcomes in advance of the study in a clear, specific and 
measurable manner. These outcomes should be comparable in both the control and case 
subjects in every way. Failure to define the objective outcomes leads to uninterpretable 
results.  
 
The outcome information can be from many sources; in many cases the most information rich 
data is identified within clinical information. However, the validity of clinical information, 
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especially when it is sourced from multiple sites or collaborators, can be highly variable. 
When outcomes are from multiple sources it is important that they are graded, e.g. 
“Definite”, “Probable” or “Suspected”. 
 
It is important to ensure that participants are tracked over the duration of the study, this is 
vital not just in the sampling period but also after to ensure that subjects do not develop 
characteristics that that could influence the outcome of the study. 
 
Reporting in cohort studies is often unsatisfactory365. An investigator should be able to 
convince the audience that the exposed and unexposed groups are indeed as similar as 
possible in all critical factors that influence the outcome. Therefore, reporting the 
demographic and other prognostic factors for both groups is vital in instilling confidence in 
the study to establish whether any differences observed are attributable to the dependent 
variable. 
 
When analysing a dichotomous outcome, i.e. sick or healthy studies, the investigator should 
provide raw data that is sufficient for the reader to be confident in the conclusion of the 
study. For incidence rates the value is expressed per unit of time and the relative risks and 
confidence intervals should be provided. Like any observational experiment, cohort studies 
should articulate the biases that are present and how these could influence or skew the results 
of the study.  
 
Prospective cohort design is well suited and has been performed many times in the study of 
NEC. This is because the study of NEC is appropriate for prospective cohort studies due to its 
clear definition, albeit with multiple levels of severity, in which infants can be diagnosed by 
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an experienced physician. Also, as NEC occurs almost exclusively in premature infants, who 
invariably stay in an NICU, it is easy to prospectively enrol infants by approaching the 
parents prior to birth or complications. This also allows for the establishment of a large 
control cohort with relative simplicity as those infants found in the same NICU environment 
are likely to be adequate candidates for control assignment.  
 
The hospital environment in conjunction with NHS  patient records allows for the curation of 
many data points that could be influential in the development of NEC, for example feeding 
regime, delivery method or gestational duration. This suits prospective enrolment design by 
providing a rich, accurate source of data for assignment of controls to NEC cases. 
 
Sample collection was also well suited to this design as the experimental requirements for 
sequencing the faecal DNA required only a small quantity of faecal matter (less than one 
gram). This could be easily obtained simply by transferring the contents of the nappy into an 
appropriate container and storing at -20°C. This meant that large scale sampling could be 
performed with minimal impact on staff working in the NICU environments and kept in 
conditions that were relatively cost effective and appropriate for DNA storage until the 
samples were required. 
1.14 Hypothesis, Aims and Objectives 
The hypothesis proposed was that the microbiome of infants with NEC differs from non-NEC 
controls around the date of diagnosis. Any differences observed within the microbiome of 
infants with NEC could be used as potential prognostic biomarkers, whereas differences 
observed between controls could be indicative of a natural microbiome structure.  
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The first aim of this project was to identify key risk factors associated with NEC. The first 
objective was for those that infants that corresponded to worst bells grading III to be selected 
as cases. Analysis of the control cohort was performed on all known risk factors assigned 
statistical weighting by medical and statistics experts. The most appropriate controls were 
then assigned to NEC infants according to those risk factors. This ensured minimal 
discrepancy between control and NEC infants for those factors most likely to be associated 
with NEC. 
 
The second objective to this aim was to establish those risk factors that were most influential 
in the community structure of the gut microbiome. To do this, local contributions to beta-
diversity (LCBD) values were used to quantify changes in the community composition and 
enabled those changes to be interpreted as a function of time. Infants were then grouped 
according to those risk factors that were influential.  
 
Following control assignment and sample extraction, the second aim was to establish 
differences between the microbiota of NEC and control counterparts. The first objective of 
this aim was to analyse the community structure using non-metric multidimensional scaling 
(NMDS) principal component analysis to observe whether the community structures 
clustered for case and control infants. The second objective was to analyse taxa that were 
seen to be significantly different between case and controls over time. The final objective was 
to utilise machine learning techniques in order to establish the genera that acted as the best 
predictors of NEC. These techniques were to be applied at the species level to establish any 
potential pathogens. After subsets were analysed they were to be compared against the whole 
cohort in order to establish conserved changes across all subsets. 
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2 Methods 
2.1 Project Initiation 
This project was led by Professor Andy Ewer at Birmingham Women’s Hospital and the 
University of Birmingham. This microbiome study built on the study of the neonatal 
metabolome in neonatal infants developing NEC by Professors Ewer and Probert. Their study 
suggested new, non-invasive methods that could be utilised in the diagnosis the disease 
through the detection of volatile organic compounds366. 
2.2 Approvals 
The study was approved by the West Midlands Research Ethics Committee (11/WM/0078) 
and sponsored by University of Birmingham. Samples were stored and disposed of in 
accordance with the Human Tissue Act (2004)367. 
2.3 Centres  
Eight NICUs took part in this study. They were responsible for acquiring faecal samples from 
the babies they managed. The NICUs were based in Birmingham Heartlands Hospital (BHH), 
Birmingham Women’s Hospital (BWH), Liverpool Women’s Hospital (LWH), Royal 
Shrewsbury Hospital (RSH), Royal Wolverhampton Hospital (RWH), Sheffield Teaching 
Hospital (STH), University Hospital of Coventry and Warwickshire (UHCW) and the 
University Hospital of Leicester (UHL). 
2.4 Recruitment 
All children born before 34 weeks gestation were eligible. 
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Parents were approached by nursing staff trained in good clinical practice and the aims of the 
study explained. Parents gave consent, on behalf of their children, for the collection of faecal 
samples on a daily basis and for the retention of demographic and clinical data. Samples were 
all subjected to the same SOPs.  
 
Enrolment was initiated in 2010 and closed in September 2014. 
2.5 Sampling & Storage 
2.5.1 Sample Collection 
Sampling was performed after confirmation of written consent.  
 
Each day stools were removed from the infant’s nappy using a plastic spoon; if the stool was 
in liquid form it was removed using a syringe. The stool was then transferred to a glass vial 
and the syringe/spoon discarded appropriately. Samples were labelled with a study number, 
the date-time of collection and then stored in -20°C freezers. If the infants had not passed 
stool over a 24-hour period, this was noted.  
 
Samples were transported to the University of Liverpool by private courier, on dry ice, in 
accordance with The Control of Substance Hazardous to Health (2002) as well as the 
following: Health and Safety at Work Act 1974.; Personal Protective Equipment at work 
2002.; The Policy for Effective and Appropriate Hand Hygiene. Birmingham Women’s 
Hospital 2nd March 2010; The Policy for the use of gloves in the clinical area. Birmingham 
Women’s Hospital, December 2008.  
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2.5.2 Sample Storage 
In total 13,434 samples were stored at the University of Liverpool in -20°C freezers located 
in CATII laboratories. Ideally -80°C storage would have limited the effect of degradation of 
bacterial DNA368As the degradation in any one sample should be observed across all 
samples, comparison within this dataset was considered acceptable. Freezer doors were 
secured with key or combination locks only accessible to researchers directly involved within 
the project. Locations of samples were maintained within the MySQL database for future 
reference. The temperature of each freezer was monitored using an independent thermometer 
with automated emergency contact capabilities. 
 
2.5.3 Sample Disposal 
Samples no longer required were anonymised, autoclaved and incinerated according to 
standards set by the Human Tissue Act of 2004. 
2.6 Patient Information & Sample Management 
2.6.1 Clinical and Demographic Data Collection 
Demographic data was collected on all infants, including: sex, date of birth, discharge/death 
date, location of birth and the NICU in which sampling took place. Additional details relating 
to risk factors for NEC were recorded: birth weight, gestational duration, antibiotic 
administration, feed type, mode of delivery and severity of NEC were included.  
 
Information that could confound comparisons between disease and controls was also 
collected, such as medical complications or interventions, surgical procedures and the 
number of blood transfusions administered. All medical information including backups were 
anonymised and encrypted on private computers with limited user access, extensive password 
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security and redundancy in the event of theft i.e. remote monitoring, locating and disk 
formatting. 
 
2.6.2 Formatting patient information 
All clinical and demographic data were standardised manually whilst dates and times were 
formatted by automated custom Perl scripts. After formatting all personal and medical 
information was aggregated into a single text document. MySQL database was created from 
patient medical data in a relational data (Supp. Fig 1). The parent table, basic_info, contained 
a unique ID for each patient and some essential information, this was linked to tables specific 
for antibiotic information, feeding regimes, NEC details, transfer, medical and surgical 
information and sample details. Formatting this data in a relational database enabled highly 
specific filtering and fine grain sub-setting of patients based on medical criteria, extent of 
sampling and experimental data. 
  
2.6.3 Defining Critical Risk Factors Associated with Necrotising Enterocolitis & 
Statistical Weighting 
To perform control matching for each NEC subject clinical staff including Prof Ewer, Prof 
Probert, Sisters Elizabeth Simcox and Rachel Jackson were consulted regarding risk factors 
associated with NEC from a clinical perspective. Then, each risk factor was assigned a 
weight with advice from the metabolomic study statistician, Rosemary Greenwood (Table 4). 
Controls were matched to NEC patients based on the combined score for these risk factors as 
well as appropriate sampling around the date of NEC diagnosis; this is discussed in detail in 
Section 2.7. 
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Table 4 Risk factors and their associated statistical weight assigned by committee with medical staff 
in conjunction with a statistician.  
Criteria Calculation Match Factors 
Calculation 
Gestational 
duration  
Confirmed NEC gestation minus 
potential control gestation  
10 – i * 10/6 with a 
minimal factor equal to 
0  
Delivery  Vaginal or Caesarean  10 if identical and 0 if 
not  
Enteral feeding 
type  
Mother expressed breastmilk 
only, formula milk only, mix of 
both or no feed given  
6 if identical and 0 if 
not  
Hospital  BHH, BWH, LWH, RSH, RWH, 
STH, UHCW & UHL  
6 if identical and 0 if 
not  
Birthweight  Confirmed NEC birth weight 
minus potential control birth 
weight  
5 if 0 ≤ i ≤ 20 3 if 21 ≤ i 
≤ 50 1 if 51 ≤ i ≤ 75 0 if 
i > 75  
Intravenous 
antibiotics (iAB)  
Shared iAB divided by the sum 
of healthy control’s iAB plus 
sum of confirmed NEC’s iAB 
minus the sum of shared iAB  
i * 5  
Gender  Female or Male  if identical and 0 if not  
 
2.6.4 Filtering Subjects Enrolled in this Study 
1,326 subjects were prospectively enrolled. 1,234 had sufficient sampling for consideration 
as controls or NEC subjects. 70 infants were missing key information regarding risk factors 
and basic medical information (gestational duration, date of birth, mode of delivery, 
birthweight, sex and feeds) that were vital in assigning controls and sampling ranges, leaving 
1,160 infants within the cohort. 
 
2.7 Cohort Selection 
In total 88 infants diagnosed with NEC had sufficient medical data to be considered 
candidates for the study. Of these 44 were considered gold standard NEC cases based on 
clinical assessment. The changes associated with NEC and the gut microbiome were 
performed over a 20-day window around the age of NEC diagnosis, +/- 10 days 
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Each of the NEC subjects were matched to two controls based on weighted risk factors 
(Supp. Table 3). Confirmed NEC infant BWH120 was diagnosed aged 155 days, only 
BWH031 was the only suitable control for this subject which was still within the NICU at 
such a late age. BWH031was also the best candidate for NEC subject BWH258 which was 
also diagnosed at a relatively late age.  
 
The control infant BHH072 was the only suitable candidate for both BHH095 and BHH107 
NEC subjects who were diagnosed very early, aged 2 and 4 days respectively. 
 
BHH061 was also used as a control for the NEC subjects BHH091 and BHH074 because of 
the late onset of NEC, 50 and 53 days respectively. In total this left 44 confirmed NEC 
infants with 85 assigned controls. 
 
Across all NEC subjects there was on average 16 potential samples available per day, with a 
minimum of four samples available on day +4 and a maximum of 28 available on -4. Control 
subjects were had at least 37 samples (day -9) and at most 65 samples (day +4) (Table 5).  
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Table 5 The number of samples and subjects with samples for infants with confirmed NEC and their 
associated controls. 
 
Age Relative 
to NEC 
diagnosis 
NEC 
Samples 
Available 
NEC 
Subjects 
Number of 
Control 
Samples 
Number 
of 
Controls 
-10 18 14 48 48 
-9 16 16 37 37 
-8 22 18 49 49 
-7 18 18 42 41 
-6 19 17 49 48 
-5 17 16 50 48 
-4 28 24 50 44 
-3 23 23 61 53 
-2 22 21 57 53 
-1 19 18 54 52 
0 27 27 58 58 
1 11 11 47 46 
2 11 11 62 54 
3 11 11 53 49 
4 6 6 65 58 
5 12 12 57 54 
6 9 9 54 53 
7 14 11 57 52 
8 14 11 51 49 
9 11 10 59 56 
10 13 10 58 55 
  
Viable samples were then distributed between this project and the affiliated metabolome 
study by alternate days. This was to aid future comparative analysis of samples using an 
overlapping time series. Not all subjects had a complete set of samples from the date of 
diagnosis +/- 10 days, as some infants did not defecate daily. 
2.8 Laboratory Methods 
2.8.1 DNA Extractions 
The STRATEC PSP Spin Stool DNA Plus kit protocol was used to extract DNA from 982 
subject samples (Table 6). 0.2-1.0 grams of faeces was placed into stool stabiliser solution for 
three days. After three days samples were shaken at 95°C for 5 minutes and the lysate was 
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vortexed with beads. This mechanical and enzymatic lysis was used to yield purer DNA in 
larger quantities369. 
Table 6 Number of faecal extractions and negative controls performed with the STRATEC PSP Spin 
Stool DNA Plus Kit. 
Status Number of Infants 
Number of 
Samples 
Assigned Controls 78 723 
Gold Standard NEC 35 228 
Suspected - Trial Experiment 1 15 
Control - Trial Experiment 1 16 
Negative Controls N/A 41 
Subject Extractions 115 982 
Total Extractions  1023 
 
2.8.2 Manual DI PCR methods 
Originally two subjects were assigned for V4 16S rRNA sequencing to test the validity of the 
protocol and ensure that the methodology was feasible. 31 samples were extracted from 
subjects UHL022 (16) and BHH004 (15). BHH004 was initially assigned as a confirmed 
NEC subject however after sequencing this was later revised to a suspected NEC status by 
clinical staff. 
 
A dual index amplicon library was constructed with a 2-step nested PCR protocol362 (Supp. 
Figure 2). The first step selected the V4 region using 25 µL PCR reaction mixture with 1ng 
DNA isolate, 12.5 µL Q5 High-Fidelity DNA Polymerase (2x), 1 µL NF F515A & 1 µL DR 
Illumina R706 (3 µM) and 9.5 µL molecular H2O. Primer sequences can be found in Supp. 
Table 4. PCR amplification was performed on a Mastercycler apparatus (Eppendorf, 
Hamburg, Germany). The amplification program was 95°C for 120 seconds; 8x cycles of 
98°C for 20 seconds, 60°C 15 seconds and 72°C 40 seconds; and 72°C for 60 seconds. 
Clean-up was performed using Ampure XP magnetic beads (0.8:1)(Roche, Basel, 
Switzerland) according to the supplier’s instructions and eluted in 15 µL TE.  
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Second stage PCR was required for indexing and adaptor annealing to the V4 amplicon; 
(11µL purified DNA, (12.5µL Q5 High-Fidelity DNA Polymerase (2x), 1µL i5 and i7 
(TruSeq Dual Index Sequencing Primer, Illumina) (3µM) (Forward and reverse primer 
sequences can be found in Supp. Table 5). The amplification program was the same as before 
but for 15x cycles. A second clean-up using Ampure beads was performed as before and the 
product was eluted in 15µL TE. Amplicon library assessment was performed on the 2100 
Bioanalyzer and the High Sensitivity DNA kit (Agilent Technologies, Hewlett-Packard-
Straße, Waldbronn, Germany). After normalizing and pooling the libraries, the pools were 
size selected with Pippen Prep (Sage Science, USA) for the V4 region (432bp). 
 
Sequencing was performed on the MiSEQ Illumina machine using 2x250 paired end reads. 
 
2.8.3 Batch DI PCR methods 
Samples were normalised to 1ng of DNA in 96-well plates at 0.2ng/µl in 5µl molecular grade 
H20. First stage PCR master mix (12.5 µL Q5 High-Fidelity DNA Polymerase (2x), 1 µL NF 
F515A & 1 µL DR Illumina R706 (3 µM) and 5.5 µL molecular H2O) was added with 
multichannel pipettes. Each PCR plate consisted of 94 DNA extractions as well as positive 
and negative controls, which were validated V4 products and molecular grade H2O 
respectively. 
 
First stage PCR products were purified using Ampure beads on the TECAN Freedom EVO 
liquid handler. Second round PCR mixture (12.5µL Q5 High-Fidelity DNA Polymerase (2x), 
1µL i5 and i7 Dual Index primers (3µM)) was added to a new 96-well PCR plate along with 
10.5 µL of Ampure purified first stage PCR product.  
  71 
 
Samples were then amplified with the second stage PCR program. PCR products underwent a 
second round of Ampure clean-up with the TECAN Freedom EVO liquid handler and were 
eluted, with molecular grade H2O, into a final volume of 15 µL. 
 
After both PCR programs were completed sample concentration was assessed with the QuBit 
HS dsDNA kit, samples which failed to amplify were re-run through the PCR protocol 
manually, including appropriate PCR controls. All samples were then diluted to 1ng/µl in 2µl 
for validation by sequence length visualisation using the Fragment Analyser (Advanced 
Analytical Technologies, Indiana, USA).  
 
Samples were then grouped into 4-5 sub-pools based on average DNA length, concentration 
and the proportion of DNA sequences within 300-500bp range in equal quantities. 
Subsequently, they were size selected within the range of 300-500bp using the Pippin Prep 
(Sage Science, Massachusetts, USA). Each size selected sub-pool was pooled into a single 
final volume in equal quantities. The concentration of the 16S rDNA amplicon library was 
determined (QuBit) and visualised on the Agilent Bioanalyzer before being submitted to the 
CGR for sequencing. 
 
762 samples were successfully sequenced on Illumina MiSEQ machines using 2x250 paired 
end reads (Table 7). 
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Table 7 Number of samples, including PCR positive and negative controls, sequenced on the illumina 
MiSeq machine 
Status Subjects Sequenced 
Samples 
Sequenced 
Assigned Control 75 570 
Confirmed - Gold Standard 31 175 
Control - Trial Experiment 1 7 
Suspected - Trial Experiment 1 10 
Extraction Negative   24 
PCR Negative   13 
PCR Positive   13 
Subjects Sequenced 108 762 
Total Number of Samples Sequenced   812 
2.9 Sequencing Data Analysis 
Pipelines were constructed using bash shell scripts and validated with data from the initial 
trial experiment. These pipelines included assembling/overlapping reads, quality control, 
error correction, taxonomic annotation and clustering (Appendix Section 15.1).  
 
All scripts were run from the command line, with Perl v5.10.0, on a Debian 7.0 OS with 
x86_64-linux-gnu-thread-multi architecture. Programs required for the pipeline include 
FASTQC v0.11.3370, PandaSeq v2.5371, SPAdes v3.3.0372, blastall v2.2.26373 and QIIME 
1.8.0374. 
 
2.9.1 16S rRNA Sequence Data Processing 
The CGR prefixes used in the dual index labelling of 16S rDNA amplicon sequences were 
removed, sequences were quantified per sample and passed through FASTQC for referencing 
in quality control. SPAdes Bayes Hammer was then used to perform error correction. Error 
corrected reads were quantified per sample and passed through FASTQC for reference. 
PandaSeq performed read overlaps. Overlaps were quantified per sample and passed through 
FASTQC. FASTQ sequences were then converted into FASTA format using fastq2fasta. 
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PhiX sequences were removed from FASTA files using blastall. FASTA sequence headers 
were annotated with sequence run information and formatted appropriately for QIIME. 
Sequence lengths outside 250-350bp range were removed. All sequences were added into the 
All_seqs_filtered.fna file. 
 
2.9.2 Taxonomic Annotation 
The QIIME informatics package was used to process FASTA sequences.  
 
Operational Taxonomic Units (OTUs) were assigned from FASTA sequences using 97% 
percentage error, 97% sequence identity and a maximum of 1,000 rejects. Taxonomy was 
assigned with 97% sequence similarity and a confidence level of 0.8 against reference 16S 
rDNA sequences within the Green Genes database.  
 
Sequences were aligned using the Pynast375 with pairwise alignment using the UCLUST 
algorithm with a minimum of 75% ID. Outliers were marked for removal with the gap filter 
threshold was set to 0.95 and sequence dissimilarity set to 3 standard deviations above the 
mean.  
 
2.9.3 Taxonomic Data Analysis 
Taxonomic Analysis was done with the statistics program R using the Phyloseq (v1.16.2)376, 
Random Forest (v4.6-12)377, Vegan (v2.4-4), DESeq2 (v1.14.1)378, plyr (v1.8.4) and ggplot2 
(v2.2.1) libraries. The methods were published by Belen Torondel379 and described by Umer 
Zeeshan Ijaz380.  
Local contributions to beta-diversity values calculations are described and added to the 
metadata table in Appendix Section 15.2. Linear regression analysis was performed using 
  74 
ggplot2 and standard R libraries using the values calculated and placed into the metadata 
table following completion of this script. 
 
 CCA analysis of risk factors is described in the R script in Appendix Section 15.3. Analysis 
for NMDS plotting, including sub-setting according to metadata variables as well as adding 
contours and ellipses for continuous data NMDS graphs is described in the R script in 
Appendix Section 15.4. Log2 fold significant differences between genera and species along 
with Random Forest analysis are described in the R script in Appendix Section 15.5. 
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3 Cohort Enrolment, Control Selection & Sampling 
This project aimed to identify whether the neonatal infant gut microbiota was associated with 
NEC using a large-scale cohort. It aimed to identify if any changes observed from ten days 
prior to diagnosis to the date of diagnosis could be used as prognostic signals. Additionally, 
whether differences after diagnosis could be used to identify a healthy microbiome. 
Metagenomic research into NEC has predominantly been via small-scale studies, although 
more recently a few large-scale cohort analyses have been published. However, there has 
been very little consistency observed between studies with some citing pathogenic 
strains209,381 and others indicating that there could be a reduced presence of probiotic 
taxa106,382. 
 
It was therefore important that further data from a large-scale perspective could be added to 
the research community, and that this data be thoroughly analysed alongside associated 
medical information. By doing so it would be possible to establish consistent trends across 
multiple locations, age ranges and account for known risk factors defined by the medical staff 
involved in this project. 
 
Using a large cohort made it possible to observe and report consistent trends within a highly 
dynamic and unique environment, and be confident in their validity. As described previously, 
the community of the human infant microbiome undergoes changes until early adulthood, at 
which point it maintains a relatively stable composition. As the microbiome is highly specific 
to the host, it is even more important that statistically significant trends are replicated across 
large cohort populations. 
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Eight NHS hospitals were used to prospectively enrol 1,326 premature infants and collect 
their medical data from the UK. Using this cohort, it was possible to describe demographics, 
identify key risk factors and select a case-control cohort for metagenomic sequencing 
analysis. As many factors are known to influence the human gut microbiome383,384, it was 
important to identify those that were seen to correlate with NEC and establish how effective 
case-control assignment was with respect to these. 
 
Initial analysis focused on the demographics of the enrolled population of infants in relation 
to key NEC risk factors described in literature, for example, antimicrobial administration112, 
location59, and birthweight385. Factors associated with changing or influencing the infant 
microbiome were then assessed for an association with NEC. Gold standard NEC subjects 
were selected from the population based on individual review by the medical team (Section 
2.7). Following assignment of controls to NEC subjects, the case-control cohort was 
statistically analysed regarding risk factors and compared against the enrolled population.  
3.1 Demographics of Enrolled Population 
There were 88 confirmed NEC infants (7.80%) and 902 infants without NEC symptoms 
(79.96%). An additional 137 infants were suspected of NEC (12.15%) but did not present 
with the full range of diagnostic criteria to be confirmed NEC cases, and were therefore 
removed from further analysis and were excluded from control assignment. 
 
3.1.1 Association of Gestational Duration with Necrotising Enterocolitis 
NEC is primarily associated with premature infants. The gestational durations of case and 
control infants within the enrolled population were analysed to identify whether there was 
any significant difference. Infants confirmed with NEC was seen to have significantly shorter 
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gestational durations than infants without NEC (T-test 0.95, 1: t=-10.467, p-value < 2.2x10-16). 
On average, infants with NEC were born before 27 weeks’ gestation and infants without NEC 
were born after 30 weeks’ gestation (Figure 4). Many existing studies that indicate that NEC 
is significantly associated with shorter gestational durations105,386,387, however the significant 
overlap between the gestations of case and control infants indicated that other factors are 
likely to influence the onset of NEC. 
No. of Infants 88 902 
 
Figure 4 Boxplot describing the significant difference in gestational duration (weeks) for infants with 
and without NEC. 
 
3.1.2 Association of Birthweight and Necrotising Enterocolitis 
While prematurity is one of the most associated risks in developing NEC it does not 
necessarily indicate an infant’s physiological immaturity even though the two are closely 
linked.  Birthweight is an important indicator in perinatal mortality and morbidity of infants 
and NEC incidents rates have been shown to be elevated in extremely low birthweight 
infants56. Infants that are small for their gestational duration are often associated with poor 
health from the perinatal period up to adulthood388. With this population, infants with NEC 
Non-NEC Confirmed 
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were seen to have significantly lower birthweights (mean = 955g) when compared to infants 
without NEC (mean = 1,419g) (T-test 0.95, 1: t=-10.743, p-value < 2.2x10-16) (Figure 5).  
 
These results support previous evidence that NEC is significantly associated with 
birthweight56. However, as with gestational duration, birthweight is not the only causative 
factor but could indicate the infant’s physiological immaturity when considered with 
gestation duration. 
No. of Infants: 88 902 
 
Figure 5 Boxplot describing the significant differences in birthweight relative to NEC status within 
the sampled population. 
 
3.1.3 Association of Delivery Method and Necrotising Enterocolitis 
The maturation of the microbiome and the development of dominant community members 
has been associated with the mode of delivery155,309,389,390. Disease states such as asthma391, 
allergies392, type 1 diabetes393 and obesity394 have also been observed to occur  in infants at 
significantly different rates depending on the delivery method. Therefore, statistical analyses 
Non-NEC Confirmed 
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were used to establish any association between the incidence of NEC and the mode of 
delivery. 
 
NEC frequency was significantly greater in infants delivered vaginally compared with those 
delivered by caesarean section. This suggested that the disease status of an infant was not 
independent of the mode of delivery (χ20.95, 1 = 6.97, p = 8.29x10-3, with Yates correction) 
(Figure 6).  
 Caesarean Delivered Vaginally Delivered 
NEC Infants 41 47 
Non-NEC infants 556 346 
 
Figure 6 Stacked barplots describing the proportion of infants with and without NEC relative to the 
mode of delivery.  
 
3.1.4 NICU Association with Necrotising Enterocolitis 
As many outbreaks of NEC has been reported previously196,203,381 it was important to 
establish any biases observed across the recruitment sites that could be indicative of 
outbreaks or sites with a significantly greater risk of infants developing NEC. The proportion 
of NEC cases across all locations (Table 8) was observed to be significantly different (χ20.95, 7 
= 22.32, p-value = 2.24x10-3, with Yates correction) but the accuracy was limited by the 
small number of cases in LWH and RWH. To account for the large differences in subject 
populations from each unit, the Marascuilo procedural analysis was performed; this method 
Confirmed 
Non-NEC 
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identified no significant difference between any two-way NICU comparisons (Supp. Table 
6). Whilst it could be argued that there was an association with the unit and the incidence rate 
of NEC this is also likely to be influenced by the enrolment rate of infants within the NICU. 
That is, very proactive units may be enrolling infants at earlier ages whereas some units may 
enrol only severely ill subjects. Therefore, the staff involved in patient recruitment are likely 
to be a major contributing factor in the enrolment rates at each unit. As these cannot be 
accounted for, the implication of an association across units involved is limited. 
Table 8 The number of infants and proportion of confirmed NEC cases per NICU  
Infants BHH BWH LWH RSH RWH STH UHCW UHL 
Total 101 253 44 92 51 150 105 194 
Without NEC 93 214 43 88 49 135 98 182 
With NEC 8 39 1 4 2 15 7 12 
Proportion with NEC 0.079 0.15 0.023 0.043 0.039 0.10 0.067 0.062 
 
3.1.5 Association of Enteral Feeding Regimes and Necrotising Enterocolitis 
Numerous studies have shown human breast milk to be associated with the incidence rate and 
severity of NEC165,395,396 as well as providing long term beneficial impacts that reduce the 
incidence of other disorders such as respiratory tract and gastrointestinal infections, allergic 
diseases, coeliac disease, and inflammatory bowel disease249. Feeding regimes are also 
known to influence the normal development of the infant microbiome 42,397 and as such it was 
considered important that the study population was tested for any significant association with 
NEC. 
 
Most infants with NEC were exclusively fed human breast milk (47.7%) or a mixture of 
human breast milk and formula milk (48.9%). The remaining 2.3% were fed formula milk 
exclusively with exception to a single infant who was not administered any enteral feeds 
during the study.  
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Most of the non-NEC infants were fed a mixture of human breast milk and formula milk 
(61.5%). 29.4% were fed human breast milk only, and 8.87% were exclusively fed formula 
milk. Two infants (0.2%) were not recorded to have been administered any enteral feeds. 
There was no significant association between NEC and feeding regimes (χ20.95, 1 = 2.85,  p = 
0.092, with Yates correction). 
 
However, there is a limitation in what we can test with regards to the feeding regimes. As 
there was not a complete record of administration times and dates for all infants it was not 
possible to know the precise proportions for infants on mixed feeding regimes. That is, it was 
not possible to establish if an infant was administered breast milk 99% of the time and 
formula 1% or any variation of this ratio. Nor was it possible to know whether the infant was 
administered only one type of feed up to and over the duration of sample, to then be switched 
to another feed thereafter.   
 
3.1.6 Association of Antimicrobial Regimes and Necrotising Enterocolitis 
Administration of antimicrobial regimes are considered routine for most infants in NICUs 
however prolonged exposure to antimicrobials has been shown to be associated with 
NEC125,172. As premature infant microbiomes are in the early stages of establishing and 
culturing a natural, beneficial microbiota it was considered important to understand any 
association with the onset of NEC and the extent of antimicrobial regimes, especially as 
antimicrobial compounds have been shown to influence the balance of the gut microbiota398.  
 
74 infants within the study cohort had no recorded antimicrobials administered (7.47%), one 
of which was confirmed with NEC. On average, significantly more types of antimicrobials 
were administered to infants with NEC relative to the rest of the population (Average number 
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of Antimicrobials ~ NEC status, T-test 0.95, 99.3: t = 14.86, p-value < 2.00x10-16), with NEC 
infants having on average twice as many (six unique antimicrobials) as infants without NEC 
(Figure 7).  
 
This association with the number of antimicrobial regimes could be linked to preventative 
measures often taken in treating and reducing the severity of NEC symptoms242. However, as 
antimicrobials have been shown to affect the microbiota399 and, importantly, the short-term 
recovery of the infant microbiota400 it was considered important that this is factored when 
comparing case and control cohorts. 
No. of Infants: 88 902 
 
Figure 7 Boxplot describing the distribution of antimicrobial regimes within infants with and without 
NEC.  
 
3.1.7 Age Necrotising Enterocolitis was Diagnosed 
The mean age of NEC diagnosis was 21 days, with the maximum age being 79 days and the 
earliest at one day old. There was no relationship between the age at which an NEC subject 
Non-NEC 
Non-NEC Confirmed 
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was diagnosed with NEC and gestational duration (Linear Regression: F1,86 = 0.84, p-value = 
0.36, R2 = 1.80x10-3), birthweight (Linear Regression: F1,86 = 2.00, p-value = 0.16, R2 = 0.11) 
, NICU at which sampling occurred (ANOVA0.95, 7: F-value = 0.359, p-value = 0.92), feeding 
regime (ANOVA0.95, 3: F-value = 2.46, p-value = 0.068) or mode of delivery (either 
simplified T-test0.95,83.6: t = -0.90, p-value = 0.37 or in detail ANOVA0.95, 7: F-value = 0.41 p-
value = 0.90). This suggests that the onset of NEC was not correlated with any of these 
factors. 
 
Previous literature suggests NEC on average is diagnosed at 12.5 days of age27,33,59,110,238,401. 
However, these infants were sampled from modern NICUs with specially trained staff, which 
could be associated with the delayed onset of NEC within this cohort when compared to 
studies spanning the last 40 years from facilities of varying locations and standards in 
preterm care. 
 
3.1.8 Mortality Rate of Infants within the Cohort 
Of the 990 infants with all the key demographic information, 45 died before discharge from 
the NICU unit (4.55%). The mortality rate in those who had NEC was 26% (23/88 confirmed 
subjects). This was within the expected range between 15 and 63%402,403. 22 infants that died 
had no NEC diagnosis (40.74%), of those infants one died from a septic ileus, one from 
meningitis, and one from a congenital heart disease (tetralogy of Fallot). The remaining 19 
infants were not observed to have any medical or surgical complications and the reasons for 
their death are unknown. There were no annotations that indicated other factors, medical or 
surgical, which contributed to the death of infants with NEC and all were considered to have 
died from symptoms of the disease. 
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3.1.8.1 Mortality Rates and Gestational Duration 
Infants with confirmed NEC status that died before discharge were also observed to have 
significantly lower gestational durations (mean = 184 days) relative to those that were 
successfully discharged (mean = 193 days) (T-test 0.95, 46.32: t = -2.39, p-value = 0.021).  
No significant difference was observed between the gestational durations of deceased infants 
with NEC relative to those without NEC (T-test 0.95, 42.01: t = 0.27, p-value = 0.021). This 
shows that there is a negative correlation between the gestational duration and the mortality 
rates of infants, and that the rate of mortality is irrespective of NEC status. 
 
3.1.8.2 Mortality Rates and Surgical Intervention 
64 infants underwent surgical procedures; of these, 45 were confirmed with NEC, ten were 
suspected of NEC, and nine did not have any NEC symptoms.  One of the nine infants that 
were not diagnosed with NEC and underwent surgery died before discharge. This infant had 
undergone both laparotomy and stoma operations. 
 
The mortality rate of infants who were diagnosed with NEC and underwent surgery was 38% 
(17/45). Ten infants underwent surgical procedures; six had both laparotomy and stoma 
operations; one had end-to-end anastomosis; two had stoma operations only; and for one 
infant, there was not any recorded information on the surgery performed. Upon visual 
inspection seven infants were deemed to have NEC that was too severe for surgical 
intervention. 
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3.1.8.3 Mortality Rate & Mode of Delivery 
Infants diagnosed with NEC were observed to have significantly higher mortality rates when 
delivered vaginally relative to those delivered by caesarean section (T-test 0.95, 3: t = 3.53, p-
value = 0.04), although this was marginal. 
 
As birthweight and gestational duration had already been associated with mortality within the 
NEC cohort, the vaginally delivered infants were assessed for associations so see whether 
these factors were confounding the mortality rate. However, no significant difference was 
observed for gestational duration (ANOVA 0.95,1: F-value = 2.31, p-value = 0.14) or 
birthweight (ANOVA 0.95,1: F-value = 0.57, p-value = 0.45).  This was also true for the 
mortality rates of NEC infants delivered by caesarean section; gestation (ANOVA 0.95,1: F-
value = 0.86, p-value = 0.36); birthweight (ANOVA 0.95,1: F-value = 2.53, p-value = 0.12).  
3.2 Analysis of Case-Control Cohort Selection 
44 infants diagnosed with NEC met clinical criteria for control selection; of these, 37 had 
sufficient sampling. These were assigned with 78 controls based on NEC risk factors (Table 
4) and sample availability. Infants were matched based on risk factors to reduce the impact of 
these factors on further analysis.  
 
Following assignment of controls to NEC subjects risk factors were still observed to be 
significantly different; gestational duration (T-test 0.95, 72.86: t= -3.81, p-value = 2.92x10-3), 
birthweight (T-test 0.95, 78.19: t= -3.62, p-value = 5.10x10-3), feeding regimes (T-test 0.95, 7: t= 
2.40, p-value = 0.048), infants per NICU (T-test 0.95, 15, t = 5.00, p-value = 1.60x10-4), the 
number of antimicrobials administered (T-test 0.95, 73.83, t = 6.6028, p-value = 5.40x10-09), and 
gender (T-test 0.95, 3: t= 4.87, p-value = 0.021). 
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3.3 Discussion 
3.3.1 Demographics of Enrolled Population 
Within our population, NEC was significantly associated with gestational duration, 
birthweight, mode of delivery and antibiotic administration. However, due to a lack of 
administration dates it was not possible to account for antimicrobials with metagenomic data 
analysis. Neither breast feeding nor antimicrobials could be considered in cause-effect 
models as infants with NEC are known to be treated through antibiotic administration55,7 and 
encouraged to feed on human breast milk404,249. This would artificially inflate the number of 
NEC infants being fed breast milk and the number of antimicrobials administered to them. 
 
NHS statistics for 2015 – 2016 suggested that the incidence rate of NEC in England and 
Wales was 509 infants per 100,000. This was much lower than the incidence rate calculated 
in this study (7,808 per 100,000), however this could have been due to the exclusive use of 
the NICUs for sampling in this study. These are highly specialised facilities with specialised 
staff and therefore probably have a greater rate of high-risk infants relative to the hospitals 
surveyed in the NHS statistics. 
 
One weakness in particular was a lack of information regarding the deaths of 19 infants who 
did not have NEC. There were no complications annotated which suggests that the medical 
information for these infants was not as thorough as it should have been. This may have been 
due to difficulties in obtaining the data or approaching the family to ensure that the data 
could be contributed to the project. These subjects and their samples were removed from 
further analysis  
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3.3.2 Case-Control Cohort Selection 
In selecting for controls prioritisation was given to gestational duration and birthweight based 
on the significant association identified within this population. Given two infants with the 
same gestational duration, there was an increased morbidity associated with decreasing 
birthweight, which indicated that in addition to gestational duration, birthweight was also a 
significant indicator in the overall maturity of an infant. 
 
An important priority of this project was the understanding of antimicrobial administration 
regimes and their association with NEC. It was hypothesised that the actions of 
antimicrobials would be likely to influence the community structure of the microbiome, 
therefore high weighting was assigned to direct matches of each antimicrobial NEC and 
control infants were administered. However, over the course of the project it was not possible 
to retrieve administration dates for each antimicrobial an infant was assigned. This was a 
fundamental limitation associated with the scale of the project.  
 
Due to the high association of NEC with gestation, birthweight, mode of delivery, and 
antibiotic administration, other match factors were seen to be have a greater statistical 
difference within the NEC-control cohort relative to the overall population. Whilst matching 
of risk the factors defined by clinical staff reduced the impact of the risk factors in the studied 
samples there was a limitation in using too many match factors, that is all match factors were 
still seen to be significantly different, whereas if infants were selected based on a single 
match factor it would be possible to control for that factor. 
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3.3.3 Conclusion 
After researching the literature for factors that were associated with NEC we sought to test 
the enrolled population of premature infants for those risk factors to establish a case-control 
cohort according to those factors seen to be significantly associated with NEC. It was also 
important to control for factors known to be influential in the development of the 
microbiome. This method aimed to increase the ability to identify differences in the gut 
microbiome that were associated with NEC and a product of differences in risk factors.  
 
The primary risk factors described in the literature to be associated with NEC are gestational 
duration, birthweight, feeding regime and antimicrobial administration. These were 
statistically tested within this cohort population and found to be significantly associated with 
NEC.  
 
Following case-control specific matching, the significant difference of the case-control cohort 
for key factors associated with NEC and influencing the gut microbiome composition was 
seen to be reduced relative to the population. Due to accounting for multiple risk factors NEC 
subjects were still observed to be significantly different for the risk factors, but this 
significance was reduced. Limiting the number of match factors could potentially reduce the 
difference of a given factor, and sub-setting of case-controls would also be able to account 
for this in some circumstances such as mode of delivery or feeding regime. 
 
It was not possible to account for an important factor that influences the microbiome 
composition; antimicrobial administration. This was due to a lack of administration dates for 
all subjects within the case-control cohort. Thus, it was not possible to integrate this factor 
into future analyses. Further research should focus on controlled sampling based on 
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antimicrobial administration, though performing this in a large cohort would be challenging 
so these might have to be limited to small scale projects.  
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4 Changes in Community Composition in Relation to 
Necrotising Enterocolitis and Associated Medical Data 
 
The bacterial community composition has been shown to be associated with the onset of 
NEC102,110, rather than an individual taxa i.e. a pathogen. However, these studies were focused 
on single sites and with small sample numbers per subject, which limited the assumptions that 
could be made in the absence of further studies that could reinforce these findings. With recent 
advances in 16S rRNA gene profiling of the microbiome, it has been possible to focus research 
on the intestinal colonisation of preterm infants at larger scales.  
 
Multiple studies have demonstrated that the preterm infant gut has significantly reduced 
abundances of beneficial species and diversity, as well as containing a greater proportion of 
potential pathogens relative to full term infants gut microbiomes110,104,405,406.  Therefore it was 
important to establish those changes that occurred in preterm infants at the community level 
before and after the onset of NEC as well as addressing how those changes differed from 
infants that did not develop NEC. 
 
Initially the gut microbiota undergoes a dynamic colonisation pattern as the intestinal tract 
develops to maturity following  the introduction of pioneering bacteria after birth329. 
Colonising bacteria are derived from the maternal microbiota (vaginal, faecal, mouth, skin, 
human milk) as well as the environment407,408,409 and develop into a community structure 
shaped by feeding regimes. Infants fed breast milk were seen to have significantly greater 
diversity within the gut microbiomes compared to infants fed formula milk64. This community 
structure changes substantially from birth to weaning and then from weaning to early 
adulthood410. 
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It was important to establish how key risk factors were associated with differing patterns of 
colonisation and the impact these had on NEC and control samples comparisons. Once those 
differences were established appropriate subgroups of samples from NEC and control subjects 
could be compared. Beta-diversity metrics quantify the diversity of an individual sample 
relative to the diversity in all the other samples within a population, enabling the association of 
trends in the community structure for groups of samples and match factors. By controlling for 
the trends observed within match factor subsets it was then possible to identify taxa that were 
significantly different in abundances relative to the NEC status of an infant (Chapter 5). 
 
This chapter aimed to establish those match factors that were significantly associated with 
changes in the development of the gut microbiome and if samples would cluster according to 
their community composition and the NEC status of the infants within the subset. Additionally, 
this enabled the detection and visualisation of unique gut communities associated subsets of 
samples within a population. 
4.1 DNA Extractions, V4 PCR Amplification, Sequencing Depth and Success  
246 successful DNA extractions were performed for 41 of the 45 gold standard NEC infants, 
and 626 sample extractions were successfully performed on 82 assigned controls. Some NEC 
subjects’ samples were not sufficiently large for the isolation of utilisable quantities of DNA 
(quantified by QuBit). 228 samples from 39 NEC infants were successfully amplified using 
dual index V4 PCR protocol alongside 436 samples associated with 68 controls. Some sample 
DNA did not amplify as well as expected; this was due to the relatively harsh DNA extraction 
procedures that included vortexing and heating. As some samples did not contain much solid 
faecal matter, it was likely that the DNA was fragmented to such an extent that amplification 
was not successful. 225 amplicon preparations for the 39 NEC infants were successfully 
sequenced alongside 431 amplicon preparations for the 68 controls. 
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4.1.1 Control Group Sampling Depth 
26 control groups, which were represented by a single NEC subject and two assigned control 
subjects, had at least three samples successfully sequenced for every subject in the group. 
Ensuring at least three samples per subject provided statistical weight to longitudinal analysis. 
In total these groups corresponded to 157 samples from 25 NEC subjects, and 313 samples 
from 44 controls. These groups were considered robust enough for thorough profiling across 
the 21-day time frame around the date of diagnosis. 
4.2 Summarising Differences in Community Structure: Local Contributions to 
Beta-Diversity  
Local contributions to beta-diversity (LCBD) values summarised the changes in the ratio of 
regional and local species diversity for samples. These values represented the beta-diversity of 
a sample (local)  by comparing it’s diversity to all the other samples in the population 
(regional)411.  
 
Changes in LCBD values indicated whether the local species diversity was altered relative to 
the regional species diversity. This method normalised changes that occurred across the entire 
population and allowed the identification of changes missed through the more traditional 
analysis such as proportional abundances associated with rarefied samples. 
 
Additionally, using LCBD values allowed for the data to be partitioned according to factors of 
interest and to test the hypotheses that the beta-diversity of samples within different subsets 
differed between case and control subjects. By ensuring that regression analysis was factored 
with time it maintained statistical viability when making assumptions across the sample 
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population412, therefore all statistical analysis of the cohort was analysed as a population 
relative to time at sampling (Figure 8). 
 
 
Figure 8 Regression analysis of LCBD values relative to the age at sampling, coloured by NEC status. 
 
Controls and NEC subjects were seen to have a greater difference in the beta-diversity of 
samples at earlier ages with controls having elevated LCBD values prior to 10 days of age. 
Between day 20 and 25 control samples were observed to have a decrease in LCBD values 
until they reached similar values observed for NEC samples. Between 28 and 45 days both 
NEC and control samples exhibited a similar peak in LCBD values, this peak occurred earlier 
in NEC samples (~28 days) compared to control samples (~32days). By 50 days of age both 
groups reached the lowest LCBD values observed. Subject and sampling density after 100 days 
of age was considered low to be statistically viable and these samples were subsequently 
removed from further analysis. Over the entire course of sampling, the error margins between 
NEC and controls (denoted by the grey shading in Figure 8) were never distinct. This indicated 
 Control 
NEC Status 
  Confirmed 
  Control 
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that at no point was there a clear distinction in the LCBD values of samples between case and 
control subjects.  
4.2.1 Subset Regression of Match Factors with Beta-Diversity 
Subset regression analysis was used to identify the factors associated with changes in LCBD. 
Antibiotics were omitted from this analysis due to the lack of administration dates for most 
subjects. The regression models aimed to account for most of the variance whilst using the 
minimum number of factors, thereby creating a minimal model that accounted for most of the 
variance associated with sample LCBD values. Only models utilising the age at sampling were 
considered to ensure statistical viability412.  
 
The best model identified included age, gestational duration and feeding regime (Table 9), 
these factors accounted for the most variance associated with LCBD values (Linear 
Regression: LCBD ~ Age + Gestation + Feeding Regime, p = 1.33x10-15) (Figure 9). Subset 
analysis with these factors was used to identify how they were associated with changes in the 
beta-diversity of samples. 
 
Table 9 Coefficients for the optimum, minimal subset regression model identified between LCBD and 
match factors (excluding antibiotic administration). Ordered by significance. *** = p-value less than 
1x10-3. 
 
  Estimate Std. Error t value Pr(>|t|)  
(Intercept) 2.70x10-3 3.34x10-4 8.079 1.67x10-14 *** 
Formula & Breast Milk -7.55x10-4 1.06x10-4 -7.114 1.38x10-12 *** 
Breast Milk only -6.12x10-4 1.11x10-4 -5.487 4.70x10-10 *** 
Age at Sampling (days) -6.27x10-6 1.75x10-6 -3.581 1.07x10-3 *** 
Gestational Duration (days) 8.45x10-7 1.51x10-6 0.558 0.42  
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Figure 9 Subset regression summary based on adjusted R2 values. Blocks indicate the inclusion of a 
factor into a model. Opaqueness represents how important that factor is. Age was to be maintained 
within the model to ensure statistical viability. R2 value represents the proportion of the data explained 
in the subset model. 
 
4.2.2 Association of Feeding Regime and Community Composition over Time  
Feeding regime was the most influential factor in the regression model therefore subsets of 
samples from each feeding regime were plotted separately to identify how the trends differed 
over time (Figure 10). Infants exclusively fed formula feeds were considered to lack statistical 
viability due to the low number of subjects and samples and were not explored in detail. 
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Figure 10 Changes in beta-diversity (LCBD) in relation to age, feeding regime and NEC status.  
 
There were clear differences in the trends of regression plots from infants fed both formula and 
breast milk compared to infants fed breast milk exclusively. The mean LCBD values of infants 
on a mixed feeding regime were stable over time, with NEC and control samples showing very 
similar values over the duration of sampling. This suggested that over time there was little 
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evidence for a taxa altering the sample’s community composition, relative to the other samples. 
For infants fed breast milk exclusively the initial LCBD values were greater for control 
samples, however NEC samples showed a steeper increase from day one. By day 10 NEC 
samples had a greater mean LCBD value. NEC samples subsequently declined from day 20 to 
day 30 but showed an increase up to day 40, after which they stabilised. Control samples, on 
average, showed a slower initial rate of increase up to ~38 days of age followed by a decline to 
day 40. After day 40 all samples from both subsets were at similar LCBD values (~0.002). 
 
As gestational duration was identified as a key factor within the subset regression analysis it 
was factored into the feeding regime subgroup analysis (Figure 11). Gestational is inherently 
associated with maturity and therefore if there is bias in the gestation of infants with the 
subgroups this could be create a bias in the comparisons made and distort the differences 
observed.  
 
Control subjects born at later gestational durations were sampled at earlier ages regardless of 
the feeding regime of the subject. The gestational duration of infants with NEC were evenly 
distributed relative to the age at sampling, however average gestational age was lower relative 
to control infants within the subsets. Since NEC and control subject samples were observed to 
have the same trends in LCBD value changes relative to time across all subgroups these 
changes were considered independent of gestational duration. 
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Figure 11 Subsets of feeding regime and NEC status relative to beta-diversity LCBD values and age at 
sampling. 
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4.2.3 Association of Delivery Method and Community Composition over Time 
The importance of the delivery method was described by the increased variability accounted 
for in models that used this match factor (Second best model identified in Figure 9) therefore 
samples were subset by the mode of delivery to establish any visible trends (Figure 12). 
Compared to the differences observed for feeding regime (Section 4.2.2), each subset showed 
greater differences in the trends of LCBD values relative to the NEC status of the sample.  
 
The initial sample LCBD values for vaginally delivered infants were observed to have the 
greatest difference between means from control and NEC subjects, but by 50 days of age there 
was a greater difference in caesarean delivered infant subgroup. This large difference in LCBD 
values between control and NEC subjects indicates that the community changes occurring are 
very different between the two groups. These results suggest that the initial colonising bacteria 
from the environment are much more similar between NEC and control samples from infants 
delivered by caesarean section, and there are relatively few changes occurring within these 
communities that are different between the two groups.  
 
Both subsets appeared to have the same trend observed in infants fed natural breast milk. A 
peak in LCBD values at approximately 38 days followed by a decline to day 50 days. This 
showed that infants fed breast milk exclusively were highly influential on the average LCBD 
score within both delivery subsets. 
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Figure 12 Changes in beta-diversity (LCBD) in relation to age, delivery method and NEC status.  
 
4.2.4 Association of Feeding Regime, Mode of Delivery, Age and Gestation with 
Community Composition over time. 
Subset regression analysis suggested that the model accounting for the most variance was a 
combination of feeding regime, mode of delivery, age and gestational duration. However, 
creating subsets based on a combination of mode of delivery and feeding regime limited the 
statistical strength of some subgroups due to the low subject and sampling densities. 
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Specifically, all the subgroups with infants exclusively fed formula milk and the subgroup of 
infants exclusively fed breast milk and delivered by caesarean section (Figure 15). 
 
 
Figure 13 Changes in beta-diversity (LCBD) in relation to age, feeding regime, delivery method and 
NEC status. 
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Those subgroups that could be compared were vaginally delivered infants fed breast milk 
exclusively and both subgroups for infants fed a mixture of formula and breast milk. These 
samples showed very little difference with regards to NEC status and beta-diversity 
fluctuations. This suggested that the trends in community composition were less affiliated with 
the NEC status of the infant sampled and more associated with feeding regime and mode of 
delivery. 
 
Both subsets for samples from infants on the mixed feeding regime were seen to have similar, 
stable, LCBD values over time, which differed from the samples of control infants fed 
exclusively breast milk. These samples showed a peak LCBD at ~30 days which declined up to 
day 40, after which all samples from all subgroups had similar LCBD values (~0.002).   
4.3 Canonical-Correlation Analysis (CCA) of Match Factors Associated with 
Trends in Community Composition 
Match factors were summarised using analysis of variance (ANOVA) with Bray-Curtis 
dissimilarity index413 to establish associations with sample distribution and beta-diversity. 
Additionally, to understand the uniqueness of each community the subject ID was included in 
this analysis. By doing so it was possible to partition the distance matrices from sources of 
variation and to fit linear models to the distance matrix.  
 
The results from the permutational ANOVA (PERMANOVA) test identified subject ID and 
the age at sampling as the only two factors significantly associated with beta-diversity. These 
accounted for 78% and 0.005% of the variance between samples respectively (Table 10).  
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Table 10 PERMANOVA analysis of match factors in relation to OTU abundance counts using Bray-
Curtis dissimilarity index with 999 permutations. *** = p-value less than 1x10-3. 
 
 
Df 
Sum Of 
Squares 
Mean 
Squares 
F 
Model R2 Pr(>F)  
Subject ID 68 129.43 1.90 23.60 0.78 0.001 *** 
Age at Sampling 1 0.75 0.75 9.32 4.45x10-3 0.001 *** 
Residuals 398 32.11 0.08  0.19   
Total 469 167.15   1   
 
This test confirmed that the microbiome was unique to each individual and altered with age. 
While these methods accounted for the trends in the beta-diversity of samples they did not 
describe the differences in the taxa of those communities. In order to establish how similar the 
community compositions were within each subset non-metric multidimensional scaling 
(NMDS) analysis was performed and used to identify unique clusters associated with NEC and 
control subjects 
4.4 NMDS Analysis of Community Composition 
Multidimensional scaling enabled the visualisation of each taxa abundance per sample relative 
to all other sample taxonomic abundances in the population. This was performed using a set of 
related ordination techniques to display the OTU presence and abundance. NMDS analysis was 
used to identify both a non-parametric monotonic relationship between the dissimilarities in the 
abundance table and the Euclidean distances between samples.  
 
NMDS depends only on a biologically meaningful view of the data, therefore the choice of 
standardisation, transformation and similarity coefficient appropriate to the hypothesis under 
investigation are important414. Bray-Curtis dissimilarity index was considered the most 
appropriate for the dataset as it is used to quantify compositional dissimilarity between samples 
using OTU counts from each sample relative to the rest. 
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Subset regression established feeding regime as the factor most significantly associated with 
LCBD value of the beta-diversity over time. Normalising for feeding regime provided the best 
means of identifying sample clustering with respect to the NEC status of the infant. 
 
 
4.4.1 Analysis of Taxonomic Ranking and Discrimination of Necrotising Enterocolitis 
Status Based on the Sample Community Composition  
It was important to establish which taxonomic level best described the NEC status of samples 
prior to analysis with demographic/medical information. To establish the most successful 
taxonomic rank in clustering samples according to NEC status, NMDS with Bray Curtis was 
performed at the Phylum, Class, Order, Family, Genus and OTU level (where OTUs were 
sequences defined as unique based on the QIIME parameters described in the methods section, 
Section 2.9.2).  
 
NMDS analysis establishes the similarity between multi-dimensional objects in a dataset by 
representing each dimension on an axis. In this case the dimension is a taxonomy and the value 
of the axis is the normalised abundance of that taxon represented as an ordered position (non-
metric) of similarity to the other objects. In this manner, objects with similar multi-dimensional 
profiles are clustered together, and this can be shown statistically using PERMANOVA 
analysis. In this case, NEC and control samples (NMDS objects) were represented at a given 
taxonomic rank, which represented the individual axis, and compared to significance using 
PERMANOVA. This was performed for all the taxonomic ranks individually. 
 
The extent and significance of NEC clustering within the NMDS plots was assessed using 
permutational PERMANOVA. This technique did not assume parametric distributions and 
could be combined with the Bray-Curtis measure of dissimilarity to compare pairs of samples 
or variables415. 
  105 
The most significant association of sample clustering and NEC status was at the genus level 
(Table 11), however there was no distinct clustering of NEC samples within the NMDS plot 
even at this level. This showed that there was a greater level of complexity within the 
community structure relative to NEC status (Figure 14). The previously described trends in 
community structure with LCBD values showed significant associations with feeding regime 
and mode of delivery (Section 4.2). Further analysis focused on subsets based on feeding 
regime and mode of delivery at genus level. 
 
Table 11 PERMANOVA analysis of community composition and NEC Status for all samples using 
different taxonomic ranks. *** = p-value less than 1x10-3, ** = p-value less than 1x10-2. 
 
 
Sums Of 
Squares 
Mean 
Squares F Model R2 Pr(>F)  
Genus 1.828 1.82789 7.1189 0.01461 0.001 *** 
Order 1.082 1.08171 6.0817 0.01251 0.001 *** 
Class 1.002 1.00163 5.9362 0.01222 0.001 *** 
Family 1.017 1.01695 5.5493 0.01143 0.001 *** 
Species 1.202 1.20183 3.26 0.00675 0.001 *** 
Phylum 0.717 0.71657 4.4577 0.0092 0.009 ** 
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Figure 14 NMDS Plot for all samples with community composition described at the Genus Level with 
the whole, viable, cohort, using PERMANOVA. 
 
4.4.2 Analysis of Community Composition and Necrotising Enterocolitis Status of 
Samples Subset by Feeding Regime  
Subset regression analysis suggested that feeding regime was one of the most influential 
factors in the changes of beta-diversity as represented by LCBD values. NMDS plots were 
constructed at the genus level for each subgroup in order to establish whether there was sample 
clustering based on NEC status with respect to feeding regime. 
 
The subgroups showed greater differentiation between sample NEC status and clustering 
relative to the entire cohort (Figure 15), as confirmed by the increased R2 value (Table 12). 
However, there was a reduced significance for the sample distribution and association with 
NEC compared with the total cohort.  
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Samples from infants fed exclusively breast milk were seen to show greater separation with 
respect to NEC status, as indicated by the ellipses on the NMDS plot. These ellipses represent 
the centroid of the samples from each group. Infants on mixed feeding regimes were seen to 
cluster by NEC status less relative to the total case-control population. The lack of sampling 
density excluded formula fed infants from analysis. 
 
Although there was an increase in the variance of the communities for all subgroups, with each 
observed to have a significant association between sample distribution and NEC status, these 
differences were less significant than PERMANOVA/NMDS analysis of the whole cohort. 
This was likely due to the influence of feeding regime on the community composition (as 
previously described) which would result in community structures that are more similar across 
all samples. As shown by the reduction in variance described in the R2 scores. 
 
Table 12 PERMANOVA analysis of community composition and NEC status for samples subset 
according to feeding regimes at the genus taxonomic rank. *** = p-value less than 1x10-3, ** = p-value 
less than 1x10-2. * = p-value less than 0.05. 
   
 
Sum Of 
Squares 
Mean 
Squares F Model R2 Pr(>F)  
Formula Milk Only 0.9935 0.9935 3.9242 0.11568 0.006 ** 
Formula & Breast Milk 1.107 1.1068 4.6355 0.01469 0.007 ** 
Breast Milk Only  0.861 0.86102 3.1728 0.02296 0.016 * 
Cohort Genus Level 1.828 1.82789 7.1189 0.01461 0.001 *** 
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Figure 15 NMDS Plot for samples with community composition described at the Genus Level. A) Infants fed Exclusively Formula Milk. B) Infants on a 
mixture of formula and breast milk. C) Infants on a diet of exclusively breast milk.  
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4.4.3 Analysis of Sample Community Composition and Necrotising Enterocolitis Status 
for Infants Subset According to Delivery Method 
Delivery method was the next most significant categorical factor in the subset regression 
analysis. Subgroups of samples were generated according to delivery method and NMDS plots 
were constructed at the genus level for each subset. 
 
The clustering of samples from infants delivered vaginally just as significant with respect to 
their NEC status as seen in PERMANOVA analysis for the total cohort. This subset also 
accounted for a greater proportion of the variance within the sample distribution. The 
clustering of samples from infants delivered by caesarean section was less significant with 
respect to NEC, although the variance accounted for was similar to the entire case-control 
cohort sample population (Table 13).  
 
This showed that differences in community composition of infants delivered vaginally was 
greater between NEC and control samples compared to those delivered by caesarean section. 
This separation was shown clearly in the NMDS plots, wherein samples from vaginally 
delivered infants showed greater clustering relative to their NEC status (Figure 16). 
 
Table 13 PERMANOVA analysis of community composition and NEC status for samples subset 
according to delivery method at the genus taxonomic rank. *** = p-value less than 1x10-3, ** = p-value 
less than 1x10-2. 
 
  
Sums Of 
Squares 
Mean 
Squares F Model R2 Pr(>F)  
Vaginal Delivery 3.755 3.7547 13.854 0.0504 0.001 *** 
Caesarean Delivery 0.729 0.72923 3.4651 0.01572 0.007 ** 
Total at Genus Level 1.828 1.82789 7.1189 0.01461 0.001 *** 
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Figure 16 NMDS Plot for samples with community composition described at the Genus Level. A) 
Samples from infants delivered by caesarean section. B) Samples from infants delivered vaginally. 
 
 
4.4.4 Analysis of Sample Community Composition and Necrotising Enterocolitis Status 
for Infants Grouped by Delivery Method and Feeding Regime 
 
Infants fed on the mixed feeding regime and delivered vaginally were the most significantly 
associated with NEC status and sample distribution as well as accounting for the most 
variance. NEC status within this subset accounted for 10% of the total variance in sample 
distribution and the highest significance of association across all the subsets analysed (p = 
0.001) (Table 14). This was clearly shown in the NMDS plot by NEC samples being 
distributed towards lower X-axis values within this subgroup (Figure 17: C).  Community 
compositions from both mixed feed subgroups were seen be significantly associated with NEC 
status with the subset of infants delivered by caesarean section increasing to 3% of the variance 
accounted for (relative to the total cohort) (Figure 17: B). 
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Table 14 PERMANOVA analysis of community composition and NEC status for samples subset 
according to delivery method and feeding regime at the genus taxonomic rank. *** = p-value less than 
1x10-3, ** = p-value less than 1x10-2. * = p-value less than 0.05. 
 
  
Sums Of 
Squares 
Mean 
Squares F Model R2 Pr(>F)  
Formula & Breast Milk 
Vaginal Delivery 3.906 3.9056 16.011 0.10396 0.001 *** 
Formula Only 
Caesarean Delivery 1.462 1.46198 12.518 0.49056 0.002 ** 
Formula & Breast Milk 
Caesarean Delivery 1.019 1.0186 5.1139 0.02904 0.004 ** 
Breast Milk only 
Caesarean Delivery 0.4526 0.45259 2.4369 0.07752 0.065  
Breast Milk Only 
Vaginal Delivery 0.6054 0.60543 2.1185 0.01996 0.077  
Formula milk Only 
Vaginal Delivery 0.4007 0.40067 1.5041 0.09113 0.242  
Total at Genus Level 1.828 1.82789 7.1189 0.01461 0.001 *** 
 
Samples from infants delivered vaginally and fed exclusively breast milk were not observed to 
have a significant association in composition and NEC status (Figure 17: F). This subgroup 
showed a lower percentage of variance accounted for by NEC status compared to either the 
entire case-control cohort or the other subsets in Figure 17. While there is a lower level of 
clustering with respect to the NEC status of samples there is also a high level of separation 
between NEC and control samples. 
 
 
 
 
  
  112 
 
 
 
 
Figure 17 NMDS Plot for samples with community composition described at the Genus Level. A) 
Formula fed infants delivered by caesarean section. B) Formula fed infants delivered vaginally. C) 
Formula and breast milk fed infants delivered by caesarean section. D) Formula and breast milk fed 
infants delivered vaginally. E) Breast milk fed infants delivered by caesarean section. F) Breast milk 
fed infants delivered vaginally.
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4.4.5 Weighting Gestation and Age in NMDS Analysis of Sample Community 
Composition with Respect to Necrotising Enterocolitis 
 
The remaining continuous match factors (birthweight, gestational duration and age at 
sampling) were plotted as vectors over each NMDS plots to establish any association with 
sample distribution for the three subgroups with sufficient sampling depth. The vectors 
represented the strength of association a variable had with the distribution of samples within 
the NMDS plot. None of these factors showed strong association with the distribution of any 
subgroups any of the subgroups (Figure 18).  
 
The age at sampling was weighted on the NMDS plot using 2-D smoothing due to the 
significant association with LCBD values (Section 4.3) and it’s importance in statistical 
viability for case-control cohort  analysis412. Additionally, this factor was considered important 
from a biological perspective due to large fluctuations in the infant gut microbiome during the 
early stages of development311. There was no improvement in clustering for infants born by 
caesarean section on a mixed feeding regime when age was weighted in the NMDS plots 
(Figure 19: A).  
 
Infants fed exclusively breast milk and delivered vaginally showed some clustering (Figure 19: 
B) but this did not appear to be a clear improvement on the original NMDS plot (Figure 17: C). 
Samples from infants delivered vaginally and fed breast milk exclusively were seen to show 
poor clustering when age was weighted in the NMDS plot, although there was again 
marginally increased separation between NEC and control samples, relative to samples from 
caesarean delivered infants fed both formula and breast milk (Figure 19: C). 
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Figure 18 NMDS Plot for samples with community composition described at the Genus Level with 
vectors describing the association of sample distribution and gestational duration, birthweight (g) and 
age at sampling (days). A) Formula and breast milk fed infants delivered by caesarean section. B) 
Formula and breast milk fed infants delivered vaginally. C) Breast milk fed infants delivered vaginally.
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Figure 19 NMDS Plot for samples with community composition described at the Genus Level. Sample 
distribution was normalised using age at sampling. A) Formula and breast milk fed infants delivered by 
caesarean section. B) Formula and breast milk fed infants delivered vaginally. C) Breast milk fed 
infants delivered vaginally.
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4.5 Discussion 
This chapter aimed to identify match factors significantly associated with trends in the 
bacterial community of samples from NEC and control infants. This was quantified using the 
LCBD beta-diversity metric and tested using linear regression, subset regression and CCA. 
Once significant match factors were established with conserved trends in the community 
composition of samples, NMDS analysis was used to visualise how similar NEC and control 
infant gut communities were over the duration of sampling. PERMANOVA analysis was 
used on the NMDS plots to statistically tested the association of NEC and sample 
distribution. 
 
4.5.1 Sample Preparation, Amplification and Sequencing 
Sampling proved challenging due to the low quantity and inconsistency of faeces from 
infants diagnosed with NEC and their associated controls. This was likely due to NEC 
treatment often being in the form of nil-by-mouth in addition to the reduced passage of stool 
due to the symptoms of the disease. Low quantities of stool on the days where faeces were 
available also limited the success of DNA extraction, and by association, 16S V4 PCR 
amplification.  
 
To ensure that the time series would accurately represent differences in the microbiome of 
infants with NEC, only samples from controls that were assigned to successfully sequenced 
NEC patients were used for microbiome analysis. In addition to this, infants within the 
control groups were selected based on the presence of at least three samples from each infant 
over the time series. This sought to ensure that each subject contributed to the time series 
with enough samples to provide an average and identify any outliers for a given subject. 
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4.5.2 Establishing Key Match Factors Associated with Different Community 
Structures 
Subset regression identified that LCBD values were significantly associated with the age at 
sampling (Pr(>|t|) = 1.07x10-3). This supported the evidence that changes in beta-diversity 
over time in the early infant life are attributed to a colonisation pattern primarily instigated by 
pioneering bacteria from the mother and environment328,320.  Therefore, it was important to 
establish comparisons that were normalised for age, especially when identifying taxonomic 
differences between infant microbiomes as in the first year of life are typically characterised 
by low diversity and high instability311,416. 
 
Linear regression of LCBD values established age at sampling, gestational duration and 
feeding regime as being significantly associated with trends in the beta-diversity (Linear 
Regression: p = 1.33x10-15). 
 
Gestational duration has been shown to be correlated with Enterobacteriaceae and other 
potentially pathogenic bacteria such as Clostridium difficile or Klebsiella pneumoniae, which 
were found in greater abundances in preterm infants417. Full term infants were characterised 
by greater diversity and more of the common genera i.e. Bifidobacterium, Lactobacillus and 
Streptococcus418. Additionally, it has been shown that infants born after a shorter gestational 
duration were seen to have a delayed acquisition of Bifidobacterium and Collinsella 
species419. 
 
However, when sample distributions in NMDS plots were weighted by gestational duration 
there was no clear increase in the level of clustering of the samples with regards to their NEC 
status. This could have been due to all infants within this study being preterm and the 
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influence of gestational duration not being as prominent as it has been observed between 
preterm and term infants. 
 
The results from subset regression show that there was a clear association with the feeding 
regime and changes in the LCBD values of infant samples. Infants on a mixed feeding regime 
were seen to be the most significantly associated with trends in LCBD values (Pr(>|t|) = 
1.38x10-12), closely followed by infants exclusively fed breast milk ((Pr(>|t|) = 4.70x10-10). 
The association of feeding regime and the development of the infant microbiota has been 
explored extensively and believed to be highly influential in the composition and 
development of the microbiome in the first six months314,317,318.  
 
Analysis of LCBD values as a function of time suggested that infants fed a mixture of 
formula and breast milk were seen to have very stable LCBD values. This indicated that there 
was little change in the beta-diversity of individual samples compared to the sample 
population within this subset. This was contrary to those infants fed breast milk exclusively 
which appeared to have an increase in LCBD values initially before stabilising around 40 
days of age. The greater proportion of breast milk within the diet maybe linked with an 
increased rate of acquisition as observed in literature42, however the influence of formula 
milk on the development of the community cannot be discounted. Formula feeds could 
potentially reduce the colonisation rate of novel species within the community resulting in 
less differences between individual samples relative to the population, however it was not 
possible to observe this due to the lack of samples from infants fed exclusively formula milk.  
 
Further analysis should establish the influence of formula milk and breast milk independently 
and combined on the development of the microbiota. There was no distinction between NEC 
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and control samples for infants fed a mixed feeding regime. Infants fed exclusively breast 
milk were seen to differ between 28-40 days of age, however there were few NEC samples 
between these days and therefore the NEC mean assumed lacked statistical weight. Where 
there was sufficient sampling, i.e. before 28 days and after 40 days, case and control samples 
were seen to have very similar LCBD values, with overlapping standard errors. 
 
Whilst mode of delivery was not observed to be significantly associated with LCBD values it 
was observed to be an influential factor in the subset regression (Figure 10). The lack of 
association with changes in the community composition may be due to the duration of 
sampling. Samples taken closer to the delivery date are more likely to be influenced by the 
mode of delivery, however over the course of sampling in the population this association may 
be non-significant across the population. Additionally, some infants would not have been 
sampled close to the date of birth and the influence of delivery method is reduced in those 
cases. 
 
The increased significance of association between subset regression analysis and the mode of 
delivery is likely associated with infants sampled closer to the date of delivery. However, 
there is no negative influence with the inclusion of this factor for samples taken from infants 
at older ages. Therefore, mode of delivery can increase the predictability of LCBD values in 
some samples/subjects but this does not apply to all subjects in the population, only those 
sampled close to the date of birth. 
 
Mode of delivery has been extensively explored in previous literature as well, with evidence 
that the microbiomes of infants delivered vaginally are closely associated with the maternal 
faecal microflora156,309 and those delivered by caesarean section resemble the environmental 
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and mother’s skin microbiota309. Due to the proximity of sampling after delivery it was 
considered pertinent that community composition was assessed according to delivery method. 
 
When LCBD values were plotted by delivery method and age there were similar trends for 
samples from both groups, these both resembled the trends seen for samples from infants 
exclusively fed breast milk.  This confirmed that infant feeding regime was more influential 
than the mode of delivery over the duration of sampling. While samples subset by delivery 
method showed the greatest discrepancy between NEC and control infants the standard errors 
from case and controls were never distinct which indicated that there was substantial overlap 
in the LCBD values of the sampling populations. 
 
Each subject was seen to have significantly specific bacterial compositions and trends. This 
was assessed through CCA analysis of LCBD values with the inclusion of subject ID. Subject 
ID was seen to account for 78% of the variance between sample LCBD values (Pr(<F) = 
0.001). This inter-individual variability has been observed in infants419,420 and is likely a 
culmination of both match factors and other factors that were not accounted for, for example 
antibiotic administration, staff and site microbiomes  This demonstrated the difficulty 
challenge of identifying differences between case and controls subject samples when subject 
microbiomes were each so unique.  
 
Of all the factors that could not be accounted for antimicrobial administration was believed to 
be the most important. Premature infants are routinely administered antimicrobials as a 
preventative measure however NEC infants within the population were shown to be 
administered significantly more antimicrobials compared to non-NEC infants (Section 3.1.7, 
T-test: 0.95, 99.3: t = 14.86, p-value < 2.00x10-16, Figure 5).  
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Research into antimicrobials has shown that there is an association with administration and 
reduced taxonomic richness, diversity and evenness of the community, but the extent of this 
change is variable among individuals421,420. The severe side-effects of antimicrobial treatment 
on the gut microbiota range include self-limiting “functional” diarrhoea and life threatening 
pseudomembranous colitis422,423. Chronic conditions such as asthma and atopic disease have 
also been linked to long-term use of antimicrobials in children in addition to an altered 
intestinal microbiota424,425,426. While it has been shown the composition of the gut community 
returns to a community of similar structure these findings are primarily based on low 
resolution techniques421,427,428 and other studies have shown the effects of a single course of 
antimicrobials can persist for years429,430,431.  
 
Current literature reviewing the impact of antimicrobials is predominantly limited to a single 
type, class or regime432. Within the NICU infants are often on multiple antimicrobials which 
raises questions about the impact and lasting changes they are likely to incur. However, this 
also lowers the likelihood of finding appropriate control subjects when considering a disease 
such as NEC. Therefore, this should be of particular note in future research that this factor is 
a likely candidate for the inter-individual variation between subjects and could ultimately 
limit the ability to detect differences between NEC and control subjects. 
 
4.5.3 Taxonomic Rank that Best Discriminated Between Necrotising Enterocolitis and 
Control Samples  
Genera was identified as the most effective taxonomic level to discriminate between NEC 
and control samples using NMDS and PERMANOVA analysis of sample distributions 
(Pr(>F) < 0.001). Even when using genera only a very small percentage of the variance 
between NEC and control samples could be accounted for (R2 = 0.015). Therefore, analysis 
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of match factor subsets was used to identify distinct changes in the gut microbiome 
community of infants with NEC. 
 
4.5.4 Differentiation of Samples Based on Necrotising Enterocolitis Status and 
Community Composition 
As stated previously, existing literature has shown that samples from infants with NEC and 
their respective controls have been clustered independently110 but this study was from a 
single location using only one sample per subject. This limited the conclusions that could be 
made and extrapolated from the data. More recent large scale studies identified differences in 
the rarefied proportional abundances of aggregated samples46 but showed no evidence of 
independent clustering with NMDS analysis. 
 
Following this analysis, it was not possible to identify distinct clusters separating samples 
from infants with NEC and controls. However, it was possible to increase this 
differentiation/clustering between samples for some subgroups established earlier in the 
chapter.  
 
1.5% of the sample variance for the overall population when presented at the genus level in 
NMDS plots was explained by the distribution of NEC and control samples (PERMANOVA 
p = 0.001). When samples were subset by feeding regime infants fed breast milk exclusively 
increased to 2.9% but were considered non-significant (p = 0.08). Infants fed a mixture of 
formula and breast milk delivered vaginally or by caesarean were seen to be the most distinct 
(10% variance, p = 0.001 and 2.9%, p = 0.004, respectively). The lack significance for infants 
fed breast milk and delivered vaginally could be attributable to the low sample count or the 
lack of NEC samples over a large portion of sampling days. 
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The demonstrated that whilst inter-individual variation within the microbiome was a 
significant factor, and the composition of the microbiomes of NEC and controls were highly 
different, this difference could be reduced by accounting for the feeding regime and mode of 
delivery. By normalising for these match factors that are known to influence the composition 
and development of the microbiome it was possible to increase the clustering or separation of 
NEC samples from their controls. What cannot be accounted for within this analysis is the 
wide range of environmental influences that also contribute to the community composition 
such as antibiotic regime, health care worker microbiomes or the NICU microbiome.  
 
Although clustering has been demonstrated in other studies subject samples were subset 
according to the week of life that a subject was sampled over105. This however was not 
considered appropriate within the dataset presented here due to the lack of information 
regarding the date of NEC onset. Instead it was considered more appropriate to monitor the 
trends over time. This enabled a direct comparison of samples over the duration of sampling 
ages as well as the identification of time periods that lacked sufficient sampling. 
 
4.6 Conclusion 
Sufficient sampling density was established and allowed for the analysis of the microbiome 
of premature infants regarding diagnostic or prognostic factors associated with NEC. Due to 
many subjects yielding fewer than three samples, these could not be included in many gold 
standard NEC groups, though this was an inherent complication of NEC and as such little 
could be done to improve sampling success. 
 
The inter-individual variation between samples was the strongest factor associated with the 
community composition of samples, regardless of the infant’s NEC status. However, match 
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factors were observed to have significant associations with the community composition and 
this was demonstrated by subset regression and NMDS analysis. But by subsetting samples 
according to delivery method and feeding regime it was possible to increase the variance 
accounted for in the community composition. Two of these three groups were also considered 
to have a significant association in the sample distribution and NEC status. The one subset 
that was seen to be non-significant also showed increased separation but was limited by 
sample counts and potentially a lack of sampling for NEC subjects. Further analysis should 
describe the differences in taxonomy between these subsets to establish how NEC and control 
sample communities are different or whether there is an underlying pathogenic/probiotic 
taxa.
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5 Taxonomic Differences between NEC and Control 
Infants 
Subsets of samples using match factors that were most significantly associated with the altered 
beta-diversity trends did not clearly differentiate between NEC and control subjects (Section 
4.3).  However, it has been shown that differences could be associated with specific taxonomic 
groups (such as Clostridia433,434, Bifidobacteria435 and Lactobacillus436) rather than changes in 
the community composition.  
5.1 Background Literature on the Taxonomic Differences Associated with 
Necrotising Enterocolitis 
Sántulli et al were the first to suggest that bacterial colonisation was one of three critical 
factors in the occurrence of NEC437,438 (alongside mucosal injury and enteral feeding regime). 
This implication was built upon by common findings of bacteraemia439,440,441 and 
endotoxinaemia442,443 in infants with NEC. Increased dominance of Escherichia species 
preceding NEC was observed in small scale twin studies,110,444 and more recently in a large 
scale study by Warner et al,  which suggested that time-by-necrotising-enterocolitis was 
positively associated with Gammaproteobacteria (p = 1.00x10-3), and negatively associated 
with strictly anaerobic bacteria, specifically Negativicutes (p = 1.90x10-3).  
 
Morrow et al suggested that early and late onset NEC could be differentiated based on 
distinctive taxonomic differences relative to samples from control subjects. In infants with 
early onset NEC, the diagnostic markers were observed when the infant was between four to 
nine days of age, and consisted of a Firmicutes dominance, specifically Bacillus, 
Staphylococcus and Enterococcus genera. Late onset NEC was characterised by a Gram-
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negative Proteobacteria signature associated with Enterobacteriaceae of which the dominant 
genera were Enterobacter and Escherichia102.  
 
Whilst no single pathogenic strain has consistently been associated with the gut microbiome of 
infants with NEC, these communities are very complex and highly unique to individuals; 
therefore identifying a specific pathogen can be challenging without multiple large scale 
studies and consideration of environmental factors that influence the gut microbiome 
composition. 
 
As discussed in Section 1.9.2, the human gut is exposed to a vast number of foreign 
microorganisms following birth, and must be able to distinguish those harmless, dietary 
microbial antigens from the potential pathogens. The neonatal immune system is dependent on 
external stimuli to develop the mature immune competence required in the formation of a 
stable, healthy gut microbiome. Breast milk and indigenous intestinal microbiotas are 
considered the most appropriate sources of maturational stimuli445. A critical paper by Sudo et 
al in 1997 demonstrated that key members of the intestinal community, Bifidobacterium 
infantis, restored oral tolerance to germ-free neonatal mice through the modulation of the IgE 
response to allergens446. In the same paper, other primary members of the murine gut 
microbiome, Bacteroides, were also shown to correct defective immune maturation. 
 
Previous evidence has shown that Bifidobacteria are one of the dominant strains in term 
infancy. In conjunction with Lactobacilli, Bifidobacteria are known to promote indigenous 
lactic-acid bacterial (bifidogenic effect) through the production of short-chain fatty acids292, 
447,448. The liberation of short-chain fatty acids is an important energy source for the intestinal 
mucosa, as well as modulating the immune response and tumour genesis in the gut6.  
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There is also evidence within gut microbiome studies of bacteria contributing beneficial effects 
to the host, i.e. probiotic bacterial species. It has been suggested that an absence or reduced 
presence of beneficial bacteria is responsible for the occurrence of NEC. One of the first 
investigations into the efficacy of probiotics was by Hoyos in 1999, who showed that daily 
administration of Lactobacillus and Bifidobacteria could be associated with a decrease in the 
mortality rates of NEC when administered as a probiotic436. Two further large-scale studies 
identified that the use of Bifidobacteria and Lactobacillus in combination with breast milk 
significantly reduced NEC incidence155,449. These studies were based on evidence that term 
infants have a higher frequency of Bifidobacteria and Lactobacillus species450 relative to 
preterm infants. Evidence has also suggested an absence of Propionibacterium in the first week 
could be implicated in the onset of NEC102. Propionibacterium is a genus of gram-positive, rod 
shaped bacteria named for their ability to synthesise propionic acid using transcarboxylase 
enzymes451. 
 
While being much simpler than the adult gut community the premature infant gut microbiome 
is still highly complex. Therefore, the interactions and contributions of community members 
are still poorly understood at the community level, meaning that the beneficial or pathogenic 
impact a given strain has on the host is difficult to establish. There are contradicting reports 
between probiotic clinical trials of NEC in relation to the efficacy of the Bifidobacteria genus 
in preventing NEC morbidity, for example, Bifidobacterium breve BBG-001 showed no 
significant difference in the rates of outcomes for infants and NEC when administered as a 
probiotic in a large scale, randomised clinical study452.  
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The literature described in this introduction shows that the presence of pathogenic taxa or the 
absence of beneficial, probiotic, bacteria are implicated in the occurrence and mortality rate of 
NEC. However, neither has been shown to be consistently responsible across studies, although 
there is an argument that Gammaproteobacteria are widely observed to be associated with NEC 
and that some Bifidobacteria have a demonstrably beneficial impact on the outcome of NEC. 
What is clear across studies is that the preterm infant microbiome is a volatile environment 
which is influenced by delivery method, NICU, antibiotic administration, and feeding 
regimes309,155,390. This results in a highly unique community specific to each individual infant, 
which was shown to be true in the CCA analysis of Chapter 4 Section 3. As such, comparisons 
between subjects are challenging, both as a community level and at the taxonomic level, as the 
microbiomes are rarely consistent between twin pairs and clearly become more disparate 
within population level studies. 
 
This places greater importance on the statistical methods in which changes in abundances of 
taxa are measured and compared between groups. The industry standard has been to rarefy 
highly variable count data produced using high-throughput sequencing technology to an 
appropriate level, using the rarefying technique developed in 1968 by Howard Sanders453. 
Rarefaction is based on the construction of rarefaction curves. These plot the number of taxa as 
a function of the number of samples. Usually the initial curve of the rarefaction plot is steep as 
the most common taxa are readily found, but the curve will plateau off as only the rare taxa 
remain to be sampled. The rarefaction curves are generated by randomly re-sampling the pool 
of samples multiple times and plotting the average number of taxa found in each sample.  
 
Whilst this methodology is straight forward and easy to understand, make comparisons and 
visualise complex datasets produced from high-throughput sequencing, it also simplifies to the 
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lowest sample count within the population and adds noise within the data through the random 
subsampling454.  
 
The DESeq2 R package378 allowed for negative binomial normalisation for abundance data 
without the requirement of rarefaction. This enabled the comparison of taxonomic abundances 
between two categorical groups without the addition of noise or omission of valid data. 
 
Log2 fold analysis identified those OTUs that were significantly elevated or decreased relative 
to NEC status. The results of this output were then used as a training set for Random Forest 
modelling to identify those OTUs that had the greatest ability to discriminate between NEC 
and controls. Random Forest results were summarised by Mean Decreased Accuracy and the 
Mean Decreased Gini Index; in both metrics, the greater the value, the more important the taxa 
were in the model. 
 
The Mean Decreased Accuracy is computed from permuting the “out of the bag” (OOB) data. 
For each tree, the prediction error on the OOB portion of the data is recorded (error rate). The 
same is then done after permuting each predictor variable. The difference between the two are 
then averaged over all the trees and normalised by standard deviation of the differences. If the 
standard deviation of the differences is equal to 0 for a variable, then the division is not done. 
This represents the mean decrease in accuracy of a model without this variable included, and 
effectively calculates the accuracy of the predictive OTU. 
 
The Gini Index is the total decrease in node impurities from splitting on the variable, averaged 
over all the trees. It is used to describe the overall explanatory power of the variables, i.e. are 
  130 
they all equally important or does one have greater explanatory value. This yields an overall 
sum of the explanatory relationships between the variables selected. 
 
The combination of these strategies enabled the identification of taxa that were consistently 
observed to be significantly different between control and NEC samples, without the loss or 
distortion of count data, and to establish predictive capability of those taxa using Random 
Forest machine learning. Analysis focused at the genus level as this taxonomic rank was shown 
by PERMANOVA to be have the most significant difference between NEC and control sample 
community compositions. Both subset regression and NMDS analysis indicated that feeding 
regime and method of delivery were key criteria in the distinction of beta-diversity trends and 
community compositions for NEC and control subject samples. Further analysis into these 
differences focused on subgroups consisting of more than three subjects per group; all infants 
fed both formula and breast milk, regardless of delivery method, in addition to infants fed 
exclusively breast milk and delivered vaginally. These methods were used initially at the genus 
level but analysis was also performed at the species level to establish potential pathogenic or 
probiotic species consistent with the occurrence or absence of NEC. Analysis was compared 
between subsets and the population of samples to identify whether there was an improvement 
in the detection of NEC based on taxonomic genera/species relative to samples from all the 
subsets investigated.  
5.2 Infants Fed Formula and Breast Milk Delivered by Caesarean Section 
5.2.1 Significantly Different Genera Between Necrotising Enterocolitis and Control 
Samples 
When sample taxonomic abundances were normalised and summarised by log2 fold change, 
that is an increase of 100% of the original abundance observed. In total 10 genera were seen to 
have significant differences between NEC and control subjects. Three of these differences had 
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high mean abundances (Figure 20); these were associated with Bifidobacterium, Streptococcus 
and Proteus (Table 15).  
 
Bifidobacterium was seen to have a much greater mean abundance (2950) relative to all other 
genera that were significantly different. Proteus and Streptococcus were also some of the most 
abundant genera observed in samples, with mean abundances of 390 and 477 respectively. All 
other significantly different genera were considered to be minor community members with 
mean abundances lower than 80.  
 
 
Figure 20 Genera with log2 fold differences between samples from NEC and control subjects delivered 
by caesarean section fed formula and breast milk. 
 
Dialister was the most significantly different genus between NEC and control subject samples 
and was seen to be elevated in NEC samples (P-adjusted = 2.685x10-33) (Figure 21). 
Bifidobacterium (P-Adjusted = 6.62x10-17), Streptococcus (P-Adjusted = 2.56x10-11) and 
Staphylococcus (P-Adjusted = 1.54x10-9) had significantly greater abundances in control 
samples. Proteus appeared to have very similar mean abundances but with a subset of control 
Dialister 
Bifidobacterium 
Proteus 
Streptococcus 
Staphylococcus 
Aggregatibacter Eubacterium 
Dorea 
Phascolarctobacterium 
Ruminococcus 
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samples with greater abundances relative to the rest of the population. This resulted in a 
significant P-adjusted value that suggests the populations are significantly different, however 
the majority of samples appeared to have similar abundances between NEC and control 
subjects.  
 
These P-adjusted values were calculated as a population without factoring in the age at 
sampling, which is known to be a key factor in the development and colonisation of the gut 
microbiota. Therefore, further assessment focused on the changes occurring relative to the age 
that an infant was sampled. 
 
Table 15 Summary of all genera with log2 fold significant differences for normalised abundances of 
NEC and control subject samples. 
 
Genera Base Mean Log2 fold Change P-Adjusted 
Dialister 71.32 -5.45 2.69x10-33 
Dorea 2.71 -2.59 1.13x10-18 
Bifidobacterium 2949.49 4.65 6.62x10-17 
Phascolarctobacterium 2.57 -2.49 9.85 x10-17 
Ruminococcus 2.27 -2.12 4.42x10-13 
Proteus 389.54 4.24 3.43x10-12 
Streptococcus 477.23 3.50 2.56x10-11 
Staphylococcus 19.69 2.48 1.54x10-9 
Aggregatibacter 27.24 2.94 5.78x10-9 
Eubacterium 6.14 2.04 2.05x10-6 
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Figure 21 Genera with log2 fold differences between samples from NEC and control subjects fed 
formula and breast milk and delivered by caesarean section.  
 
5.2.2 The presence of Different Genera between Necrotising Enterocolitis and Control 
Samples over Time 
Initially, Aggregatibacter was seen to have similar mean abundances at earlier ages in both 
control and case samples over time. After 30 days of age controls, samples maintained a lower 
mean abundance of Aggregatibacter compared to NEC samples (Figure 22: A). However, 
across the sampling period the standard error consistently showed an overlap between the two 
groups, indicating that the overall the abundances were similar. 
 
Bifidobacterium was the only genus observed to have greater normalised abundances in 
samples from control subjects relative to NEC subjects. In both case and control samples there 
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was a positive correlation with age and the abundance of this genus. The increase in abundance 
occurred at an earlier age in control subjects (~15 days) compared to NEC subjects (~28 days). 
NEC samples were seen to decline in abundance after ~35 days of age (Figure 22: B). 
 
Dialister was seen to fluctuate in NEC samples over time, with an initially high abundance at 
earlier ages which declined up to ~25 days of age. Between 25 - 35 days, NEC samples 
increased in mean abundance before returning to similar levels to those observed in controls by 
day 50. In contrast, controls maintained a very low, stable abundance over the duration of 
sampling (Figure 22: C). 
 
The mean abundance of Dorea in NEC samples showed a continued increase from the start of 
sampling up to ~35 days of age, after which there was a decline to similar levels observed in 
control samples. Control samples maintained a very low, stable abundance similar to that 
observed for Dialister (Figure 22: D). 
 
The mean abundance of Eubacterium in both control and NEC samples was similar over the 
duration of sampling, with overlapping standard errors. The normalised abundances in samples 
from case and controls were seen to increase gradually over time, although there was some 
evidence that NEC samples declined in abundance after 40 days of age (Figure 22: E). 
 
Up to ~25 days of age, the mean abundance of Phascolarctobacterium was seen to be very low 
and stable in both case and control samples. After 25 days of age, NEC samples showed an 
increase in mean abundance up to ~35 days of age, after which there was a decline to similar 
levels observed in control samples. Control samples maintained the same level of abundance 
over the duration of sampling (Figure 22: F). 
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 Figure 22 Nonparametric regression analysis for normalised log-abundances for genera 
observed to be significantly different between NEC and control samples, plotted against the age at 
sampling and coloured by NEC status. (A) Aggregatibacter. (B) Bifidobacterium. (C) Dialister. (D) 
Dorea. (E) Eubacterium. (F) Phascolarctobacterium. (G) Proteus. (H) Ruminococcus. (I) 
Staphylococcus. (J) Streptococcus. 
 
The mean abundance levels for Proteus were observed to maintain a stable level over the 
duration of sampling for both NEC and control samples. There was some evidence of a slow 
decline in abundance for controls, and a similarly slow increase in abundance for NEC 
samples. However, the overlap of standard error over the duration of sampling suggested that 
these differences would not differentiate between the case and controls (Figure 22: G). 
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The normalised abundances for Ruminococcus in both NEC and control samples taken at early 
ages were similar up to 20 days of age. After 20 days, NEC samples saw an increase in the 
abundance of Ruminococcus up to ~35 days of age; returning to similar levels observed in 
controls by day 50. In contrast, control samples maintained the same normalised abundance 
level over the duration of sampling (Figure 22: H) 
 
The mean abundance of Staphylococcus appeared to be greater in controls at earlier ages, but 
both case and control samples showed a similar decline in abundance after the start of 
sampling. NEC samples were seen to increase in abundance after 20 days of age up to ~38 
days, before declining from then on. Staphylococcus in control samples were seen to increase 
in abundance after 25 days of age but at a slower rate relative to NEC samples.  The standard 
errors between the case and control samples overlapped for much of the sampling duration, 
again suggesting that as a population there was little differentiation between the samples 
(Figure 22: I). 
 
Over the duration of sampling the changes in mean abundance of Streptococcus in both case 
and control samples exhibited similar trends, with a decline in abundance up to 30 days of age 
followed by a gradual increase in abundance. There was some evidence for a decline in control 
samples after 40 days of age. The mean abundances for both groups were similar over the 
duration of sampling and the overlap in standard error indicated that this genus would not 
provide a clear means of differentiation (Figure 22:I). 
 
Bifidobacterium was the only genus observed to be significantly elevated in control samples 
over the duration of sampling and maintained a high mean abundance, as demonstrated by the 
lack of overlapping standard error in the graph. Dialister, Dorea, Phascolarctobacterium and 
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Ruminococcus were all observed to show distinct peaks in NEC samples at later ages however 
they were also heavily influenced by a small number of samples with high abundances. 
 
5.2.3 Random Forest Analysis of Genera Predictive of Necrotising Enterocolitis 
Using machine learning techniques it was possible to identify complex patterns in the different 
abundances of bacteria that would otherwise be extremely time consuming and prohibitively 
difficult to perform manually. Using Random Forest it was possible to attribute a schema for 
the different bacterial abundances and a success rate in the identification of NEC subjects.   
 
Confusion matrices for Random Forest models were generated using the ten significantly 
different genera and compared against models using all genera (total number of genera = 221) 
observed within the samples. The model that used significantly different genera had a 9% 
improvement in correctly identifying samples from NEC subjects compared to models utilising 
all the genera observed within this subset of infants (Table 16). 
Table 16 Summary Tables for Random Forest model predictions of the NEC status of infants using the 
genera composition of samples. 1,500 trees were constructed for both models. (A) Using only genera 
identified as being significantly different between NEC and controls, three variables tried at each split. 
(B) Using all genera identified within the communities, twelve variables tried at each split 
A) 
Confusion matrix Confirmed Control Class Error 
Confirmed 35 17 0.33 
Control 5 116 0.04 
OOB estimate of error rate 0.13% 
B) 
Confusion matrix Confirmed Control Class Error 
Confirmed 30 22 0.42 
Control 8 113 0.07 
OOB estimate of error rate 0.17% 
 
All genus with log2 fold differences were seen to be important in the Random Forest model 
generation, however, Bifidobacterium demonstrated the most association with increased model 
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prediction in both the accuracy and the Gini Index scores (Figure 23). Bifidobacterium, which 
was associated with increased abundances in control samples, reduced the model accuracy by 
~45%. Dialister, which was shown to be associated with NEC subjects, was of similar 
importance and the second most influential genus in the model generation. The mean decreased 
Gini Index scores also indicated that Staphylococcus was important in the prediction accuracy 
of the model.  
 
These scores were reinforced when the model tree structure was represented graphically. 
Samples with normalised abundances of Bifidobacterium > -9.28 and Staphylococcus > -11.54 
were observed to be associated with control subjects only. Infants that had Dorea abundances 
of < -11.67, even when Staphylococcus was in abundance < -11.54, were also observed not to 
be associated with NEC. Even if infants were seen to have low abundances of Bifidobacterium 
(< -9.28), if they also maintained low abundance of Aggregatibacter (< -11.97) and high 
abundances of Staphylococcus (>-12.08), they were not associated with NEC (Figure 24). 
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Figure 23 Random Forest summary graphs describing the ability of genera that were seen to be 
significantly different between NEC and control samples in formula and breast milk delivered by 
caesarean section to predict the NEC status of an infant. (A) Mean Decreased Accuracy for phyla with 
log-2 fold. (B) Mean Decrease Gini Index scores. 
 
 
0
10
20
30
40
B
ifi
do
ba
ct
er
iu
m
D
ia
lis
te
r
St
ap
hy
lo
co
cc
us
Ph
as
co
la
rc
to
ba
ct
er
iu
m
D
or
ea
A
gg
re
ga
tib
ac
te
r
E
ub
ac
te
ri
um
R
um
in
oc
oc
cu
s
Pr
ot
eu
s
St
re
pt
oc
oc
cu
s
M
ea
n 
D
ec
re
as
e 
A
cc
ur
ac
y
0
3
6
9
12
B
ifi
do
ba
ct
er
iu
m
D
ia
lis
te
r
St
ap
hy
lo
co
cc
us
Ph
as
co
la
rc
to
ba
ct
er
iu
m
D
or
ea
A
gg
re
ga
tib
ac
te
r
Pr
ot
eu
s
E
ub
ac
te
ri
um
R
um
in
oc
oc
cu
s
St
re
pt
oc
oc
cu
s
M
ea
n 
D
ec
re
as
e 
G
in
i
  141 
 
Figure 24  
Tree representation of 
Random Forest decision 
based prediction of NEC 
status using the log-
normalised genera 
abundance of taxa observed 
to be significantly different 
in abundance between case 
and control samples. Values 
in the tree represent the log 
normalised value that a 
given decision is made upon. 
There is a complex hierarchy 
of decisions in the prediction 
of NEC status with an error 
rate of 0.33. The importance 
of Bifidobacterium is 
represented with three of 
four forks associated with 
log scores greater then -9.28 
resulting in a control 
diagnosis. This diagnosis is 
also associated with a high 
abundance of 
Staphylococcus. 
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5.2.4 Diagnostic Species 
Many studies focus analysis at the genus level, however very few give reasons for doing so. 
Using the Bray-Curtis measure of dissimilarity, PERMANOVA analysis of the NMDS for the 
community compositions at the different taxonomic levels showed that the greatest distinction 
between NEC and control samples was observed at the genus level. This would provide the 
best level to identify taxa that discriminated between NEC and control samples, therefore it 
was the focus of further analysis. However, there is evidence that this leads to over 
simplification and that at the sub-genus level there have been observed associations, 
particularly with Prevotella and Bacteroides, to specific dietary patterns455. 
 
This subgroup was analysed for diagnostic species that could be indicative of NEC or 
associated with the genera that were seen to be significantly different between NEC and 
control samples. Three species were observed to be significantly different between NEC and 
control subjects (Table 17), however, only Clostridium butyricum was observed to differ in 
normalised abundance when age at sampling was factored in (Figure 25). This species was 
seen to be elevated in NEC subjects, though this was specifically associated with the one 
subject UHCW062 and therefore not representative of the whole NEC population. 
 
Table 17 Summary of all species with log2 fold significant differences for normalised abundances of 
NEC and control subject samples. 
 
Species Base Mean Log2 fold Change P-Adjusted 
Clostridium butyricum 11.98 -4.56 2.69x10-35 
Streptococcus anginosus 126.51 6.58 7.17x10-34 
Eubacterium dolichum 6.11 2.19 5.67x10-7 
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Figure 25 Nonparametric regression analysis for normalised log-abundances for Clostridium butyricum 
observed to be significantly different between NEC and control samples, plotted against the age at 
sampling and coloured by NEC status.  
 
Using the species that were significantly different between NEC and control samples in the 
Random Forest model showed that there was a reduction in the ability to identify samples from 
NEC subjects by 9% compared to the model that used genera that were significantly different 
(Table 18: A). The error rate of the Random Forest model was increased to 48% when utilising 
all the species observed within samples (Table 18: B). This suggested that species’ differences 
were not as useful in discriminating between NEC and control samples compared to the 
predictive capabilities of models using genera. 
 
 
 
 
 
 
NEC Status 
  Confirmed 
  Control 
 
  144 
 
Table 18 Summary Tables for Random Forest model predictions of the NEC status of infants using the 
species composition of samples. 1,500 trees were constructed for both models. (A) Using only species 
identified as being significantly different between NEC and controls, one variable tried at each split. (B) 
Using all species identified within the communities, ten variables tried at each split. 
(A) 
Confusion matrix Confirmed Control Class Error 
Confirmed 30 22 0.42 
Control 17 104 0.14 
OOB estimate of error rate 22.54% 
 
(B) 
Confusion matrix Confirmed Control Class Error 
Confirmed 27 25 0.48 
Control 9 112 0.07 
OOB estimate of error rate 19.65% 
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5.3 Infants Fed Formula and Breast Milk Delivered Vaginally 
5.3.1 Significantly Different Genera Between Necrotising Enterocolitis and Control  
NEC and control samples from infants that were delivered vaginally and fed both formula and 
breast milk were seen to have four significantly different genera when all samples were 
compared (Figure 26). Bifidobacterium and Bacteroides had the highest mean abundances 
(8678 and 6652, respectively) and log2 fold changes (9.36 and 7.90, respectively) of all genera. 
Veillonella was also seen to have a high mean abundance (6971) but with the lowest difference 
represented by log2 fold change (2.22). Megamonas was seen to be the third most significant 
genus of the four but had the lowest mean abundance of all the significant genera (16) (Table 
19).  
 
 
Figure 26 Genera with log2 fold differences between samples from NEC and control subjects fed 
formula and breast milk and delivered vaginally. 
 
 
 
 
Bifidobacterium 
Bacteroides 
Megamonas 
Veillonella 
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Table 19 Summary of all genera with log2 fold significant differences in normalised abundances 
between  
Genera Base Mean Log2 fold Change P-Adjusted 
Bifidobacterium 8678.09 9.36 1.72x10-86 
Bacteroides 6652.56 7.90 9.17x10-54 
Megamonas 16.14 3.63 6.25x10-17 
Veillonella 6971.39 2.22 9.00x10-6 
 
When time was not factored into the analysis, samples from control subjects were seen to have 
greater means for log normalised abundances in Bifidobacterium and Veillonella. NEC subjects 
were seen to have a greater mean abundance for Bacteroides. Megamonas had very similar 
means for both case and control samples, however a small subset of control samples were seen 
to have elevated abundances relative to the rest of the cohort, this led to the significance 
observed in the P-adjusted score. Overall, the majority of samples had similar abundances of 
Megamonas (Figure 27). 
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Figure 27 Genera with log2 fold differences between samples from NEC and control subjects delivered 
vaginally fed formula and breast milk.  
 
5.3.2 Significantly Different Genera between Necrotising Enterocolitis and Control 
Samples over Time 
The normalised abundances of Bacteroides in both NEC and control samples showed very 
similar trends and normalised abundances over time, as characterised by the overlapping 
standard errors. However, an increase in abundance was seen for control infants in samples 
taken after 50 days of age. NEC samples did not show this increase in abundance and had 
similar levels on day 75 as on day 50 (Figure 28:A). 
 
Overall, Bifidobacterium was observed to have consistently greater normalised abundances in 
control samples for the duration of sampling and exhibited an increase from the start of 
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sampling up to ~25 days of age, before declining to similar values observed in NEC samples. 
At day 50, the abundance of Bifidobacterium in control samples rose again. By day 75, 
samples had the greatest mean abundance observed for control samples over the course of 
sampling (Figure 28:B). Samples from NEC subjects showed little to no change over time 
aside from a slight decrease at ~40 days of age. The standard error for the mean abundance of 
Bifidobacterium was clearly distinct aside from days 30-40.  This suggests that the initial 
abundance and abundances at later ages differed between case and controls, although there 
were some control samples with abundances of Bifidobacterium that were as low or lower than 
those observed in NEC samples. 
 
Megamonas showed no difference in the trends or abundance of NEC and control samples over 
the duration of sampling, with the exception of an elevated initial abundance in control samples 
at the start of sampling (Figure 28:C). This initially high abundance value was skewed by 
samples from UHCW078 only. UHCW078 had a higher than average gestation duration (31 
weeks) and birthweight (1,880g) relative to the control cohort (27 weeks and 1,419g) which 
could have accounted for the initial high abundance of Megamonas. 
 
Veillonella maintained a higher abundance in control samples and showed a clear, steady 
increase over time (Figure 28:D). NEC samples fluctuated over the course of sampling, with an 
initial increase up to ~30 days of age, after which there was a dramatic decline up to day 50. 
The mean abundance for Veillonella appeared to stabilise after this time point. After ~38 days 
of age the standard error for each group showed little crossover, suggesting that as a 
population, control subjects maintained a higher normalised abundance of Veillonella at later 
ages compared to NEC subjects. 
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Figure 28 Nonparametric regression analysis for normalised log-abundances for genera observed to be 
significantly different between NEC and control samples, plotted against the age at sampling and 
coloured by NEC status. (A) Bacteroides. (B) Bifidobacterium. (C) Megamonas. (D) Veillonella. 
 
5.3.3 Random Forest Analysis of Genera Predictive of Necrotising Enterocolitis 
Confusion matrices for Random Forest models were generated using the four significantly 
different genera and compared against models using all genera observed within the samples 
(total number of genera = 166). The model using significantly different genera was observed to 
have a much greater error rate when predicting NEC samples (24%) when compared to the 
model using all genera observed in the samples (12%). Both models from samples within this 
subset could discern samples from NEC subjects with lower class error scores than those 
observed for infants delivered by caesarean section on the same feeding regime. 
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Table 20 Summary Tables for Random Forest model predictions of the NEC status of infants using the 
genera composition of samples. 1,500 trees were constructed for both models. (A) Using only genera 
identified as being significantly different between NEC and controls, three variables tried at each split. 
(B) Using all genera identified within the communities, twelve variables tried at each split. 
(A) 
Confusion matrix: Confirmed Control Class Error 
Confirmed 44 14 0.24 
Control 13 69 0.16 
OOB estimate of error rate 19.29 
(B) 
Confusion matrix: Confirmed Control Class Error 
Confirmed 51 7 0.12 
Control 7 75 0.09 
OOB estimate of error rate 10.00 
 
Bifidobacterium was the most important genus in the distinction of NEC and control samples; 
this is seen through both the mean decreased accuracy and mean decreased Gini scores for the 
model constructed from significantly different genera (Figure 29). This genus was seen to have 
almost double the mean decreased accuracy score relative to Veillonella, the next most 
important genera in the model decision tree.  
 
Further investigation found that an unknown genus was observed to be the most important in 
the Random Forest tree construction when all genera were considered for the model, however, 
no further information was available in terms of taxonomic annotation. Additionally, the genus 
Pantoea was seen to be the second most significant taxa in discriminating between NEC and 
control samples, followed by Bifidobacteria.  
 
The importance of Bifidobacterium was further reinforced when the Random Forest tree was 
visualised (Figure 30). Samples with Bifidobacterium abundances greater than -8.17 were 
highly likely to be assigned as controls. After Bifidobacterium, Veillonella and Bacteroides 
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were seen to be important in the assignment of NEC status, specifically, low Veillonella (< -
1.99) and high Bacteroides (> -7.85) abundance.  
 
Figure 29 Random Forest Summary graphs describing the ability of genera that were seen to be 
significantly different between NEC and control samples in formula and breast milk delivered vaginally 
to predict the NEC status of an infant. (A) Mean Decreased Accuracy for phyla with log-2 fold. (B) 
Mean Decrease Gini Index scores. 
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Figure 30 Tree representation of 
Random Forest decision based 
prediction of NEC status using the 
log-normalised genera abundance of 
taxa observed to be significantly 
different in abundance between case 
and control samples. Values in the 
tree represent the log normalised 
value that a given decision is made 
upon. There is a complex hierarchy 
of decisions in the prediction of 
NEC status with an error rate of 
0.24. Increased abundance of 
Bifidobacterium associated with 
controls when values were greater 
than -8.17. High abundances of 
Veillonella (>-1.99) and Bacteroides 
(>-7.85) were associated with NEC 
samples  
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5.3.4 Diagnostic Species 
Three species were identified as being significantly different between NEC and control samples 
when the age at sampling was not considered in the analysis (Table 21). Only Streptococcus 
agalactiae showed a clear diagnostic signal when plotted over time, however, the standard error and 
trend lines for the NEC samples were heavily skewed by the NEC subject BWH221 (Figure 31). 
BWH221 was the only subject to have normalised sample abundances between -2.5 and -7.5 and 
therefore did not reflect the NEC population accurately. The species was therefore not considered to 
be a diagnostic signal. 
Table 21 Summary of all species with log2 fold significant differences for normalised abundances of NEC 
and control subject samples.  
 
Species Base Mean Log2 fold Change P-Adjusted 
Bacteroides fragilis 6626.32 8.40 5.94x10-54 
Streptococcus agalactiae 11.80 -4.16 1.28x10-29 
Clostridium perfringens 809.04 2.85 2.84x10-8 
 
 
Figure 31 Nonparametric regression analysis for normalised log-abundances for Streptococcus agalactiae 
observed to be significantly different between NEC and control samples, plotted against the age at sampling 
and coloured by NEC status. 
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The class error for NEC sample identification was the same when using significantly different 
species as when using significantly different genera (24%, Table 22: A), however, this error rate was 
increased when all genera were used in the model construction (Table 22: B). In contrast, when all 
genera were used to construct a Random Forest model, the error rate was substantially reduced to 
12%. 
Table 22 Summary Tables for Random Forest model predictions of the NEC status of infants using the 
species composition of samples. 1,500 trees were constructed for both models. (A) Using only species 
identified as being significantly different between NEC and controls, one variable tried at each split. (B) 
Using all species identified within the communities, seven variables tried at each split. 
(A) 
Confusion matrix Confirmed Control Class Error 
Confirmed 44 14 0.24 
Control 15 67 0.18 
OOB estimate of error rate 20.71% 
 
(B) 
Confusion matrix Confirmed Control Class Error 
Confirmed 43 15 0.26 
Control 10 72 0.12 
OOB estimate of error rate 17.86% 
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5.4 Infants Exclusively Fed Breast Milk and Delivered Vaginally 
5.4.1 Significantly Different Genera Between Necrotising Enterocolitis and Control 
Samples 
Of the five genera observed to have significantly different abundances between NEC and 
control samples in infants delivered vaginally and fed exclusively breast milk, three were seen 
to have high log2 fold changes and mean abundances (Figure 32). 
 
Figure 32 Genera with log2 fold differences between samples from NEC and control subjects 
exclusively fed breast milk and delivered vaginally. In total four genera were observed to be 
significantly different between case and control samples within this subset. 
 
Proteus was the most significantly different genera between NEC and control subjects when 
age was not factored into the analysis (P-adjusted = 3.46x10-30), but Bacteroidetes had the 
greatest mean abundances across all samples (15403). Clostridium and Bifidobacterium were 
also seen to be significantly different and maintain high mean abundances (374 and 265, 
respectively). Yersinia was the genus with the lowest significant difference (5.59x10-5), base 
Bifidobacterium Clostridium 
Bacteroides 
Yersinia 
Proteus 
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mean abundance (6), and log2 fold change (2.11) of all significantly different genera (Table 
23). 
Table 23 Summary of all genera with log2 fold significant differences in normalised abundances 
between NEC and control samples for all infants fed breast milk exclusively and delivered vaginally. 
Ordered by adjusted P-value scores. 
Genera Base Mean Log2 fold Change P-Adjusted 
Proteus 240.72 -5.86 3.46x10-30 
Clostridium 374.43 4.93 2.88x10-18 
Bifidobacterium 265.33 5.04 1.73x10-17 
Bacteroides 15402.50 4.29 3.30x10-10 
Yersinia 5.66 2.11 5.59x10-5 
 
Proteus displayed similar means for both case and control sample normalised abundances, with 
a marginally greater mean in NEC samples (Figure 33). Clostridium appeared to have the 
greatest difference when samples were analysed as a whole, with a greater mean abundance in 
control samples. Bifidobacterium and Bacteroides also had greater mean abundances in control 
samples, whereas Yersinia showed negligible differences, although control samples did appear 
to have a higher abundance in the 3rd quantile. 
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Figure 33 Genera with log2 fold differences between samples from NEC and control subjects 
exclusively fed breast milk and delivered vaginally. 
 
5.4.2 Significantly Different Genera between Necrotising Enterocolitis and Control 
Samples over Time 
When plotted against time, Bacteroides showed an increase in abundance for samples from 
control infants, up to approximately 40 days of age (Figure 34: A). However, this was skewed 
by one subject (BWH204) which had very high abundances relative to the other controls. 
BWH204 had a lower than average gestational duration of 28 weeks compared to the control 
cohort average of 30, though the birthweight of 1,200g was similar to that observed for most 
control subjects (mean = 1,419g). The only other medical information that could have 
differentiated this subject was that the vaginal delivery was a breach. If BWH204 was not 
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considered, the abundances in NEC and control samples would be very similar over the 
duration of sampling. 
 
On average, Bifidobacterium abundance was greater in control samples than NEC samples over 
the duration of sampling. In both control and NEC samples Bifidobacterium maintained a 
stable abundance throughout the sampling period. However, the difference in abundance was 
not enough to discriminate between NEC and control samples due to the overlapping standard 
errors (Figure 34: B).  
 
The mean abundance of Clostridium was seen to increase in control samples from an early age, 
up to day 30. After this the mean abundance declined but was relatively stable up to 60 days of 
age. Within NEC samples there was little change in the abundance of Clostridium over time, 
though it was seen to be lower than the mean normalised abundance in control samples. Whilst 
there was little overlap in the standard errors of the groups, there were samples from the 
control group that showed lower abundances than NEC samples at the same time period 
(Figure 34:C). 
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Figure 34 Nonparametric regression analysis for 
normalised log-abundances for genera observed 
to be significantly different between NEC and 
control samples, plotted against the age at 
sampling and coloured by NEC status. (A) 
Bacteroides. (B) Bifidobacterium. (C) 
Clostridium. (D) Proteus. E) Yersinia. 
 
 
 
Proteus was seen to increase in both NEC and control samples over the duration of sampling, 
however the rate of increase was much greater in the NEC samples (Figure 34:D). The initial 
abundance of Yersinia was observed to be much greater in control samples than in NEC 
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samples, however, from the age of 20 days it appeared to maintain a stable abundance at 
similar levels for samples from both subject groups (Figure 34:E). 
 
Trends or changes observed in samples after 60 days of age were considered inappropriate to 
analyse due to the lack of comparable NEC samples. This subgroup was limited in the 
conclusions that could be made when considering the sampling density over time due to the 
sparsity of samples. This was particularly notable for NEC samples over ~28 and ~35 days of 
age.  
 
5.4.3 Random Forest Analysis of Genera Predictive of Necrotising Enterocolitis 
The success rate of Random Forest model predictions for NEC samples was the lowest of all 
the subgroups analysed (58%). However, this was substantially greater than the accuracy for 
the model using all genera observed (total number of genera = 154) in the samples for this 
subgroup (42%) (Table 24). 
 
Table 24 Summary Tables for Random Forest model predictions of the NEC status of infants using the 
genera composition of samples. 1,500 trees were constructed for both models. (A) Using only genera 
identified as being significantly different between NEC and controls, two variables tried at each split. 
(B) Using all genera identified within the communities, twelve variables tried at each split. 
A) 
Confusion matrix Confirmed Control Class Error 
Confirmed 14 10 0.42 
Control 5 70 0.07 
OOB estimate of error rate 15.15% 
B) 
Confusion matrix Confirmed Control Class Error 
Confirmed 10 14 0.58 
Control 1 74 0.01 
OOB estimate of error rate 15.15% 
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Proteus was observed to be the most significant genus within the Random Forest models, 
accounting for more than a 35% decrease in accuracy when removed (Figure 35). Clostridium 
was the next most significant genus in distinguishing NEC from control samples, accounting 
for an approximate decrease in accuracy of 30% when removed. Whilst Bifidobacterium was 
not observed to account for as much accuracy in the model (~20%), it was seen to have a 
highly similar mean decreased Gini score, suggesting that it was of similar importance in 
partitioning the data as Clostridium.  
 
 
Figure 35 Random Forest Summary graphs describing the ability of genera that were seen to be 
significantly different between NEC and control samples in infants fed exclusively breast milk 
delivered and delivered vaginally to predict the NEC status of an infant. (A) Mean Decreased Accuracy 
for phyla with log-2 fold. (B) Mean Decrease Gini Index scores. 
 
The tree representation of the model highlights the importance of Bifidobacterium in 
partitioning the data, with high abundances being associated with the prediction of control 
samples. Low abundances of Bacteroides, Clostridium, and Proteus were mostly associated 
with the prediction of control samples (Figure 36). 
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Figure 36 Tree 
representation of 
Random Forest decision 
based prediction of NEC 
status for samples using 
the log-normalised 
genera abundance of taxa 
observed to be 
significantly different in 
abundance between case 
and control samples. 
Values in the tree 
represent the log 
normalised value that a 
given decision is made 
upon. Bifidobacterium 
was seen to be highly 
influential in partitioning 
the data however it did 
not contribute as much to 
the accuracy of the model 
as Proteus or 
Clostridium. Generally, 
low abundance of 
Proteus and Clostridium 
were associated with 
control samples whilst 
high abundances of 
Bacteroides were seen to 
be associated with NEC 
samples 
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5.4.4 Diagnostic Species 
Six species were seen to be significantly different in normalised abundances of NEC and 
control samples (Table 25). Bacteroides fragilis and Corynebacterium kroppenstedtii were 
the only two species to show different trends in abundance when factored with the age at 
sampling (Figure 37). Bacteroides fragilis was disproportionately represented by a BWH204 
whose samples all had normalised abundance values of 0. This distorted the trends in the 
species over time and made it an unlikely candidate in discerning NEC and control samples.  
 
Corynebacterium kroppenstedtii was not overrepresented by any single NEC or control 
sample over the duration of time and could be a viable candidate for a probiotic species of 
bacteria. However, where there is a rise in the abundance of Corynebacterium kroppenstedtii, 
there is also a lack of NEC samples, suggesting that further investigation into the influence of 
this species on the microbiota would be essential before any conclusions could be drawn. 
 
Table 25 Summary of all species with log2 fold significant differences for normalised abundances of 
NEC and control subject samples. All samples were from infants delivered vaginally fed breast milk 
exclusively. The table is ordered by P-adjusted values. 
 
Species Base Mean Log2 fold Change P-Adjusted 
Bacteroides fragilis 15473.701 8.63 6.95x10-28 
Clostridium perfringens 375.68 5.86 1.44x10-20 
Corynebacterium kroppenstedtii 4.59 2.28 7.80x10-6 
Pantoea agglomerans 141.36 2.27 3.35x10-4 
Acinetobacter rhizosphaerae 3.90 2.07 3.40x10-4 
Streptococcus agalactiae 20.31 -2.33 4.39x10-4 
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Figure 37 Nonparametric regression analysis for normalised log-abundances for species observed to 
be significantly different between NEC and control samples, plotted against the age at sampling and 
coloured by NEC status. (A) Bacteroides fragilis. (B) Corynebacterium kroppenstedtii. The elevated 
level of Bacteroides fragilis was influenced by control subject BWH204. BWH204 was the only 
subject to have samples with a value of 0 and significantly skewed the trend line and standard errors 
for control samples. No single subject was observed to represent upper or lower log-normalised 
abundance values for Corynebacterium kroppenstedtii. 
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Random Forest models using significantly different species had an increased error rate in the 
identification of NEC samples (50%) relative to the model using significantly different 
genera (42%) (Table 26:A). This further increased to 58% when using all observed species; 
the same error rate as the model using all genera observed in the samples (Table 26:B). 
Table 26 Summary Tables for Random Forest model predictions of the NEC status of infants using 
the species composition of samples. 1,500 trees were constructed for both models. (A) Using only 
species identified as being significantly different between NEC and controls, two variables tried at 
each split. (B) Using all species identified within the communities, seven variables tried at each split. 
(A) 
Confusion matrix Confirmed Control Class Error 
Confirmed 12 12 0.5 
Control 6 69 0.08 
 OOB estimate of error rate 18.18% 
 
(B) 
Confusion matrix Confirmed Control Class Error 
Confirmed 10 14 0.58 
Control 2 73 0.03 
OOB estimate of error rate 16.16% 
 
5.5 All Viable Subgroups: All infants Fed both Formula and Breast Milk & 
Infants Exclusively Fed Breast Milk Delivered Vaginally 
Following individual analysis of these subgroups, elevated occurrence of Bifidobacterium 
appeared to be consistent in control samples from all groups. With the exception of 
Bacteroides, which showed significant differences between NEC and control samples 
collectively but little difference in abundance when plotted over time, there was a lack of 
consistent trends across all NEC samples for these subgroups. Further analysis aimed to 
establish whether this was a correct assumption by performing analysis on all of these 
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samples collectively and ascertaining whether the subgroup analysis was an improvement on 
the population as a whole in discerning NEC samples from controls. 
 
5.5.1 Significantly Different Genera Between Necrotising Enterocolitis and Control 
Samples 
Four taxa displayed significant differences in normalised abundances of samples from NEC 
and control infants; Bifidobacterium, Bacteroides, Dialister, and Megamonas. Two of these 
taxa were observed to have high mean abundances and a high level of log2 fold changes 
(Figure 38). These were associated with Bifidobacterium, which had the highest base mean 
abundance (4986) and level of significance (P-adjusted = 8.64x10-145) relative to all taxa that 
showed significantly different abundances between case and control samples. Bacteroides 
was the only one of the four taxa to maintain a high mean abundance (1422) and level of 
significance (3.94x10-91) (Table 27). 
 
Compared to the subgroup analyses previously described, Bifidobacterium and Bacteroides 
were seen to have the greatest significant differences between case and control samples of all 
genera across all subgroups. Dialister and Megamonas were also significantly different, these 
were the same genera, in the same order, within the subgroup of infants delivered vaginally 
and fed both formula and breast milk.  
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Figure 38 Genera with log2 fold differences between samples from all NEC and control subjects 
within the three subgroups previously analysed. 
 
Table 27 Summary of all genera with log2 fold significant differences in normalised abundances 
between all NEC and control samples in the three subgroups previously analysed. 
Genera Base Mean Log2 fold Change P-Adjusted 
Bifidobacterium 4685.91 8.82 8.64x10-145 
Bacteroides 1421.93 7.58 3.94x10-91 
Dialister 45.16 -2.78 2.72x10-18 
Megamonas 6.30 2.51 4.01x10-21 
 
On the whole, Bifidobacterium and Bacteroides were elevated in control samples, although 
the difference was considerably more for Bifidobacterium. Abundances of Dialister were 
seen to be greater in NEC samples on average, whilst Megamonas showed little difference 
between case and control samples (Figure 39). 
 
 
 
 
Bifidobacterium 
Bacteroides 
Megamonas 
Dialister 
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Figure 39 Genera with log2 fold differences between samples from all NEC and control subjects in 
the three subgroups previously analysed in this chapter. 
 
 
5.5.2 Significantly Different Genera between Necrotising Enterocolitis and Control 
Samples over Time 
Overall, Bacteroides was seen to maintain a higher abundance in control samples when 
observed as a function of time. NEC samples showed similar trends in the changes of 
Bacteroides abundance, however, these samples always maintained an average lower than 
that observed in control samples (Figure 40).  
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Bifidobacterium showed the greatest difference between case and controls. Controls 
maintained a greater mean abundance and displayed a tendency to increase their abundance 
of Bifidobacteria at older ages. NEC subjects showed the same trend in the normalised 
abundance of samples up to day 50. However, these samples had significantly lower mean 
abundances and after 50 days of age there was no evidence to support an increase in 
abundance. 
 
Dialister was the only genus to show a clear association with NEC samples; the mean 
abundance increased up to approximately 30 days of age, after which it declined before 
returning to similar levels observed in control samples by day 50. 
 
There was some evidence for an increase in the mean abundance of Megamonas up to ~40 
days of age in NEC samples, whilst control samples were seen to decrease in abundance over 
the same time period. However, the normalised abundances were not clearly distinct as 
indicated by the high crossover in the standard errors of the two groups.  
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Figure 40 Nonparametric regression analysis for normalised log-abundances for genera observed to be 
significantly different between NEC and control samples, plotted against the age at sampling and 
coloured by NEC status. (A) Bacteroides. (B) Bifidobacterium. (C) Dialister. (D) Megamonas. 
 
Bifidobacterium was the only genus consistently found in each subgroup and in the overall 
population with a significantly elevated mean abundance in control samples. This difference 
in normalised abundance was maintained over the duration of sampling for all subgroups. 
Controls delivered by caesarean section and fed formula and breast milk showed a consistent 
increase over time in the mean abundance of Bifidobacterium up to 50 days of age. All 
controls delivered vaginally saw an increase in the mean abundance of Bifidobacterium but 
also exhibited a decline at later ages; this occurred earlier in infants fed formula and breast 
milk relative to those fed breast milk exclusively.  
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Bacteroides displayed significantly different abundances for both subgroups in which infants 
were delivered vaginally, however, these subgroups showed distinct trends from each other. 
Samples from infants fed a mixture of formula and breast milk were only seen to diverge in 
mean abundance relative to NEC status after ~60 days of age, where the sampling density 
was much lower. The difference observed in samples from infants fed exclusively breast milk 
was also seen to be associated with lower sampling density and especially high abundances in 
one subject (BWH206). When all samples were analysed as a population, the trends in 
Bacteroides mean abundances were very similar between NEC and control infants. It is likely 
that the observed increased mean abundance for control samples was influenced by BWH206 
and reduced NEC sample densities. 
 
Dialister was only associated with infants delivered by caesarean section and fed both 
formula and breast milk. The observed peak corresponds to high abundance in samples from 
two infants with NEC and three controls. 
 
Significant differences in the mean abundance of Megamonas were only seen in infants 
delivered vaginally and fed both formula and breast milk. When plotted over time there was 
no clear distinction between NEC and control samples aside from control samples having a 
greater initial abundance relative to NEC samples. In the population analysis however, there 
appeared to be a peak associated with NEC subjects at ~30-40 days of age. 
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5.5.3 Random Forest Analysis of Genera Predictive of Necrotising Enterocolitis 
When using significantly different genera, the probability of the Random Forest algorithm to 
correctly identify samples from NEC subjects when all subgroups were assessed as a single 
cohort was decreased relative to all previously analyses. When all samples were analysed, the 
Random Forest had a 47% error rate in detecting NEC. In contrast, samples from infants 
delivered by caesarean section and fed both formula and breast milk had a 33% error rate; 
samples from infants delivered vaginally and fed both formula and breast milk had a 24% 
error rate; and infants delivered vaginally and fed breast milk exclusively had a 41% error 
rate. 
 
When all genera observed in all the samples were used, the class error rate in correctly 
identifying NEC samples from all subgroups was 56%. This was lower when compared to 
samples from infants fed formula and breast milk and delivered both by caesarean section 
(42%) and vaginally (12%). However, this was an improvement on the error rate for samples 
from infants delivered vaginally and fed breast milk exclusively (58%). 
Table 28 Summary Tables for Random Forest model predictions of the NEC status of infants using 
the genera composition of samples. 1,500 trees were constructed for both models. (A) Using only 
genera identified as being significantly different between NEC and controls, two variables tried at 
each split. (B) Using all genera identified within the communities, twelve variables tried at each split. 
 
A) 
Confusion matrix Confirmed Control Class Error 
Confirmed 71 63 0.47 
Control 52 226 0.19 
OOB estimate of error rate 27.91% 
B) 
Confusion matrix Confirmed Control Class Error 
Confirmed 59 75 0.56 
Control 16 262 0.06 
OOB estimate of error rate 22.09% 
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The importance of Bifidobacterium in the distinction between NEC and control samples was 
highlighted in the mean decreased accuracy (~80) and mean decreased Gini scores (>60) 
relative to the other genera observed to have significantly different abundances between NEC 
and control samples (Figure 41). This mean decreased accuracy accounted for approximately 
twice the accuracy in the model relative to the next most important genera, Dialister. 
Dialister, which also had the second highest mean decreased Gini score, was only observed 
to be significant for samples from caesarean delivered infants fed formula and breast milk. 
Megamonas and Bacteroides were seen to be similarly important in the model construction, 
both in terms of the mean decreased accuracy and Gini scores. Whilst a tree representation of 
this model was constructed, the complexity and size of the figure meant that it provided no 
useful information in the prediction of NEC nor was there a feasible method of incorporating 
it on paper. 
 
Figure 41 Random Forest Summary graphs describing the ability of genera that were seen to be 
significantly different between all NEC and control samples from subgroups previously analysed in 
this chapter in the prediction of an infant’s NEC status (A) Mean Decreased Accuracy for phyla with 
log-2 fold. (B) Mean Decrease Gini Index scores. 
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5.5.4 Diagnostic Species 
Four species were observed to have significantly different normalised abundances when the 
age at sampling was not factored into the analysis (Table 29). Only two of these species 
demonstrated different trends in abundance over time; S. agalactiae and C. butyricum. 
However, these differences were localised to a small number of subjects and were not 
consistent for the majority of samples (Figure 42). Samples with log normalised abundance 
between -7.5 and 0 for S. agalactiae were seen to be represented by three subjects; two 
controls BWH204 and STH051, and the NEC subject RSH114. The elevated abundances for 
C. butyricum were associated with NEC subject UHCW062 only. 
Table 29 Summary of all species with log2 fold significant differences for normalised abundances of 
NEC and control subject samples. Samples were from all infants subgroups analysed within this 
chapter. 
 
Species Base Mean Log2 fold Change P-Adjusted 
Bacteroides fragilis 1416.29 8.074 5.67x10-98 
Streptococcus agalactiae 11.09 -4.57 2.20x10-88 
Clostridium butyricum 5.97 -3.35 4.29x10-52 
Streptococcus anginosus 32.56 4.17 2.72x10-40 
 
Both Random Forest models showed an increase in the error rate for classifying NEC 
samples compared to the models utilising genera. An increase of 6% was observed for the 
model using significantly different species to identify NEC samples, and an increase of 11% 
was seen for the model using all species (relative to the models using genera) (Table 30). 
This indicated that models using species were less effective in identifying samples from NEC 
subjects. 
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Figure 42 Nonparametric regression analysis for normalised log-abundances for species observed to 
be significantly different between NEC and control samples, plotted against the age at sampling and 
coloured by NEC status. (A) Streptococcus agalactiae. (B) Clostridium butyricum.  
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Table 30 Summary Tables for Random Forest model predictions of the NEC status of infants using 
the species composition of samples. 1,500 trees were constructed for both models. (A) Using only 
species identified as being significantly different between NEC and controls, two variables tried at 
each split. (B) Using all species identified within the communities, eleven variables tried at each split. 
 
(A) 
Confusion matrix Confirmed Control Class Error 
Confirmed 63 71 0.53 
Control 50 228 0.18 
OOB estimate of error rate 29.37% 
 
(B) 
Confusion matrix Confirmed Control Class Error 
Confirmed 45 89 0.66 
Control 25 253 0.09 
OOB estimate of error rate 27.67% 
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5.6 Discussion 
As stated in the introduction, Chapter 1.10.1, throughout the first year of life the infant gut is 
colonised by blooms of bacteria which are predominantly anaerobic. Initial colonisation is 
thought to be mainly by facultative anaerobes such as Staphylococcus, Streptococcus, 
Escherichia, and Enterobacteria. Whilst the maternal vaginal microbiome is predominantly 
Lactobacillus, these do not actively colonise the infant gut, instead it is the maternal faecal 
bacteria (Enterobacteriaceae and Bifidobacteria) that have been associated with the 
colonisation of infants delivered vaginally156. In contrast, caesarean infants were observed to 
harbour bacterial communities similar to the skin microbiota of the mother309. This influence 
was reinforced by the subset regression and NMDS analysis in Chapter 4.  
 
In addition to the method of delivery, the feeding regime was also identified as a significant 
factor in the trends of beta-diversity. This  variable had previously been reported to influence  
the microbiota composition and development, especially in the first six months of life314,315. 
Therefore, it was considered pertinent to ensure that subgroups based on feeding regime and 
means of birth were established and compared independently to isolate differences in how the 
microbiota changed over time in NEC and control infants. 
 
Chapter 4 also indicated that the best taxonomic level to differentiate between NEC and 
control samples was at the genus level. This was used as the primary comparison level, 
however, to ensure that there were not any common pathogenic species, further analysis was 
performed at the species level in the same manner. 
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5.6.1 Infants Delivered by Caesarean Section and Fed Formula Feeds & Breast Milk 
Analysis of infants delivered by caesarean section and fed a mixture of formula and breast 
milk identified 10 unique genera that were significantly different between samples from NEC 
and control infants. Three genera were seen to have elevated normalised mean abundances 
within the samples: Bifidobacterium, Streptococcus, and Proteus. This suggested that these 
genera constituted a significant proportion of the community composition in addition to being 
significantly different between NEC and control samples. Bifidobacterium had the greatest 
abundance and this was significantly elevated in control samples. Dialister was the genus 
observed to be most significantly elevated in NEC samples, but it had a lower mean sample 
abundance relative to the other genera that were significantly different. 
 
When plotted as a function of time, the only genera that was seen to be consistently different 
between NEC and control samples was Bifidobacterium. This genus was seen to have 
consistently greater mean abundances in control samples over the duration of sampling. 
However, there were control subjects with lower normalised sample abundances relative to 
NEC subjects sampled at the same age. These were predominantly samples taken prior to 30 
days of age. There was some evidence of genera that were seen to peak in NEC subject 
samples, however these were exclusively associated with individuals and not conserved in the 
population. 
 
Random Forest model prediction of NEC samples from the population had a reasonable 
accuracy when using the genera observed to be in significantly different abundances between 
NEC and control subjects (33%). This accuracy was reduced when all genera were 
incorporated into the model predictions (42%). This decrease in accuracy could be indicative 
of the complexity and specificity of each individual infant’s microbiome; by including all 
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genera the uniqueness of each microbiome decreases the accuracy of successful NEC 
identification.  
 
The importance of Bifidobacterium was clearly established in the mean decreased accuracy 
and Gini index scores, as well as the tree representation of the model. Additionally, Dialister 
and Staphylococcus were identified as being important in model predictions, with elevated 
normalised abundances of Dialister and Staphylococcus being associated with NEC samples. 
However, the tree structure in the model predictions demonstrated how complex and specific 
each prediction pathway was, which had an overall error rate of 33%. 
 
Analysis at the species level did not identify any species associated with genera that were 
significantly different within this subgroup of infants. Of the three species identified 
(Clostridium butyricum, Streptococcus anginosus, and Eubacterium dolichum), only C. 
butyricum was observed to show differences over time, and when further analysis was 
performed on this species (which appeared to be elevated in NEC samples) it was clear that a 
single subject (UHCW062) had a bloom over the duration of sampling and that this was not 
representative of the NEC sample population. This also highlighted the importance of high 
sample counts with respect to understanding the population trends associated with microbiota 
changes at the community level. Our sampling for NEC subjects could be considered limited 
even at this level due to the skew in normalised abundances introduced by a single infant. 
 
The reduced accuracy of the Random Forest model at the species level also lends itself to the 
theory that the infants’ highly specific composition is unique and at higher resolutions 
introduces more noise than clarity. This theory was somewhat supported by the CCA analysis 
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and high attribution of variation associated with trends in beta-diversity (LCBD values) to the 
subject ID (Chapter 4.3).  
 
Bifidobacterium has been shown to naturally occur in many niches that are associated with 
the animal gastrointestinal tract. This genus has metabolic abilities and genetic traits that aid 
in the evasion of the host adaptive immune system and colonisation through specific 
appendages456. These metabolic abilities include the production of acetate and lactate which 
contributes to the lower of the gastrointestinal tract pH via short-chain fatty acid production. 
This improves the availability of caesium, magnesium and inhibition for potentially 
pathogenic bacteria457. Bifidobacterium dominate the gut population in healthy breast-fed 
infants290,292,458. On average, more than 12% of the annotated open reading frames within the 
Bifidobacterial genome are predicted to encode carbohydrate metabolic enzymes459. 
Additionally, Milani et al demonstrated that Bifidobacterium species have a wide range of 
carbohydrate genes, greater than that observed in other known members of the gut microbiota 
– specifically, glycan-degrading abilities of Bifidobacteria which are believed to reflect the 
available carbon sources in the human gut459. Transcript profiling of the genomes also 
provided evidence for the involvement of various chromosomal loci in glycan metabolism. 
This supports the hypothesis that saccharidic resource sharing among Bifidobacteria – 
through species-specific metabolic specialising and cross-feeding – results in trophic 
relationships between members of the gut microbiota. 
 
Human isolates of Dialister species are reported to produce propionate460,461 and their 
abundances have been implicated in disease states such as obesity, IBD, and Crohn’s disease. 
Within a normal microbiota, Dialister has been categorised as a member of the low gene 
count microbiomes due to its relatively low community abundance462,285. This concept of low 
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gene count members has been implicated in the health and disease states of individuals with 
obesity, wherein low gene count members harboured a higher proportion of pro-
inflammatory bacteria such as Bacteroides and Ruminococcus gnavus, both of which are 
known to be associated with IBD463.  
 
The genus Dialister has very little characterisation in literature with regards to its functional 
metabolic pathways within the gut microbiome community. This could be due to its low 
abundance within the community, although there does appear to be evidence that it is 
elevated in communities that seem to be associated with disease states such as Crohn’s 
Disease270.  
 
During vaginal delivery, Staphylococcus (among other facultative anaerobic species) colonise 
the infant gut in the first few days of life, this allows strict anaerobes such as Bacteroides and 
Bifidobacterium to establish a presence464. Additionally, breast milk is dominated by 
Staphylococcus and genera such as Bifidobacterium and Lactobacillus465. Using culture and 
strain level discrimination, Lactobacillus has also been shown to transfer to the gut after 
feeding on breast milk466,467. Whilst Staphylococcus has been shown to be present in the gut 
colonisation of vaginally delivered infants, they are dominant in infants delivered by 
caesarean section309, with the latter’s communities showing a closer resemblance to the 
human skin microbiota.  
 
Staphylococcus was initially elevated in control infant samples relative to NEC samples but 
returned to similar levels to those observed in NEC infants by the age of 30 days. Whilst this 
is a limited difference, it could suggest that NEC infants delivered by caesarean section 
showed an abnormal colonisation pattern. Very few control samples were seen to have 
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abundances of Streptococcus lower than those observed in NEC samples in the early 
sampling duration.  
 
However, it is important to consider that the difference in Bifidobacteria and Staphylococcus 
abundances could be associated with differences in feeding regimes. NEC infants are often 
restricted in their feeding intake and struggle to take on feeds. Evidence has clearly been 
shown that associated these genera with breast milk, therefore the reduced abundances could 
in fact not be associated with a gut dysbiosis but rather a reduced feeding regime relative to 
controls. This would be more an effect of the treatment, which would occur after the 
detection of NEC, than a cause of the disease. 
 
5.6.2 Infants Delivered Vaginally Fed Formula and Breast Milk 
Bifidobacterium was again observed to be a genus that is significantly different between NEC 
and control samples within the vaginally delivered infants on a mixed feeding regime. 
However, Bacteroides, Megamonas, and Veillonella were the other genera observed to be 
significantly different, none of which were seen to be significantly different in caesarean 
delivered infants on a mixed feeding regime. 
 
Bifidobacterium and Bacteroides were seen to have the greatest mean abundances and log2 
fold changes; while Veillonella had a high normalised mean abundance, it also had the lowest 
difference between NEC and control samples. Megamonas had the lowest abundance of all 
the significantly different genera and a marginally greater difference between NEC and 
controls relative to Veillonella, suggesting it was a low abundance member of the 
community. 
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Bifidobacterium and Veillonella had greater mean log-relative abundances in control samples 
overall, while Bacteroides had a greater mean log-relative abundance in NEC samples. 
Megamonas was seen to have very similar normalised abundances between case and control 
samples. 
 
As a function of time, Bacteroides were seen to have similar normalised abundances until 50 
days of age, after which control samples showed an increase in abundance which was not 
observed in NEC subjects. Of the 133 samples within this group, 33 were taken after 50 days 
of age (NEC = 14, Controls = 19). Bifidobacterium was shown to have consistently greater 
normalised abundances in control samples over the duration of sampling. Normalised 
abundances of Megamonas showed no clear differences in trends for the duration of 
sampling. Veillonella maintained a higher abundance in control samples, and a clear steady 
increase over time. In contrast, NEC subjects showed a sharp increase in abundance of 
Veillonella at early ages which dropped off after ~30 days of age. These results suggested 
that when time was factored, the only clear differences observed were between 
Bifidobacterium and Veillonella. 
 
This was further confirmed by the Random Forest analysis which showed that 
Bifidobacterium and Veillonella had the greatest mean decreased accuracy and Gini index 
scores as part of the models that utilised the genera that were significantly different. The error 
rate for models using the significantly different genera were seen to be much higher (24%) 
than when the model utilised all the genera observed within the samples (12%) in the 
identification of NEC samples from the population. However, both of these values were 
lower than the best error rate observed for infants delivered by caesarean section. 
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This suggests that the detailed composition of the microbiome from infants on mixed feeding 
regimes who were delivered vaginally provided a more accurate means of identifying the 
NEC status of a given sample. Therefore, the influence of the genera that were seen to be 
significantly different, whilst being better predictors than those observed in caesarean 
delivered infants, were not as good at predicting the NEC status of samples compared to 
models that incorporated the entire community composition at the genus level. However, 
importantly, high abundances of Bifidobacterium were clearly assigned as controls within the 
tree structure of the Random Forest model, suggested that Bifidobacterium was highly 
associated with a reduced risk of NEC. 
 
Veillonella have been primarily observed as a core member of the oral microbiome468 but 
they have also been characterised throughout the digestive tract in differing abundances469,470.  
Whilst there is little to no intake of non-digestible carbohydrates in the premature infant diet 
– which is predominantly associated with proteins, fats and sugars in the form of human milk 
oligosaccharides471– the Veillonella species are known to metabolise propionate from non-
digestible carbohydrates. It could be that this genus was introduced into the infant 
microbiome from the maternal faecal microbiome.  
 
Propionate has been shown to have hypophagic and hypocholesterolemic properties in many 
studies, with potentially health-promoting implications such as anti-lipogenic, cholesterol 
reducing, anti-inflammatory and anti-carcinogenic effects472,473. The supplementation of 
propionate in white bread has been shown to improve blood-glucose responsiveness, 
increased faecal mass, and microflora, specifically Bifidobacteria. There appeared to be 
evidence that propionate enhanced satiety, however the implications of this for infants are 
unknown473. The elevated abundance of Veillonella could increase levels of propionate in the 
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microbiome and by association the abundance of Bifidobacteria, which have been shown to 
be negatively correlated with the incidence of NEC within this cohort. 
 
In addition, Veillonella parvula has been shown to gain additional energy from succinate in 
the presence of lactate as the main growth substrate474. This may explain the elevated 
abundance in infants more than any other factor, as a high proportion of breast milk is 
composed of lactate.   
 
Of the two species that showed increasing abundance up to ~45 days old (Bacteroides fragilis 
and Corynebacterium kroppenstedtii), significant differences were only observed where NEC 
subjects were poorly sampled in terms of age. Bacteroides fragilis was disproportionately 
represented by a single control subject with a very high abundance relative to all other infants 
within the cohort. Where sampling was sufficient for both controls and NEC infants, between 
40 and 50 days there was little difference between samples for both species. This indicated 
that there was no clear beneficial or pathogenic species associated with control or NEC 
infants within this subset of the cohort. The reduction in the accuracy of NEC sample 
identification in the Random Forest models generated at the species level relative to those 
generated at the genus level further confirms this. 
 
5.6.3 Infants Delivered Vaginally and Fed Breast Milk Exclusively 
Infants delivered vaginally and fed breast milk exclusively were the smallest viable subgroup 
of the three derived from the cohort and as such there were limits in the comparisons that 
could be made with respect to sampling age. Specifically, prior to 40 days of age there were 
very few NEC samples to compare against control samples. This limited comparisons within 
this subset to an age range between 40 and 60 days. This highlights the importance of plotting 
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the data over time. A genus that may be seen to be significantly different with respect to the 
population of samples, based on normalised abundance, might not be comparable if there was 
limited sampling or if within the time frame where comparisons could be made there was no 
observable difference. 
 
For infants delivered vaginally and fed breast milk exclusively Proteus was the genus with 
the greatest difference between NEC and control samples, this translated with time as infants 
with NEC had greater normalised abundances on average between 40 and 60 days of age. 
Although this was not the case for all NEC samples there was a clear difference as indicated 
by the error margins, which showed no overlap between the case and control samples after 50 
days of age. 
 
Clostridium was also seen to be significantly different between controls and NEC subjects, 
with a decreased normalised abundance in NEC subjects. As with Proteus this was not seen 
to be exclusively lower in NEC subjects, with some control samples having comparable 
abundances, but on average there was a much lower abundance with very little overlapping of 
error margins. 
 
All other genera (Bacteroides, Bifidobacterium and Yersinia) had overlapping error margins, 
and similar trends in mean abundances between 40 and 60 days of age. Of note was 
Bifidobacterium, which was observed to be consistently different between the two previous 
subsets of infants and appeared to contribute the greatest role within their respective Random 
Forest models.  
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In contrast, and as expected based on the regression plots and log-2 fold significance results, 
Proteus and Clostridium were the most significant taxa within this subset to contribute to the 
Random Forest models. However, the error rates for both models were seen to be greater than 
those observed within the previous two subgroups.  
 
None of the species was identified as being significantly different between case and control 
subjects when factored with time. The error rates of both Random Forest models constructed 
were greater than their respective models generated at the genus level; 50% and 58%, 
respectively.  
 
The genus Proteus includes proteolytic rod shaped Gram-negative facultative anaerobic 
heterotrophs that can be opportunistic human pathogens475. Proteus is a highly adaptable 
genus that has been isolated from multiple human and environmental environments. Within 
the human environment they have been characterised as both commensals and pathogens. 
Their prevalence in human infections has been extensively characterised and attributable to 
the O-antigen variability and virulence factors. They have been associated with infections of 
the urinary tract, wound and burns, respiratory tract, bacteraemia, meningitis, intestine 
(diarrhoea) and nosocomial476,477,478,479,480,481,482,483. These infections are primarily associated 
with people with impaired immune systems. However, within our study Proteus was 
associated with control subjects that were considered otherwise healthy. 
 
It is believed that Proteus is part of the naturally occurring faecal microflora in a proportion 
of the population even though it has been considered an opportunistic pathogen. It has been 
observed that there are differences in the Proteeae members within health and diarrhoeal 
patients and it was speculated that Proteus becomes pathogenic when the onset of illness is 
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attributable to another genera484,485. It has been suggested that whilst some strains are 
associated with urinary tract infections these are isolated from an intestinal reservoir486, 
where they were more frequently isolated 487.  Of interest was the evidence of high fat diets 
within animal models and increased numbers of P. mirabilis in a study into the association of 
the gut microbiome of rats and obesity. A significant positive correlation was found between 
the abundance of P. mirabilis and all ten of the metabolic parameters associated with 
obesity488. 
 
The Clostridium genus is composed of gram-positive, rod-shaped bacteria from the 
Firmicutes phylum. Those that inhabit the gut microbiome are predominantly represented by 
the fusiform-shaped bacteria from cluster XIVa and IV (10-40%) of the total bacteria within 
the gut microbiome489,490,491. Clostridia have bene shown to colonise the human intestine of 
infants fed breast milk within the first month of life492. This was clearly observed within the 
control samples which showed an increase up to 40 days of age, after which the abundance of 
Clostridium stabilised. There was a reduced abundance at later ages (>60 days) but these 
were represented by a single subject and as such this limited the conclusions that could be 
made at these ages. Within this study there as little evidence for increased abundances in 
Clostridium with NEC samples.  
 
Mouse models Clostridium have been shown to colonise specific regions of the intestinal 
mucosa. 20% of the sequences from the interfold region have been classified as members of 
the Clostridium cluster XIVa group. In contrast only 3% of were represented by the genus in 
the digestive region493,494. Regions of the central lumen consisted primarily of 
Bacteroidaceae, Enterococcaceae and Lactobacillaceae495. It is possible that the commensal 
species of Clostridia are associated with specific regions within the intestinal mucosa in order 
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to maintain a close spatial arrangement with host gut cells required to perform physiological 
co-operative functions in an optimal manner496.  
 
The location of the Clostridium species in the mucosa implies an impact on normal intestinal 
structure and physiology and an association with functions relating to mucus production, 
water retention, epithelial cell cycles and peristalsis. All of these functions have been shown 
to be abnormal within germ-free mouse models497. Importantly, Clostridia play a role in the 
maintenance of colonocytes by releasing butyrate as an end-product of fermentation498. In 
another study, samples seen to have a high abundance of Bifidobacterium had a low 
abundance of Clostridium312. A similar pattern was observed within this cohort. Infants 
delivered vaginally and fed exclusively breast milk were seen to have a lower abundance of 
Bifidobacterium (base mean =265) relative to the other two groups (2949, 8678), and was 
also the only group to show a significant difference in the abundance of Clostridia in NEC 
and control samples. Clostridium was also identified as a significant genus in the Random 
Forest Analysis. 
 
This short chain fatty acid, along with acetate and propionate, appears to be a primary energy 
source for colonocytes499,500. Additionally, these have been shown to have an important role 
in the health of the colon501,502. Butyrate is not detectable in the portal blood vessels although 
the colonic mucosa absorbs 95% of it, this provides an indication of the speed at which 
butyrate is utilised. Butyrate has also been implicated in gene expression through 
hyperacetylation of chromatin by its action as a non-competitive inhibitor of histone 
deacetylases503. Butyrate appears to have an impact of pro-inflammatory cytokines by 
inhibiting the activation of the transcription factor NF-kB504,505. The concentration of butyrate 
has been implicated in the cell growth and differentiation and in the prevention or reduction 
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of conditions such as ulcerative colitis501,502,503,506,507. Conditions which lead to a reduction in 
the energy supply of colonocytes (70% of which is provided by butyrate) can lead to colitis, 
with additional implications in colorectal cancer and IBD503,506,507. 
 
Butyrate production is common across many Clostridium species, especially those of the 
XIVa and IV phylum clusters related to Roseburia and F. prausnitzii which express Butyryl 
CoA: acetate CoA transferase activity508. The majority of this metabolic information is 
sourced from industrial experimentation of solventogenic Clostridia and the validity of this 
data within the gut microbiome environment should not be assumed to be correct. 
Additionally much of the information previously described about Clostridia within the 
microbiome environment within this discussion is based on animal models. Whilst there is 
clear evidence of Clostridia’s location within the human gut microbiome the complexity of 
the community may result in differing actions within different hosts, however the wealth of 
evidence suggests that Clostridia does have a beneficial, commensal impact on the host that 
appears to limit the onset of colitis among other conditions. The importance of Clostridia is in 
accordance with the data of La Rosa et al that demonstrated the progression of the 
microbiome in term infant gut microbiomes from Bacilli to Gammaproteobacteria to 
Clostridia, irrespective of the initial colonising conditions108. 
 
Clostridia have also been implicated in priming the host immune system through the 
promotion of αβ T-cell receptor intraepithelial lymphocyte (IEL) and immunoglobulin A 
producing cells509. Evidence has suggested that IEL, IG-A producing cells and intestinal 
epithelial cells are vital to the nature of the immune response to antigens or pathogens 
ingested. Reduced numbers observed within Germ-free mouse models are associated with a 
low Thy-1 expression and a low cytolytic activity of IEL510,511. This was built up by 
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transplantation of 46 strains of Clostridia that were cultured from wild-type to Germ free 
mice which lead to an increase in the ratio of CD4- CD8+ cells to CD4+ CD8- in αβIEL within 
the large intestine509. Additionally, species of Clostridium associated with clusters XIV and 
IV have been associated with strong induction of colonic T regulatory  cell accumulation512, 
placing further importance on their role with the host immune system. It has been suggested 
that the high proportion of  T regulatory cells within the intestine, wherein they are present in 
greater numbers than any other location, may be responsible for the development of the 
microbiome as Foxp3+ T regulatory cells have been observed to markedly influence the 
community513. This would suggest that infants with lower abundances of Clostridia are likely 
to have impaired immune responses to bacterial colonisation events or upon exposure to 
potential pathogens. Inappropriate immune responses can lead to excessive inflammation 
which is a known symptom of NEC. 
 
There is evidence that Clostridia are influential in the development and maintenance of both 
the response to bacteria colonising the intestine and the colonocytes utilising metabolites 
produced by commensals within the gut microbiome. The limited number of samples within 
this subset from our study inhibits our ability to form conclusions. Specifically, consistent 
sampling across a larger age range would help to clarify whether the microbiome of NEC 
subjects fails to cultivate sufficient numbers of Clostridia to establish a balanced community 
and maintain metabolic pathways vital for the host intestinal cells.       
 
5.6.4 All Subgroups Analysed as a Population 
When all samples from each subgroup of the cohort were analysed a whole Bacteroides, 
Bifidobacterium, Dialister and Megamonas were observed to be significantly different 
between NEC and control samples. When factored with time Bifidobacterium was 
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consistently observed to be maintained at significantly elevated normalised abundances in 
control samples relative to NEC samples. This genus was also the most distinctly separated 
between case and control samples with no overlapped standard errors over the duration of 
sampling. Although many control samples were observed to have lower normalised 
abundances relative to NEC samples, as a population this genus was the most differentiated 
between case and control samples.  
 
Whilst Bacteroides were considered one of the most significantly different genera based on 
the normalised mean abundance and without factoring for time, there was little difference 
between NEC and control samples over the duration of sampling. Whilst there was a 
consistently elevated abundance in control samples over the duration of sampling and 
evidence of a late increase that was distinct to control samples after 50 days of age, there was 
little distinction between case and controls, as indicated overlapping standard errors. 
 
Dialister was the only genus to be positively associated with NEC samples. Early sampling 
showed a trend for increased abundances in NEC samples up to the age of ~35 days, after 
which levels returned to that observed in control samples by 50 days of age.  
 
The Random Forest model predictions were worse than all subgroups models when 
performed on the combined sample population. The best model was produced when using 
only those genera that were seen to be significantly different between NEC and was able to 
correctly identify NEC samples 47% of the time. Bifidobacterium was the most significant 
genus to contribute to successful predictions within the models, this was approximately twice 
the accuracy in the model compared to the next most important genus, Dialister.  
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The model also demonstrated the strength of the association between Dialister and NEC 
subjects. However, this was isolated to those infants delivered by caesarean section, fed 
formula and breast milk, as these were the only NEC subjects observed to have a clear 
association with this genus over time. 
 
Of the four species observed to be significantly different only two were seen have different 
trends when factored with time; Streptococcus agalactiae and Clostridium butyricum. These 
were seen to have trends for increasing normalised abundances in NEC samples up to the age 
of ~35 days of age. Controls were not observed to have such trends, although both case and 
control samples had similar abundances by 50 days of age. These trends were limited to a 
small number of samples and subjects and were not consistently observed in all NEC 
samples. 
 
Streptococcus agalactiae is a group B streptococcus and implicated as a major pathogen 
causing a wide variety of problems. It has been found to be a member of the gut community 
in 10-30% of healthy adults514,515,516  and it has also been linked to severe pneumonia, sepsis 
and meningitis in neonates517. There are two distinct developments from the group B 
Streptococci infection. Early onset of the disease is usually accompanied by sepsis and 
pneumonia from day 0 to 7, whereas the late-onset presentation is often associated with 
meningitis from day seven until three months of age. Maternal colonisation by S. algalactiae 
is a known risk factor in the development of this disease518,519 and often associated with 
vertical transmission from the faecal microbiota515. As these infants all went through 
vigorous diagnostic criteria the idea that sepsis instigated by S. algalactiae was misdiagnosed 
as NEC is unlikely, however whether some patients went on to have further complications 
and develop full NEC after infection could indicate either a causative agent or a subset of 
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infants that develop NEC in a unique manner. However, there were no data regarding 
positive bacterial cultures and as such it was not possible to know which infants had 
infections. 
 
Clostridium butyricum is a strictly anaerobic spore-forming bacillus and a common member 
of the human and animal gut microbiota. As described earlier the infant microbiome is 
progressively colonised by increasing proportions of strictly anaerobic bacteria, including C. 
butyricum520 and by 33 weeks  44% of asymptomatic infants positive for its presence in 
faecal samples521. Whilst this bacterium has been considered beneficial and even used as a 
probiotic, predominantly in Asia522, is has also been implicated in botulism and NEC more 
recently. 
 
Botulism is an acute paralytic disease caused by the botulinum neurotoxin which is secreted 
by Clostridium botulinum523. In 1976 Pickett et al described the first instance of botulism 
occurring in an infant in America524; in 1986 it was first described in Italy and since has been 
observed in other countries (China, India, Japan, Ireland and the USA)525. This occurrence of 
the botulinum neurotoxin gene across multiple Clostridium species appears to be linked to 
horizontal transmission mediated by plasmids or phage526.  
 
As stated in the introduction, no one species has been consistently linked to NEC, however 
Clostridium is one of the most commonly associated with its occurrence434. The first 
association of NEC and C. butyricum was in 1977 when it was observed in nine out of ten 
faecal samples from preterm neonates during an outbreak of NEC181. Further studies 
indicated that this could be due to the introduction of the species by medical staff after staff 
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tested positive for the presence of C. butyricum on their hands during an NEC outbreak433, 
and preventative measures were seen to control such outbreaks51.  
 
A more recent, large scale study identified C. butyricum specifically in NEC samples using 
16S rRNA sequencing and culture based methods, indicating a possible toxigenic mechanism 
alongside dysbiosis, with an oxidised, acid, and poorly diversified gut microbiota527. Four 
genes have been identified as potential homologues of haemolysins associated with swine 
dysentery522. Of these haemolysins the pore-forming β-haemolysin has been implicated in 
causing enterocyte necrotic lesions via the culture supernatant528,51. Experimental models in 
animals have also proven that C. butyricum can cause NEC-like lesions529,434. C. butyricum 
has been implicated in the pathogenesis of NEC via the fermentation of carbohydrate 
products, however this was dependent on the lactase deficiency of preterm neonates530,531. 
 
5.6.5 Conclusion 
All subgroups were seen to have significantly elevated abundances of Bifidobacterium when 
samples were analysed at the genera level and without considering time as a factor. When 
time was factored into the analysis, only the vaginally delivered control infants exclusively 
fed breast milk were not seen to be clearly divergent from NEC infants with respect to 
Bifidobacterium abundances. When analysed at the species level no subgroup showed 
significant differences in the normalised mean abundances of Bifidobacterium species. Whilst 
the genus is important in the discrimination between NEC and control samples there appeared 
to be no clear probiotic species. This indicated that multiple Bifidobacterium species were 
associated with the community structure of control subjects and less likely to be found in 
high abundances in NEC subjects. However, the species of Bifidobacterium that were 
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observed across control subjects varied per infant and were not consistently present in all 
subjects. 
 
The influence of subject specific variation was observed multiple times and across multiple 
subgroups. This was most evident for the subgroup of infants delivered vaginally and fed 
breast milk exclusively, this highlighted the importance of sampling density and cohort size. 
The subset of infants vaginally delivered and fed exclusively breast milk was inhibited by the 
lack of sampling for NEC subjects between 25 and 39 days of age. This severely limited the 
conclusions that could be made with regards to colonisation patterns as infants were seen to 
have spikes in taxonomic abundances or a subject specific dominance of taxa that distorted 
the overall trends of the population.  
 
Random Forest tress were effective at identifying the NEC samples from controls in both 
subgroups fed a mixture of formula and breast milk. This was likely to be due to the 
increased sampling density of these subgroups. However, consistently observed across all 
models was an increased abundance of Bifidobacterium negatively associated with NEC 
samples.  Subsets showed a marked improvement in the model predictions and the 
discrimination of samples, especially with respect to the genus Bifidobacterium. This was 
clearly shown by the reduced class error in mode/feed subset models relative to the model 
predictions for all samples from each of these subsets being analysed as a whole.  
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6 Discussion 
The aim of this project was to establish the taxonomic changes in the microbiome of 
premature infants that could be used prognostically to identify subjects who develop NEC. 
By doing so it could aid in the early introduction of treatments known to reduce the incidence 
or severity of NEC. Previous studies had demonstrated an association with the developing 
microbiome and the onset of NEC however very few characterised consistent changes 
between studies or across large datasets. By leveraging the low cost and high throughput 
potential of modern sequencing technologies it was possible to perform a large scale, 
prospective cohort analysis by sequencing the V4 region of the 16S ribosomal subunit. In 
doing so it was possible to assess the presence of trends in the community (LCBD values), 
similar community structures (NMDS) and unique taxonomic signals (Random Forest) 
associated with NEC in relation to relevant medical information. Through high sampling 
rates and careful case-control cohort assignment the trends and taxa that associated with 
NEC, one of the most important neonatal diseases currently afflicting premature infants, were 
established. 
6.1 Cohort Demographics 
The cohort demographics were seen to have the same significant associations with NEC 
incidence previously described in literature532, namely gestational duration419, birthweight533 
and the number of antimicrobials administered534. In addition to mode of delivery gestational 
duration and birthweight were metrics or events that occurred prior to the onset of NEC with 
which a clear cause-effect hypothesis could be established. One major limitation with this 
project was the inability to make associations with antimicrobial regimes and changes in the 
microbiome. This was due to the lack of administration timing and dosage being included in 
the patient metadata.   
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Whilst there was a great effort invested in obtaining the antimicrobial administration dates for 
each subject they were not obtained for the majority of enrolled infants in this project, or for 
most of the subjects assigned in case-control cohort. Antimicrobials have been shown to have 
an influential impact both in the short term and long term composition of the gut microbiome 
community429,432. It was considered especially important that these could be accounted for 
when comparing NEC and control infant community profiles, however without the date and 
duration an infant was administered the antimicrobial it was impossible to make any 
conclusive statements about the influence they had on the microbiome. However, the validity 
of antimicrobial administration analysis is debatable as many of the infants were 
administered multiple antimicrobials over their sampling duration. Being able to discriminate 
the influence of combined antimicrobial regimes on the microbiome of an infant could be 
beyond the capabilities of even the most regimented and strictly controlled studies.  
 
This time-of-effect also limited the conclusions that could be made from different feeding 
regimes. Since no metadata was provided that described when an infant was administered a 
specific feed it was not possible to establish the effect feeds had on the microbiota. However, 
it was possible to identify conserved trends over time for generalised feeding regimes, as well 
as the differences between those regimes, and this was sufficient in demonstrating significant 
taxonomic differences during the development of infant microbiome, and whether NEC had a 
greater association to a given feeding regime. 
 
6.2 Case-Control Cohort Selection 
It was important that match factors were identified to appropriately assign a case-control 
cohort due to the scale of prospective enrolment in this project. The weighting of match 
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factors was done with the assistance of medical staff who had extensive experience in the 
NICU environment and medical research alongside an experienced statistician. This made it 
possible to incorporate many factors and prioritise them accordingly in order to identify the 
best possible candidates to analyse. The sampling density from the best candidates was then 
assessed and those with sufficient sampling depth at the appropriate ages were analysed. 
 
Across the population all NEC subjects were observed to be significantly different from 
infants that did not develop NEC for all the match factors. Following control assignment this 
was still observed but the difference was less than that of the general population with regards 
to key risk factors. However, by combining all the match factors into a single weighting score 
it limited the ability to normalised controls for each match factor.  
 
While some factors were observed to increase in significance difference due to the lower 
weighting assigned to them (gender, location and feeding regime), these were not seen to be 
significantly association to NEC. However, risk factors that were associated with NEC 
(gestation, birthweight, mode of delivery) were seen to be less different between case and 
control subjects relative to the whole cohort.  
 
Sampling was a limiting factor within this project. Premature infants do not pass faeces as 
often as full-term infants and, additionally, premature infants produce less stool when they do 
pass. This greatly reduced the number of eligible NEC infants that could be used within this 
study and limited control assignment and comparisons across infants based on the age at 
sampling. This issue was more pronounced when subjects were subset according to important 
match factors in Chapters 4 and 5. It was possible to identify those groups that had sufficient 
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sampling to provide statistically viable results whilst spanning a sufficient number of days to 
establish a time series.  
 
This dearth in sampling was associated with NEC infants who are often treated with nil-by-
mouth or have symptoms that lead to a reduction in the frequency and quantity of stools 
produced. Unfortunately, this is a limitation in studying the disease that cannot be avoided in 
a non-invasive analysis of the premature microbiome done in such a manner. However, the 
aggregation of this sequence data, through community databases, with future research could 
help to complement future projects on NEC. 
 
Stool samples are also limited in how accurately they can describe the true profile of the 
intestinal microbiome in vivo. The intestinal tract has multiple communities at various stages 
which currently cannot be discriminated in each stool sample analysed, regardless of the 
quantity535. Whether the stool sample accurately depicts these communities in the premature 
infants within this study was not a prerogative, although it would aid in understanding the 
functions and pathways that may be different between case and control subjects. Stool 
samples were used because they provided a non-invasive technique of sampling close to, and 
intimately related with, events happening in the intestine, close to the known disease sites. 
6.3 Match Factors Associated with Trends in a Developing Microbiome 
CCA analysis demonstrated that LCBD values were most associated with the individual and 
showed high inter-individual variation across the sample population. This has been observed 
in infants previously419,420 and is unsurprising due to the high number of unique factors that 
are likely to influence the development of the microbiome e.g. environment, visitors, 
antimicrobial regimes, SOPs etc.  
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Linear regression and subset regression identified significant associations with the LCBD 
values in infant samples and the age at sampling, gestational duration and feeding regime. 
This confirmed that the age at which an infant was sampled was an important factor to 
normalise for as the taxonomic differences between infant microbiomes over the first year of 
life are great. Therefore, comparisons were made between NEC and controls that were of 
similar ages when sampled. 
 
Gestational duration was an important factor and has been correlated with increased 
abundances of pathogenic taxa as well are reduced diversity and lower abundances of the 
more common, communal, microbiota taxa419,536. However, these differences described in 
literature were observed between preterm and term infants and further analysis of samples 
based on gestation showed little association with changes in LCBD values over time. This 
could be considered unexpected as gestational duration is correlated to maturation and as 
discussed in the introduction of the thesis, the maturity of the intestinal tract has important 
health implications for premature infants. However, this is likely to be due to the cohort 
consisting exclusively of premature infants thus reducing the range in gestational duration 
sampled within the cohort. Therefore, the differences in the LCBD values describing the 
individual sample species diversity relative to all the collective sample diversity is likely to 
be much less than if the samples were compared over a larger gestational range or with full 
term infant samples. An additional point to consider is that the data were analysed as a time 
series and other environmental factors will play a more significant role in influence changes 
in diversity the further from the date of delivery an infant is analysed.  
 
Infants either on a mixed feeding regime or fed exclusively breast milk were seen to have a 
significant association with trends in LCBD values over time.  This association of feeding 
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regimes and changes in the microbiome has been explored extensively and it was suggested 
to be vital in the development of the microbiome during the first six months314. For example 
infants fed breast milk, relative to those fed formula milk, are seen to acquire more 
Bifidobacteria and Lactobacillus318. 
 
The data presented here show that infants fed a mixture of formula and breast milk were seen 
to have stable LCBD values over the duration of sampling, regardless of the NEC status of 
the infant. In contrast, infants fed breast milk exclusively were observed to have an increase 
in LCBD scores before stabilising at ~40 days of age. These results show that there are 
different trends in the colonisation of the microbiota depending on which feeding regime the 
infant was administered.  
 
Mode of delivery was not observed to be significantly associated to LCBD trends over time, 
however it was considered an important match factor in the case-control cohort assignment. 
Additionally, there is evidence that vaginally delivered infants showed more similarity to the 
maternal faecal microflora than those delivered by caesarean section, who had a greater 
similarity to the maternal skin flora and the microbiome of the NICU156,309. Because of this 
evidence and the close duration between birth and sampling it was considered important to 
factor into the analysis.  
 
Similar trends were observed for sample LCBD values over time, irrespective of the delivery 
method. Both groups exhibited similar trends seen for samples from infants fed exclusively 
breast milk. This indicated that feeding regime, specifically those exclusively fed breast milk, 
was the main factor influencing the LCBD values within these sample subsets. 
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6.4 Comparison of Community Compositions of Samples from Infants with 
Necrotising Enterocolitis and Assigned Controls 
Literature has described clustering associated with the taxonomic composition of samples and 
the NEC status of infants in NMDS plots110. Even though this study only described a single 
site and small number of subjects it provided evidence that the communities of NEC subjects 
might be more similar to each other than to controls, indicating an underlying, consistent 
signal for NEC. This warranted investigation with the larger dataset presented here.  
 
The clustering of microbiota community compositions does not appear in larger populations 
from multiple sites. One of the factors that would influence these results was the high inter-
individual variability. The results presented within this thesis showed no evidence of discrete 
clustering of NEC samples or control samples. The overall population showed the lowest 
discrimination between case and control samples (1.5%) which was improved upon in certain 
subsets, namely samples from infants fed breast milk exclusively (2.2%). 
 
The significance of clustering, established with PERMANOVA, showed that samples subset 
by feeding regime and mode of delivery increased the discrimination of NEC and control 
samples. However only samples from infants fed mixed feeding regimes delivered either by 
caesarean section or vaginally were significantly clustered. Further analysis that attempted to 
incorporate gestation and the age at sampling failed to improve or contribute to the clustering 
in any meaningful way. 
 
Overall NMDS analysis with feeding regimes and mode of delivery provided the most 
effective clustering, however it was not possible to re-create the clustering demonstrated by 
Richmond et al. This implied that the community composition was not a significant factor in 
  204 
descriminating NEC and controls samples. Further investigation focused on identifying 
unique taxonomic signatures that could be associated with increased or decreased 
susceptibility to NEC. 
6.5 Taxonomic Differences Between Subjects with Necrotising Enterocolitis 
and Assigned Controls 
The data showed that there are significant differences in the abundance of genera between 
infants who developed NEC and those who did not. The taxonomic abundances of genera 
were initially analysed within subgroups shown to either be significantly associated with the 
trends in the microbiome (feeding regime) or important in the initial colonisation of the 
microbiome (mode of delivery). Following this, samples from these subsets were analysed as 
a population to establish whether there were conserved differences between NEC and control 
sample taxonomic abundances in the population relative to subsets of samples. In total, 16 
NEC subjects had between three and eight samples pre-NEC (mean = 5.36) with a total of 86 
samples, two more subjects had a single sample each pre-NEC diagnosis. Overall the pre-
diagnosis samples represented 58% of all samples from NEC subjects. 
 
Bifidobacterium was observed to be significantly different over time for samples taken from 
infants delivered by caesarean section and fed breast milk and formula feeds. This genus had 
greater normalised mean abundances in control samples consistently over the duration of 
sampling. The error rate for Random Forest predictions of NEC for samples from infants with 
NEC was 33% when using significantly different genera between NEC and control samples 
and irrespective of time. Other genera seen to be significant within the model generation were 
Dialister and Staphylococcus. There has been no clear research suggesting characteristics 
shared between these genera in relation to the gut microbiota disorders, however there is 
some evidence that they are co-associated in the oral microbiota of patients suffering from a 
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range of disorders including chemomechanical preparation537, persistent root canal 
infections538 and irreversible pulpitis539. 
 
Bifidobacterium was also observed to have significantly different normalised abundances 
between NEC and control samples taken from infants delivered vaginally and fed both 
formula milk and breast milk. Veillonella was the only other genus seen to be significantly 
different in normalised mean abundance for this subset when factored with time. These 
genera also the greatest influence in the model generation (as shown by the mean decreased 
accuracy and Gini Index scores) and were seen to be elevated in control samples. Error rates 
for models produced with this subset of samples were much lower than those for caesarean 
delivered infants on mixed feeds (12%). This suggested that the differences between samples 
based on genera were clearer within this group of infants. 
 
Whilst there was evidence of differences for genera within the subgroup that were delivered 
vaginally and fed breast milk exclusively this group lacked consistent sampling for NEC 
subjects when factored with time. This resulted in a high degree of bias from control subjects 
and limited the conclusions that could be made. However, there was evidence that increased 
abundances of Bifidobacterium, Bacteroides and Clostridium in control samples and Proteus 
had greater normalised mean abundances in NEC samples where the sampling density was 
acceptable (between 40-60 days of age). The limitations of this subgroup were further 
confirmed with the high error rate in predicting the NEC status of subjects. 
 
Further support for the positive association of Bifidobacterium within the microbiome of 
healthy subjects was seen when all samples from these subsets were combined and assessed 
  206 
as a population. Bacteroides was also seen to be significantly associated with control samples 
within this population analysis, but was not conserved through all subsets. 
 
There were no clear signs of species that presented as either probiotic or pathogenic in either 
subsets or population analysis. This demonstrated that there is no single causative agent 
associated NEC in this dataset. Interestingly there were no annotations for Bifidobacterium 
species and only three OTUs assigned to the genus in total. This meant that it was not 
possible to observe whether a particular species was significantly elevated in any subset or 
across the population despite the consistent association of the genus with controls samples.  
This could suggest that multiple species contribute in small proportions to the microbiome of 
health subjects. 
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7 Conclusion 
This project demonstrated that the unique nature of the microbiome and the high degree of 
inter-individual variation within the community makes direct comparisons challenging. In 
testing match factors defined by leading medical personnel for significant association with 
NEC infants and establishing subsets based on these results it was possible to increase the 
ability to differentiate between NEC and control samples at the community level.  
 
Further analysis with non-reductive normalisation of abundance data in conjunction with 
machine learning methodologies enabled the detection of taxonomy significantly associated 
with control infant microbiomes. These results support the current interest in utilising 
Bifidobacterium as a probiotic, however there was no evidence for a specific species from 
this genus that would provide the scaffold for a community associated with healthy 
outcomes.  
 
Additionally, the results from this project indicate that there is no clear pathogenic species 
associated across large populations and NEC. There was limited evidence for taxa at any 
taxonomic level being associated with NEC microbiomes, although further research into the 
influence of Dialister and Proteus could prove enlightening. 
 
This project was able to utilise a large cohort and high sample counts to generate subsets of 
samples based on key match factors with sufficient sampling depth that would otherwise have 
been difficult. However, case-control matching would have been better implemented with a 
smaller number of match factors that were more closely associated with NEC. This could 
have improved the similarity between NEC and control subjects with respect to more 
important risk factors. 
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Additionally, the lack of antimicrobial administration information severely limited the use of 
this information. This was considered one of the most important factors to influence the 
microbiome of premature infants and being able to match case and controls based on the 
same administration regimes at the time of sampling could have provided a wealth of 
information with regards to the impact on the microbiome and any association with NEC. 
 
The initial premise of this project was to identify diagnostic or prognostic factors associated 
with the microbiome and the development of NEC. Whilst it was possible to identify key taxa 
associated with non-NEC microbiomes it was not possible to establish whether these 
established a presence prior to the onset of NEC. This was due to the large time frame over 
which patients developed NEC. As it was not possible to account for the extremely active 
colonisation process during the early stages of life it would have been inappropriate to 
compare NEC or control subjects relative to the date of diagnosis irrespective of the age at 
sampling.  
 
Further research should aim to establish the impact the antimicrobials have on the premature 
infant microbiome and their association with the development of NEC. Additionally, feeding 
regimes and probiotic trials should look to establish the underlying changes being made to 
the microbiome and how these are associated with patient health or whether they can be used 
to reduce the impact of antimicrobial administration on the health of the microbiome. 
 
Overall in NEC subjects there is a clear trend for lower abundances of bacteria known to be 
beneficial within the gut microbiome, principally Bifidobacterium. It was possible to increase 
the discrimination between NEC and control subject gut microbiotas by factoring in large 
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scale sampling and establishing subsets according to feeding regime and the mode of 
delivery. Further work should aim to establish the impact of antimicrobial regimes on the 
high inter-individuality of subject microbiomes. Whilst each microbiome will be unique it is 
important to understand how the trends in the establishment of stable, healthy infant 
microbiomes are influenced by outside factors and to what extent these have microbiome 
associated diseases. 
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Supp. Table 1 The bacterial species detected in amniotic fluid by both culture and DNA based methods; * Culture in findings reported as ‘mixed anaerobes’ 
are not listed.  ** Per culture, one case was positive for Prevotella melaniogenica, † in 4 cases, Strep. agalactiae was identified by DNA when culture 
detected Group B Streptococcus, ‡ in 2 cases, culture identified Fusobacterium spp., while in two other cases, both culture and DNA based methods detected 
Fusobacterium nucleatum. §in two cases, Ureaplasma urealyticum was identified by culture only, while DNA analysis resulted in U. parvum. ¶ in two cases, 
G. vaginalis was identified by culture only, while DNA analysis resulted in Sneathia sanguinegens, †† in two cases, Shigella was identified by culture, while 
DNA analysis resulted in E. coli 
Species Detected by DiGiulio305  Species* Detected by Han306 
Gram-positive Firmicutes      
 
Streptococcus mitis DNA only    
 
Streptococcus agalactiae Culture and DNA Strep. Agalactiae DNA only  
    Streptococcus Group B DNA only  
Lactobacillus sp.  Culture and DNA   
 
Bacillus sp. (not anthracis) Culture only    
 
Coagulase-negative Staphylococcus sp. Culture only   
 
Peptostreptococcus sp. Culture only  Peptostreptococcus sp. 
 
    Clostridiales bacterium 
 
Peptostreptococcus asaccharolyticus Culture Onl   
 
Fusobacteria     
 
Fusobacterium nucleatum Culture and DNA, culture 
only 
Fus. nucleatum DNA only, culture‡ 
Uncultivated Fusobacterium DNA only   
 
Sneathia (formerly Leptotrichia) 
sanguinegens 
DNA only Sneathia (formerly Leptotrichia) 
sanguinegens 
DNA only  
Leptotrichia amnionii DNA only Leptotrichia amnionii DNA only  
Tenericutes      
 
Mycoplasma hominis  Culture and DNA Myc. hominis Culture only 
Ureaplasma urealyticum  Culture only U. urealyticum Culture only§) 
Ureaplasma sp. DNA only Ureaplasma parvum DNA only§ 
Actinobacteria      
 
Gardnerella vaginalis Culture only   
 
Gram-negative Bacterioidetes      
 
Uncultivated Bacteroidetes bacterium DNA Only Bacteroides ureolyticus DNA only, DNA and culture 
    Bacteroides fragilis DNA only 
Prevotella sp. DNA onle, NDA and 
Culture** 
Prevotella bivia Culture only, culture and 
DNA 
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Supp. Table 1 continued 
 
Species Detected by DiGiulio  Species* Detected by Han 
Gram-negative Proteobacteria    Bergeyella sp. DNA only 
Delftia acidovorans  DNA Only   
 
Neisseria cinerea DNA Only   
 
    Citrobacter koseri Culture and DNA 
    Klebsiella pneumoniae Culture only 
    Shigella spp. DNA only†† 
    Escherichia coli Culture only†† 
    Eikenella corrodens Culture only 
253 
  254 
Supp. Table 2 Species which the V4 region of the 16S rRNA subunit universal primers are difficult to identify 
accurately 
Species 
Chlorobium phaeovibrioides DSM 265  
Desulfovibriodesulfuricans ATCC 27774  
Rhodospirillum rubrum ATCC 11170 
Salinispora arenicola CNS-205 
Shewanella baltica OS185 
Sulfitobacter sp. NAS-14.1 
Sulfolobus tokodaii 7(S311) 
Sulfurihydrogenibium yellowstonense SS-5 
Thermotoga neapolitana DSM 4359  
Acidobacterium capsulatum ATCC 51196  
Burkholderia xenovorans LB400 
Dictyoglomus turgidum DSM 6724  
Gemmatimonas aurantiaca T-27T  
Nitrosomonas europaea ATCC 19718  
Thermotoga petrophila RKU-1  
Treponema denticola ATCC 35405  
Zymomonasmobilis mobilis ZM4  
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Supp. Table 3 The original 45 gold standard confirmed NEC subjects and their associated control selection. This was reduced to 42 NEC subjects and 81 
controls after sample assessment and control selection 
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Supp. Table 4 16S V4 rDNA Primer Sequences. These sequences were identified by D’Amore et al362. as the best performing universal primer of the V1-V9 
variables regions that target the 16S subunit  
 
 
 
Supp. Table 5 3’ and 5’ Dual Index barcode primer sequences used for multiplexing samples on the Illumina MiSeq apparatus. 3’ and 5’ primer sequences are 
in tables (A) and (B) respectively. 
(A) 
Name 3' adapter i7 index pad/linker 
DI_N701Rev CAAGCAGAAGACGGCATACGAGAT TCGCCTTA GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N702Rev CAAGCAGAAGACGGCATACGAGAT CTAGTACG GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N703Rev CAAGCAGAAGACGGCATACGAGAT TTCTGCCT GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N704Rev CAAGCAGAAGACGGCATACGAGAT GCTCAGGA GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N705Rev CAAGCAGAAGACGGCATACGAGAT AGGAGTCC GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N706Rev CAAGCAGAAGACGGCATACGAGAT CATGCCTA GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N707Rev CAAGCAGAAGACGGCATACGAGAT GTAGAGAG GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N708Rev CAAGCAGAAGACGGCATACGAGAT CCTCTCTG GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N709Rev CAAGCAGAAGACGGCATACGAGAT AGCGTAGC GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N710Rev CAAGCAGAAGACGGCATACGAGAT CAGCCTCG GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N711Rev CAAGCAGAAGACGGCATACGAGAT TGCCTCTT GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
DI_N712Rev CAAGCAGAAGACGGCATACGAGAT TCCTCTAC GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
 
 
 
Name Sequence 
515Fw CTACACTCTTTCCCTACACGACGCTCTTCCGATCTGTGCCAGCMGCCGCGGTAA 
806Rv GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGGACTACHVGGGTWTCTAAT 
256 
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[Supp. Table 5 continued] 
(B) 
Name 5' adapter i5 index pad/linker 
DI_N501For ATTGATACGGCGACCACCGAGATCTACAC TAGATCGC ACACTCTTTCCCTACACGACG 
DI_N502For ATTGATACGGCGACCACCGAGATCTACAC CTCTCTAT ACACTCTTTCCCTACACGACG 
DI_N503For ATTGATACGGCGACCACCGAGATCTACAC TATCCTCT ACACTCTTTCCCTACACGACG 
DI_N504For ATTGATACGGCGACCACCGAGATCTACAC AGAGTAGA ACACTCTTTCCCTACACGACG 
DI_N505For ATTGATACGGCGACCACCGAGATCTACAC GTAAGGAG ACACTCTTTCCCTACACGACG 
DI_N506For ATTGATACGGCGACCACCGAGATCTACAC ACTGCATA ACACTCTTTCCCTACACGACG 
DI_N507For ATTGATACGGCGACCACCGAGATCTACAC AAGGAGTA ACACTCTTTCCCTACACGACG 
DI_N508For ATTGATACGGCGACCACCGAGATCTACAC CTAAGCCT ACACTCTTTCCCTACACGACG 
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 Supp. Table 6 Marascuilo procedural analysis of Chi-squared results for proportions of NEC between 
NICUs. NICU populations were limited to confirmed and non-NEC infants. No significant difference was 
observed between the proportion of NEC infants between any two given NICUs. 
 
Comparison Difference in Proportions Critical Value 
BHH-BWH 0.075 0.703 
BHH-LWH 0.056 0.702 
BHH-RSH 0.036 0.694 
BHH-RWH 0.040 0.733 
BHH-STH 0.021 0.715 
BHH-UHCW 0.013 0.714 
BHH-UHL 0.017 0.670 
BWH-LWH 0.131 0.670 
BWH-RSH 0.111 0.661 
BWH-RWH 0.115 0.706 
BWH-STH 0.054 0.685 
BWH-UHCW 0.087 0.684 
BWH-UHL 0.092 0.634 
LWH-RSH 0.021 0.660 
LWH-RWH 0.016 0.704 
LWH-STH 0.077 0.684 
LWH-UHCW 0.044 0.683 
LWH-UHL 0.039 0.632 
RSH-RWH 0.004 0.697 
RSH-STH 0.057 0.675 
RSH-UHCW 0.023 0.674 
RSH-UHL 0.018 0.621 
RWH-STH 0.033 0.717 
RWH-UHCW 0.027 0.716 
RWH-UHL 0.023 0.673 
STH-UHCW 0.033 0.697 
STH-UHL 0.038 0.649 
UHCW-UHL 0.005 0.648 
   
  259 
12 Supplementary Figures 
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Supp. Figure 1 Schematic view of the MySQL database structure used to maintain and associated patient medical information and sample details. 
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Supp. Figure 2 Diagram of dual index, nested, V4 PCR.  Barcode primers are found on the far outside of the diagram, linked by adaptor sequences to the V4 
primers, which in turn bind to the V4 region of the 16S rRNA sequence. 
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13 Supplementary Table Index 
Supp. Table 1 The bacterial species detected in amniotic fluid by both culture and DNA 
based methods; * Culture in findings reported as ‘mixed anaerobes’ are not listed.  ** 
Per culture, one case was positive for Prevotella melaniogenica, † in 4 cases, Strep. 
agalactiae was identified by DNA when culture detected Group B Streptococcus, ‡ in 2 
cases, culture identified Fusobacterium spp., while in two other cases, both culture and 
DNA based methods detected Fusobacterium nucleatum. §in two cases, Ureaplasma 
urealyticum was identified by culture only, while DNA analysis resulted in U. parvum. ¶ 
in two cases, G. vaginalis was identified by culture only, while DNA analysis resulted in 
Sneathia sanguinegens, †† in two cases, Shigella was identified by culture, while DNA 
analysis resulted in E. coli ......................................................................................... 252 
Supp. Table 2 Species which the V4 region of the 16S rRNA subunit universal primers  are 
difficult to identify accurately.................................................................................... 254 
Supp. Table 3 The original 45 gold standard confirmed NEC subjects and their associated 
control selection. This was reduced to 42 NEC subjects and 81 controls after sample 
assessment and control selection ............................................................................... 255 
Supp. Table 4 16S V4 rDNA Primer Sequences. These sequences were identified by 
D’Amore et al362. as the best performing universal primer of the V1-V9 variables 
regions that target the 16S subunit ............................................................................. 256 
Supp. Table 5 3’ and 5’ Dual Index barcode primer sequences used for multiplexing samples 
on the Illumina MiSeq apparatus. 3’ and 5’ primer sequences are in tables (A) and (B) 
respectively. .............................................................................................................. 256 
Supp. Table 6 Marascuilo procedural analysis of Chi-squared results for proportions of NEC 
between NICUs. NICU populations were limited to confirmed and non-NEC infants. No 
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significant difference was observed between the proportion of NEC infants between any 
two given NICUs. ..................................................................................................... 258 
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15 Appendix 
15.1 Bash Script for Pipeline of Sequence Data QC, Assembly and Error 
Correction 
#set default directory: 
dir=$(dirname -- $(readlink -fn -- "$0")) 
## Creating folder structure 
echo Creating directories... 
mkdir Analysis 
mkdir Assembly 
mkdir Assembly/reads 
mkdir Assembly/Panda_assembled/ 
mkdir Assembly/Spades 
mkdir Analysis/QC 
mkdir Analysis/QIIME 
mkdir Assembly/QC  
mkdir Analysis/PhiX 
  
##Moving reads from trimmed folder 
echo Copying reads to Analysis/reads/ folder... 
cp  ./Trimmed/*/*.fastq.gz ./Assembly/reads/ 
 
#unzip reads 
echo Unzipping reads... 
gunzip Assembly/reads/*.gz 
 
#Renaming if they those that have numbers 
echo Removing number prefixes 
cd Assembly/reads/ 
for f in *.fastq; do fh=$(ls $f | cut -d '-' -f 2-); mv $f $fh; done; 
cd $dir 
 
##fastqc on raw reads 
echo Establishing Read Quality... 
cat Assembly/reads/*.fastq > Assembly/reads/All_Raw_Reads.fastq 
fastqc Assembly/reads/All_Raw_Reads.fastq -o Assembly/QC/ 
rm Assembly/reads/All_Raw_Reads.fastq 
 
#read counts 
echo Calculating read counts... 
for f in Assembly/reads/*.fastq; do count=$(grep -c '@' $f); echo  "$f 
$count" >> Assembly/QC/Read_Counts.txt;done; 
cut -d '/' -f 3 Assembly/QC/Read_Counts.txt > 
Assembly/QC/Raw_Read_Count.txt #cleanup list 
rm Assembly/QC/Read_Counts.txt 
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##Bayes Hammer Error Correction 
echo Running SPAdes Bayes Hammer error correction only... 
cd Assembly/reads/ 
fastq=$(pwd) 
ls *.fastq > files.txt 
 
perl ~/scripts/Perl/yaml.pl files.txt all_samples.yaml ./ 
 
python ~/bin/SPAdes-3.0.0-Linux/bin/spades.py \ 
 --only-error-correction \ 
 -o ../Spades \ 
 --dataset all_samples.yaml 
 
echo Changing to Spades directory 
cd $dir/Assembly/Spades/corrected/ 
gunzip *.gz 
for fh in ' *R1_001*.fastq'  ; do 
          for sample in $fh ; do 
                        i=$( echo $sample | cut -d _ -f 1 ) 
 
                        BC=$( echo $sample  | cut -d _ -f 2 ) 
 
                        for r in 1 2 ; do 
echo /Assembly/reads/${i}_*_R${r}_001.fastq 
awk -- '{if(ARGIND==1)bc[$1]=$2; else if(ARGIND==2){if($1 in bc)printf "%s 
%s\n",$0,bc[$1]; else printf "%s\n",$0; } }' \ 
<(paste - - - - <$dir/Assembly/reads/${i}_*_R${r}_001.fastq) 
$dir/Assembly/Spades/corrected/${i}_*_R${r}_001.*.fastq \ 
>${i}_${BC}_R${r}_Spades_001.fastq 
done; done; done; 
 
###Post Spades Trimming Overlap counts 
echo Counting contigs left post Spades error correction... 
for f in *.fastq; do count=$(grep -c '@' $f); echo  "$f $count" >> 
$dir/Analysis/QC/Spades_Count.txt; done; 
cd $dir 
echo Calculating quality scores for spades corrected contigs... 
fastqc Assembly/Spades/corrected/All_spades.fastq -o $dir/Assembly/QC/ 
rm Assembly/Spades/corrected/All_spades.fastq 
 
PandaSeq Step 
echo Overlapping reads with PandaSeq, min length 240, max length 260... 
cd Assembly/Spades/corrected/ 
for fh in *R1*.fastq ; do 
          for sample in $fh ; do 
   i=$( echo $sample | cut -d _ -f 1 ) 
   echo Sample $i processing ;  
 
   BC=$( echo $sample  | cut -d _ -f 2 ) 
   echo Sample Barcode =  $BC ; 
 
   pandaseq \ 
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   -f ${i}_${BC}_R1*.fastq \ 
   -r ${i}_${BC}_R2*.fastq \ 
   -F \ 
   -T 24 \ 
   > ../../Panda_assembled/${i}_${BC}_spades_panda_assembly.fastq 
  done; 
done; 
  
cd $dir/Assembly/Panda_assembled/ 
 
Panda Assembly Overlap counts 
echo Counting Panda assemblies, check Assembled/QC/Panda_Overlap_Counts.txt 
for details. 
for f in *.fastq; do 
 count=$(grep -c '@' $f); echo  "$f $count" \ 
 >> ../QC/Panda_Overlap_Counts.txt; 
done; 
 
cd $dir 
 
echo Establishing Panda Assembly quality... 
cat Assembly/Panda_assembled/*.fastq > 
Assembly/Panda_assembled/All_Panda_overlaps.fastq 
fastqc Assembly/Panda_assembled/All_Panda_overlaps.fastq -o Assembly/QC/ 
rm Assembly/Panda_assembled/All_Panda_overlaps.fastq 
  
#Converting to FASTA 
echo Converting Spades assembly from FASTQ to FASTA and moving to 
Analysis/Assembly/Spades_fasta... 
mkdir Analysis/Spades_fasta 
cd Assembly/Panda_assembled/ 
for f in *.fastq; do 
 s=$(ls $f | cut -d '_' -f 1 ); 
 bc=$(ls $f | cut -d '_' -f 2); 
 fastq2fasta < $f > $dir/Analysis/Spades_fasta/$s'_'$bc'_assembled.fasta'; 
done; 
cd $dir 
 
# Blast against PhiX DB 
cp Analysis/Spades_fasta/*.fasta Analysis/PhiX 
cd Analysis/PhiX/ 
for f in *.fasta; do 
 i=$(ls $f | cut -d '_' -f 1 ); 
 BC=$(ls $f | cut -d '_' -f 2); 
 
 formatdb -i "$i"_"$BC"_assembled.fasta -p F; 
 blastall -p blastn -d "$i"_"$BC"_assembled.fasta -i 
/pub40/nfellaby/db/phiX.fa -f 2 | sort | uniq > "$i".phiX.list; 
 cat "$i"_"$BC"_assembled.fasta | \ 
 perl -ne '$_=~s/^(>.+?)\n/$1\t/; print $_;' | \ 
 grep -vf "$i".phiX.list | \ 
 perl -ne '$_=~s/\t/\n/; print $_;' \ 
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 > "$i"_"$BC"_phiXfiltered.fa; 
done; 
 
rm Analysis/PhiX/*assembled.fasta 
 
cd $dir 
 
cd Analysis/PhiX/ 
for f in *.fasta; do 
 i=$(ls $f | cut -d '_' -f 1 ); 
 BC=$(ls $f | cut -d '_' -f 2); 
 cat "$i"_"$BC"*phiXfiltered.fa | \ 
 perl -ne 'if($_=~m/^>/) {$x++; $_=~s/^>(\S+)\s+/>'"$i"'_$x 
orig_bc='"$BC"'\n/} print $_;' \ 
 > ../QIIME/"$i"."$BC".assembled.phiXfiltered.qiimeHeaders.fa; 
done; 
 
cd ../QIIME/ 
rm All.PandaSpades*.fa 
 
cat *.assembled.phiXfiltered.qiimeHeaders.fa | \ 
perl -ne '$_=~s/^(>.*?)\n/$1\t/; print $_;' | \ 
sort -k6 | \ 
perl -ne '$_=~s/\t/\n/; print $_;' \ 
> All_seqs.fna 
 
f=$(grep -c '>' All_seqs.fna); echo -e "All_seqs_count $f" 
>>../QC/All_seqs_counts.txt 
 
perl ~/scripts/Perl/Seq_filter.pl \ 
 -i All_seqs.fna \ 
 -min 250 \ 
 -max 350 
mv sequences_ok.fas All_seqs_filtered.fna 
mv sequences_too_long.fas ../QC/ 
mv sequences_too_short.fas ../QC/ 
f=$(grep -c '>' All_seqs_filtered.fna); echo -e "All_seqs_filtered $f" 
>>../QC/All_seqs_counts.txt 
cd $dir 
echo Extracting lengths for assemblies from each sample... 
rm Analysis/QC/Final_Lengths.txt 
for FILE in Analysis/QIIME/*.fna; do 
 grep -v '^>' $FILE | perl -ne 'print "'$FILE'"."\t".length($_)."\n";'; 
done >> Analysis/QC/Final_Lengths_tmp.txt 
cat Analysis/QC/Final_Lengths_tmp.txt | cut -d '/' -f 3  > 
Analysis/QC/Final_Lengths.txt 
rm Analysis/QC/Final_Lengths_tmp.txt 
cd Analysis/QC/ 
Rscript ~/scripts/Length_Boxplot.R 
cd $dir 
echo Finished Assembly, QC and filtering.  
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15.2 R Script for LCBD Value Calculation 
library(phyloseq) 
library(vegan) 
library(ggplot2) 
library(plyr) 
library(phangorn) 
library(ape) 
library(grid) 
setwd("/LCBD/") 
physeq<-import_biom("20_sorted_otu_table.biom") 
abund_table<-otu_table(physeq) 
abund_table<-t(abund_table) 
OTU_taxonomy<-as.data.frame(tax_table(physeq)) 
colnames(OTU_taxonomy)<-
c("Kingdom","Phylum","Class","Order","Family","Genus","Species") 
#Ensure that all columns of OTU_taxonomy are character and not factors 
OTU_taxonomy[] <- lapply(OTU_taxonomy, function(x) as.character(x)) 
OTU_taxonomy[is.na(OTU_taxonomy)]<-"" 
OTU_taxonomy[]<-lapply(OTU_taxonomy,function(x) 
gsub("k__|p__|c__|o__|f__|g__|s__","",x)) 
OTU_tree <-read.tree("16_pfiltered_pynast_aligned_rep_set_tree.txt") 
meta_table<-read.csv("metadata.tsv",row.names=1,header=T,sep="\t") 
#Get rid of N/As 
meta_table[meta_table=="N/A"]<-NA 
meta_table[meta_table=="No data"]<-NA 
abund_table<-abund_table[rownames(meta_table),] 
abund_table<-abund_table[,colSums(abund_table)>0] 
OTU_taxonomy<-OTU_taxonomy[colnames(abund_table),] 
#DEFINE GROUPING AND THE TAXONOMIC LEVEL & DISTANCE MEASURE############### 
meta_table$Groups<-
as.factor(paste(meta_table$NEC.status,meta_table$Study_No)) 
which_level<-"Genus" #Phylum Class Order Family Genus Otus 
#COLLATE OTUS AT A PARTICULAR LEVEL####################################### 
new_abund_table<-NULL 
if(which_level=="Genus"){ new_abund_table<-abund_table} else {list<-
unique(OTU_taxonomy[,which_level])new_abund_table<-NULL for(i in list){ 
tmp<-data.frame( rowSums( 
abund_table[,rownames(OTU_taxonomy)[OTU_taxonomy[,which_level]==i],drop=F]
))    if(i==""){colnames(tmp)<-c("__Unknowns__")} else {colnames(tmp)<-
paste("",i,sep="")} if(is.null(new_abund_table)){new_abund_table<-tmp} 
else {new_abund_table<-cbind(tmp,new_abund_table)}}} 
 
new_abund_table<-as.data.frame(as(new_abund_table,"matrix")) 
abund_table<-new_abund_table 
#Convert the data to phyloseq format 
OTU = otu_table(as.matrix(abund_table), taxa_are_rows = FALSE) 
TAX = tax_table(as.matrix(OTU_taxonomy)) 
SAM = sample_data(meta_table) 
physeq<-NULL 
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if(which_level=="Otus"){physeq<-merge_phyloseq(phyloseq(OTU, TAX), SAM, 
midpoint(OTU_tree))} else {physeq<-merge_phyloseq(phyloseq(OTU),SAM)} 
beta.div <- function(Y, method="hellinger", sqrt.D=FALSE, samp=TRUE, 
nperm=999, save.D=FALSE, clock=FALSE) 
### Internal functions 
{  centre <- function(D,n) 
# Centre a square matrix D by matrix algebra 
# mat.cen = (I - 11'/n) D (I - 11'/n) 
  {  One <- matrix(1,n,n) 
     mat <- diag(n) - One/n 
     mat.cen <- mat %*% D %*% mat 
  } 
   BD.group1 <- function(Y, method, save.D, per, n) 
  { if(method=="profiles") Y = decostand(Y, "total") 
    if(method=="hellinger") Y = decostand(Y, "hellinger") 
    if(method=="chord") Y = decostand(Y, "norm") 
    if(method=="chisquare") Y = decostand(Y, "chi.square") 
    s <- scale(Y, center=TRUE, scale=FALSE)^2   # eq. 1 
    SStotal <- sum(s)          # eq. 2 
    BDtotal <- SStotal/(n-1)   # eq. 3 
    if(!per) { SCBD<-apply(s,2,sum)/SStotal }else{ SCBD<-NA }  # eqs. 4a 
and 4b 
    LCBD <- apply(s, 1, sum)/SStotal  # eqs. 5a and 5b 
    # 
    D <- NA 
    if(!per & save.D)   D <- dist(Y) 
    # 
    out <- list(SStotal_BDtotal=c(SStotal,BDtotal), SCBD = SCBD, LCBD=LCBD, 
method = method, D=D) 
  } 
  BD.group2 <- function(Y, method, sqrt.D, n) 
  { 
    if(method == "divergence") { 
      D = D11(Y)     
     } else if(any(method ==  
                    c("jaccard","sorensen","ochiai")))  
    { 
      if(method=="jaccard") D = dist.binary(Y, method=1) # ade4 takes 
sqrt(D) 
      if(method=="sorensen")  D = dist.binary(Y, method=5) #ade4 takes 
sqrt(D) 
      if(method=="ochiai") D = dist.binary(Y, method=7) # ade4 takes 
sqrt(D) 
       
    } else if(any(method ==  
                    c("manhattan","canberra","whittaker","%difference","ruz
icka","wishart")))  
    { 
      if(method=="manhattan") D = vegdist(Y, "manhattan") 
      if(method=="canberra")  D = vegdist(Y, "canberra") 
      if(method=="whittaker") D = vegdist(decostand(Y,"total"), 
"manhattan")/2 
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      if(method=="%difference") D = vegdist(Y, "bray") 
      if(method=="ruzicka")   D = RuzickaD(Y) 
      if(method=="wishart")   D = WishartD(Y) 
    } else { 
      if(method=="modmeanchardiff") D = D19(Y) 
      if(method=="kulczynski")  D = vegdist(Y, "kulczynski") 
      if(method=="ab.jaccard")  D = chao(Y, coeff="Jaccard", samp=samp) 
      if(method=="ab.sorensen") D = chao(Y, coeff="Sorensen", samp=samp) 
      if(method=="ab.ochiai")   D = chao(Y, coeff="Ochiai", samp=samp) 
      if(method=="ab.simpson")  D = chao(Y, coeff="Simpson", samp=samp) 
    } 
    if(sqrt.D) D = sqrt(D) 
    SStotal <- sum(D^2)/n      # eq. 8 
    BDtotal <- SStotal/(n-1)   # eq. 3 
    delta1 <- centre(as.matrix(-0.5*D^2), n)   # eq. 9 
    LCBD <- diag(delta1)/SStotal               # eq. 10b 
    out <- list(SStotal_BDtotal=c(SStotal,BDtotal), LCBD=LCBD,  
                method=method, D=D) 
  } 
  epsilon <- sqrt(.Machine$double.eps) 
  method <- match.arg(method, c("euclidean", "manhattan", 
"modmeanchardiff", "profiles", "hellinger", "chord", "chisquare", 
"divergence", "canberra", "whittaker", "%difference", "ruzicka", 
"wishart", "kulczynski", "ab.jaccard", 
"ab.sorensen","ab.ochiai","ab.simpson","jaccard","sorensen","ochiai","none
")) 
  if(any(method == c("profiles", "hellinger", "chord", "chisquare", 
"manhattan", "modmeanchardiff", "divergence", "canberra", "whittaker", 
"%difference", "kulczynski"))) require(vegan) 
  if(any(method == c("jaccard","sorensen","ochiai"))) require(ade4) 
  if(is.table(Y)) Y <- Y[1:nrow(Y),1:ncol(Y)]    # In case class(Y) is 
"table" 
  n <- nrow(Y) 
  if((n==2)&(dist(Y)[1]<epsilon)) stop("Y contains two identical rows, 
hence BDtotal = 0") 
  aa <- system.time({ 
    if(any(method ==  
             c("euclidean", "profiles", "hellinger", "chord", 
"chisquare","none"))) {note <- "Info -- This coefficient is Euclidean" 
      res <- BD.group1(Y, method, save.D, per=FALSE, n) 
      # Permutation test for LCBD indices, distances group 1 
      if(nperm>0) {  p <- ncol(Y) 
        nGE.L = rep(1,n) 
        for(iperm in 1:nperm) { 
          Y.perm = apply(Y,2,sample) 
          res.p <- BD.group1(Y.perm, method, save.D, per=TRUE, n) 
          ge <- which(res.p$LCBD+epsilon >= res$LCBD) 
          nGE.L[ge] <- nGE.L[ge] + 1 
        } 
        p.LCBD <- nGE.L/(nperm+1) 
      } else { p.LCBD <- NA } 
      if(save.D) { D <- res$D } else { D <- NA } 
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      out <- list(SStotal_BDtotal=res$SStotal_BDtotal, SCBD=res$SCBD, 
LCBD=res$LCBD, p.LCBD=p.LCBD, method=method, note=note, D=D) 
    } else { 
       if(method == "divergence") { 
        note = "Info -- This coefficient is Euclidean" 
      } else if(any(method == c("jaccard","sorensen","ochiai"))) { 
        note = c("Info -- This coefficient is Euclidean because dist.binary 
","of ade4 computes it as sqrt(D). Use beta.div with option sqrt.D=FALSE") 
      } else if(any(method == c("manhattan", "canberra", "whittaker", 
"%difference", "ruzicka", "wishart"))) { 
        if(sqrt.D) { 
          note = "Info -- In the form sqrt(D), this coefficient, is 
Euclidean" 
        } else { 
          note = c("Info -- For this coefficient, sqrt(D) would be 
Euclidean", "Use is.euclid(D) of ade4 to check Euclideanarity of this D 
matrix") 
        } 
      } else { note = c("Info -- This coefficient is not Euclidean", "Use 
is.euclid(D) of ade4 to check Euclideanarity of this D matrix") 
      } 
      res <- BD.group2(Y, method, sqrt.D, n) 
      # Permutation test for LCBD indices, distances group 2 
      if(nperm>0) { 
        nGE.L = rep(1,n) 
        for(iperm in 1:nperm) { 
          Y.perm = apply(Y,2,sample) 
          res.p <- BD.group2(Y.perm, method, sqrt.D, n) 
          ge <- which(res.p$LCBD+epsilon >= res$LCBD) 
          nGE.L[ge] <- nGE.L[ge] + 1 
        } 
        p.LCBD <- nGE.L/(nperm+1) 
      } else { p.LCBD <- NA } 
      if(sqrt.D) note.sqrt.D<-"sqrt.D=TRUE"  else  note.sqrt.D<-
"sqrt.D=FALSE" 
      if(save.D) { D <- res$D } else { D <- NA } 
      out <- list(SStotal_BDtotal=res$SStotal_BDtotal, LCBD=res$LCBD, 
p.LCBD=p.LCBD, method=c(method,note.sqrt.D), note=note, D=D) 
    } 
  }) 
  aa[3] <- sprintf("%2f",aa[3]) 
  if(clock) cat("Time for computation =",aa[3]," sec\n") 
  class(out) <- "beta.div" 
  out 
} 
RuzickaD <- function(Y # Compute the Ruzicka dissimilarity = (B+C)/(A+B+C) 
(quantitative form of Jaccard). 
{ 
  n = nrow(Y) 
  mat.sq = matrix(0, n, n) 
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# A = W = sum of minima in among-site comparisons B = sum_site.1 - W = K[1] 
- W   # sum of differences for sp(site1) > sp(site2) C = sum_site.2 - W = 
K[2] - W   # sum of differences for sp(site2) > sp(site1) 
  W <- matrix(0,n,n) # matrix that will receive the sums of minima (A) 
  K <- apply(Y,1,sum)  # row sums: (A+B) or (A+C) 
  for(i in 2:n) for(j in 1:(i-1)) W[i,j] <- sum(pmin(Y[i,], Y[j,])) # sums 
of minima (A) 
  for(i in 2:n) { 
    for(j in 1:(i-1)) { 
      mat.sq[i,j]<-(K[i]+K[j]-2*W[i,j])/(K[i]+K[j]-W[i,j]) } # 
(B+C)/(A+B+C) 
  } 
  mat = as.dist(mat.sq) 
} 
D11 <- function(Y, algo=1) 
  # Compute Clark's coefficient of divergence. This is coefficient D11 in 
Legendre and Legendre (2012, eq. 7.51).License: GPL-2 Author:: Pierre 
Legendre, April 2011 
{ Y <- as.matrix(Y) 
  n <- nrow(Y) 
  p <- ncol(Y) 
  # Prepare to divide by pp = (p-d) = no. species present at both sites 
  Y.ap <- 1 - decostand(Y, "pa") 
  d <- Y.ap %*% t(Y.ap) 
  pp <- p-d   # n. species present at the two compared sites 
  if(algo==1) {   # Faster algorithm 
    D <- matrix(0, n, n) 
    for(i in 2:n) { 
      for(j in 1:(i-1)) { 
        num <- (Y[i,]-Y[j,]) 
        den <- (Y[i,]+Y[j,]) 
        sel <- which(den > 0) 
        D[i,j] = sqrt(sum((num[sel]/den[sel])^2)/pp[i,j]) 
      } 
    } 
  } else {   # Slower algorithm  
    D <- matrix(0, n, n) 
    for(i in 2:n) { 
      for(j in 1:(i-1)) { 
        temp = 0 
        for(p2 in 1:p) { 
          den = Y[i,p2] + Y[j,p2] 
          if(den > 0) { 
            temp = temp + ((Y[i,p2] - Y[j,p2])/den)^2 
          } 
        } 
        D[i,j] = sqrt(temp/pp[i,j]) 
      } 
    } 
  }  
  DD <- as.dist(D) 
} 
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D19 <- function(Y) 
  # Compute the Modified mean character difference. This is coefficient D19 
in Legendre and Legendre (2012, eq. 7.46). Division is by pp = number of 
species present at the two compared sites License: GPL-2 Author:: Pierre 
Legendre, April 2011 
{  Y <- as.matrix(Y) 
  n <- nrow(Y) 
  p <- ncol(Y) # Prepare to divide by pp = (p-d) = n. species present at 
both sites 
  Y.ap <- 1 - decostand(Y, "pa") 
  d <- Y.ap %*% t(Y.ap) 
  pp <- p-d # n. species present at the two compared sites 
  D <- vegdist(Y, "manhattan") 
  DD <- as.dist(as.matrix(D)/pp) 
} 
WishartD <- function(Y) 
# Compute dissimilarity = (1 - Wishart similarity ratio) (Wishart 1969). 
License: GPL-2. Author:: Pierre Legendre, August 2012 
{ 
  CP = crossprod(t(Y)) 
  SS = apply(Y^2,1,sum) 
  n = nrow(Y) 
  mat.sq = matrix(0, n, n) 
  for(i in 2:n) { 
    for(j in 1:(i-1)) { mat.sq[i,j] = CP[i,j]/(SS[i] + SS[j] - CP[i,j]) } 
  } 
  mat = 1 - as.dist(mat.sq) 
} 
chao <- function(mat, coeff="Jaccard", samp=TRUE) 
{ require(vegan) 
  nn = nrow(mat) 
  res = matrix(0,nn,nn) 
  if(samp) {   # First for sample data 
    for(k in 2:nn) { 
      for(j in 1:(k-1)) { #cat("k =",k,"  j =",j,"\n") 
        v1 = mat[j,]   # Vector 1 
        v2 = mat[k,]   # Vector 2 
        v1.pa = decostand(v1,"pa")   # Vector 1 in presence-absence form 
        v2.pa = decostand(v2,"pa")   # Vector 2 in presence-absence form 
        N.j = sum(v1)   # Sum of abundances in vector 1 
        N.k = sum(v2)   # Sum of abundances in vector 2 
        shared.sp = v1.pa * v2.pa   # Vector of shared species ("pa") 
        if(sum(shared.sp) == 0) {  
          res[k,j] = 1 
        } else { 
          C.j = sum(shared.sp * v1)   # Sum of shared sp. abundances in v1 
          C.k = sum(shared.sp * v2)   # Sum of shared sp. abundances in v2 
          # a1.j = sum(shared.sp * v1.pa) 
          # a1.k = sum(shared.sp * v2.pa) 
          a1.j = length(which((shared.sp * v2) == 1)) # Singletons in v2 
          a1.k = length(which((shared.sp * v1) == 1)) # Singletons in v1 
          a2.j = length(which((shared.sp * v2) == 2)) # Doubletons in v2 
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          if(a2.j == 0) a2.j <- 1 
          a2.k = length(which((shared.sp * v1) == 2)) # Doubletons in v1 
          if(a2.k == 0) a2.k <- 1 
          # S.j = sum(v1[which(v2 == 1)]) #Sum abund. in v1 for singletons 
in v2 
          # S.k = sum(v2[which(v1 == 1)]) # Sum abund. in v2 for singletons 
in v1 
          sel2 = which(v2 == 1) 
          sel1 = which(v1 == 1) 
          if(length(sel2)>0) S.j = sum(v1[sel2]) else S.j = 0 
          if(length(sel1)>0) S.k = sum(v2[sel1]) else S.k = 0 
          U.j = (C.j/N.j) + ((N.k-1)/N.k) * (a1.j/(2*a2.j)) * (S.j/N.j) # 
Eq. 11 
          if(U.j > 1) U.j <- 1 
          U.k = (C.k/N.k) + ((N.j-1)/N.j) * (a1.k/(2*a2.k)) * (S.k/N.k) # 
Eq. 12 
          if(U.k > 1) U.k <- 1 
          if(coeff == "Jaccard") {                     # "Jaccard" 
            res[k,j] = 1 - (U.j*U.k/(U.j + U.k - U.j*U.k)) 
          } else if(coeff == "Sorensen") {         # "Sorensen" 
            res[k,j] = 1 - (2*U.j*U.k/(U.j + U.k)) 
          } else if(coeff == "Ochiai") {           # "Ochiai" 
            res[k,j] = 1 - (sqrt(U.j*U.k)) 
          } else if(coeff == "Simpson") {  
            # Simpson (1943), or Lennon et al. (2001) in Chao et al. (2006) 
            res[k,j] = 1 - 
              (U.j*U.k/(U.j*U.k+min((U.j-U.j*U.k),(U.k-U.j*U.k)))) 
          } else { #  
            stop("Incorrect coefficient name")}}}} else {   # Now for 
complete population data 
    for(k in 2:nn) { 
      for(j in 1:(k-1)) { 
        v1 = mat[j,]   # Vector 1 
        v2 = mat[k,]   # Vector 2 
        v1.pa = decostand(v1,"pa")   # Vector 1 in presence-absence form 
        v2.pa = decostand(v2,"pa")   # Vector 2 in presence-absence form 
        shared.sp = v1.pa * v2.pa    # Vector of shared species ("pa") 
        if(sum(shared.sp) == 0) {  
          res[k,j] = 1 
        } else { 
          N1 = sum(v1)   # Sum of abundances in vector 1 
          N2 = sum(v2)   # Sum of abundances in vector 2 
          U = sum(shared.sp * v1)/N1   # Sum of shared sp. abundances in v1 
          V = sum(shared.sp * v2)/N2   # Sum of shared sp. abundances in v2 
           
          if(coeff == "Jaccard") {                     # "Jaccard" 
            res[k,j] = 1 - (U*V/(U + V - U*V)) 
          } else if(coeff == "Sorensen") {         # "Sorensen" 
            res[k,j] = 1 - (2*U*V/(U + V)) 
          } else if(coeff == "Ochiai") {           # "Ochiai" 
            res[k,j] = 1 - (sqrt(U*V)) 
          } else if(coeff == "Simpson") { # "Simpson" 
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            res[k,j] = 1 - (U*V/(U*V+min((U-U*V),(V-U*V)))) # Eq. ? 
          } else { #  
            stop("Incorrect coefficient name")}}}}}res <- as.dist(res)} 
######## End of beta.div function 
beta_div<-
beta.div(otu_table(physeq),method="hellinger",sqrt.D=F,samp=T,nperm=999) 
#meta_table<-
read.csv("../../data/All_gold_standard_case_control_metadata.tsv",row.name
s=1,header=T, sep="\t") 
meta_table<-
data.frame(meta_table,data.frame(LCBD=beta_div$LCBD,p.LCBD=beta_div$p.LCBD
)) 
df_LCBD<-
data.frame(Sample=names(beta_div$LCBD),LCBD=beta_div$LCBD,p.LCBD=beta_div$
p.LCBD) 
df_LCBD<-
data.frame(df_LCBD,Type=meta_table[rownames(df_LCBD),"Groups",drop=F]) 
names(meta_table) 
#Apply proportion normalisation 
x<-otu_table(physeq)/rowSums(otu_table(physeq)) 
x<-x[,order(colSums(x),decreasing=TRUE)] 
 
#Extract list of top N Taxa 
N=0 
if(which_level=="Otus"){N<-21} else {N<-22} 
taxa_list<-colnames(x)[1:N] 
#remove "__Unknown__" and add it to others 
taxa_list<-taxa_list[!grepl("Unknown",taxa_list)] 
N<-length(taxa_list) 
#Generate a new table with everything added to Others 
new_x<-data.frame(x[,colnames(x) %in% 
taxa_list],Others=rowSums(x[,!colnames(x) %in% taxa_list])) 
if(which_level=="Otus"){ 
  colnames(new_x)<-c(paste(colnames(new_x)[-(N+1)],sapply(colnames(new_x)[-
(N+1)],function(x) 
gsub(".*;","",gsub(";+$","",paste(sapply(OTU_taxonomy[x,],as.character),co
llapse=";"))))),"Others")} 
15.3 R Script for CCA Analysis of Risk Factors and LCBD Value Association 
library(ggplot2)  
library(vegan) 
library(grid) 
library(phyloseq) 
setwd("/CCA analysis/") 
physeq<-import_biom("20_sorted_otu_table.biom") 
abund_table<-otu_table(physeq) 
abund_table<-t(abund_table) 
meta_table<-read.csv("metadata.csv",  
#Convert to relative frequencies 
abund_table<-abund_table/rowSums(abund_table) 
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#Use adonis to find significant environmental variables 
abund_table.adonis <- adonis(abund_table ~ ., data=meta_table) 
# # adonis(formula = abund_table ~ ., data = meta_table)  
## remove LCBD and p.LCBD columns 
meta_table <- subset(meta_table, select = -LCBD ) 
meta_table <- subset(meta_table, select = -p.LCBD ) 
abund_table.adonis <- adonis(abund_table ~ ., data=meta_table, method = 
"bray",) 
abund_table.adonis 
#Extract the best variables 
bestEnvVariables<-
rownames(abund_table.adonis$aov.tab)[abund_table.adonis$aov.tab$"Pr(>F)"<=
0.01] 
 #We are now going to use only those environmental variables in cca that 
were found significant 
eval(parse(text=paste("sol <- cca(abund_table ~ 
",do.call(paste,c(as.list(bestEnvVariables),sep=" + 
")),",data=meta_table)",sep=""))) 
#Use the following to use all the environmental variables 
scores(sol, display=c("sp"))[1:5,] 
scores(sol, display=c("wa"))[1:5,] 
scores(sol, display=c("lc"))[1:5,] 
scores(sol, display=c("bp"))[1:5,] 
scores(sol, display=c("cn"))[1:5,] 
scrs<-scores(sol,display=c("sp","wa","lc","bp","cn")) 
summary(scrs$sites) 
#Check the attributes 
## Rename CCA1 and CC2 to x and y (axis) 
colnames(scrs$sites)<-c("x","y") 
#Extract site data first 
names(meta_table) 
df_sites<-data.frame(scrs$sites,as.data.frame(meta_table)) 
df_sites[1:5,]  
#Draw sites 
p<-ggplot() 
p<-p+geom_point(data=df_sites,aes(x,y,colour= Study_No)) 
p<-p#+guides(col=guide_legend(ncol=1)) 
#Draw biplots 
multiplier <- vegan:::ordiArrowMul(scrs$biplot) 
summary(meta_table$Age.Days) 
df_arrows<- scrs$biplot*multiplier 
colnames(df_arrows)<-c("x","y") 
df_arrows=as.data.frame(df_arrows) 
p<-p+geom_segment(data=df_arrows, aes(x = 0, y = 0, xend = x, yend = y), 
                 arrow = arrow(length = unit(0.2, 
"cm")),color="#808080",alpha=0.5) 
p<-p+geom_text(data=as.data.frame(df_arrows*1.1),aes(x, y, label = 
rownames(df_arrows)),color="#808080",alpha=0.5) 
p<-p+guides(col=guide_legend(ncol=1))  
# Draw species 
df_species<- as.data.frame(scrs$species) 
colnames(df_species)<-c("X","Y") 
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names(df_species) 
rownames(df_species) 
p<-p+theme_bw()+theme(text=element_text(family="Times New Roman", 
face="bold", size=11))+labs(x="X", y="Y", colour="Subject ID") 
png("CCA.png", width=12, height=6.5, units="in", pointsize=1, res=1200) 
print(p) 
dev.off() 
15.4 R Script for NMDS Analysis  
library(phyloseq) 
library(vegan) 
library(ggplot2) 
library(ape) 
library(phangorn) 
physeq<-import_biom("20_sorted_otu_table.biom") 
abund_table<-otu_table(physeq) 
abund_table<-t(abund_table) 
OTU_taxonomy<-as.data.frame(tax_table(physeq)) 
colnames(OTU_taxonomy)<-
c("Kingdom","Phylum","Class","Order","Family","Genus","Species") 
#Ensure that all columns of OTU_taxonomy are character and not factors 
OTU_taxonomy[] <- lapply(OTU_taxonomy, function(x) as.character(x)) 
OTU_taxonomy[is.na(OTU_taxonomy)]<-"" 
OTU_taxonomy[]<-lapply(OTU_taxonomy,function(x) 
gsub("k__|p__|c__|o__|f__|g__|s__","",x)) 
#Load the tree using ape package 
OTU_tree <- read.tree("16_pfiltered_pynast_aligned_rep_set_tree.txt") 
meta_table<-read.csv("metadata.csv",row.names=1,header=T,sep=",") 
### Subsetting cohort using meta_table and delivery method 
attach(meta_table) 
meta_table<-meta_table[ which(Delivery=='Vaginal' & Feeds =="Natural"),] 
detach(meta_table) 
abund_table<-abund_table[rownames(meta_table),] 
abund_table<-abund_table[,colSums(abund_table)>0] 
OTU_taxonomy<-OTU_taxonomy[colnames(abund_table),] 
#DEFINE GROUPING AND THE TAXONOMIC LEVEL & DISTANCE MEASURE############### 
meta_table$Groups<-as.factor(paste(meta_table$NEC.status)) 
which_level<-"Genus" #Phylum Class Order Family Genus Otus 
which_distance<-"bray" #bray unifrac wunifrac 
#COLLATE OTUS AT A PARTICULAR LEVEL####################################### 
new_abund_table<-NULL 
if(which_level=="Otus"){new_abund_table<-abund_table} else { list<-
unique(OTU_taxonomy[,which_level]) new_abund_table<-NULL for(i in 
list){tmp<-data.frame (rowSums (abund_table[,rownames (OTU_taxonomy) 
[OTU_taxonomy [,which_level]==i],drop=F])) if(i==""){colnames(tmp)<-
c("__Unknowns__")} else {colnames(tmp)<-paste("",i,sep="")} 
if(is.null(new_abund_table)){new_abund_table<-tmp} else {new_abund_table<-
cbind(tmp,new_abund_table)}}} 
new_abund_table<-as.data.frame(as(new_abund_table,"matrix")) 
abund_table<-new_abund_table 
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#Convert the data to phyloseq format 
OTU = otu_table(as.matrix(abund_table), taxa_are_rows = FALSE) 
TAX = tax_table(as.matrix(OTU_taxonomy)) 
SAM = sample_data(meta_table) 
physeq<-NULL 
if(which_level=="Otus"){ physeq<-merge_phyloseq(phyloseq(OTU, 
TAX),SAM,midpoint(OTU_tree))} else {physeq<-
merge_phyloseq(phyloseq(OTU),SAM)} 
 
#Plotting Elipses  
veganCovEllipse<-function (cov, center = c(0, 0), scale = 1, npoints = 
100)  
{ theta <- (0:npoints) * 2 * pi/npoints 
  Circle <- cbind(cos(theta), sin(theta)) 
  t(center + scale * t(Circle %*% chol(cov)))} 
#coloring function   
gg_color_hue<-function(n){ 
  hues=seq(15,375,length=n+1) 
  hcl(h=hues,l=65,c=100)[1:n]} 
sol<-NULL 
if(which_distance=="bray"){ 
  sol<-ordinate(physeq, "NMDS",distance="bray") 
} else if(which_distance=="wunifrac" & which_level=="Otus") { 
  sol<-ordinate(physeq, "NMDS",distance="wunifrac") 
} else if(which_distance=="unifrac" & which_level=="Otus"){ 
  sol<-ordinate(physeq, "NMDS",distance="unifrac") 
} 
if(!is.null(sol)){ 
  NMDS=data.frame(x=sol$points[,1],y=sol$points[,2],meta_table) 
   
  plot.new() 
  ord<-ordiellipse(sol, meta_table$Groups,display = "sites", kind ="se", 
conf = 0.95, label = T) 
  dev.off() 
  
 #Generate ellipse points 
 df_ell <- data.frame() 
 for(g in levels(NMDS$Groups)){ 
   if(g!="" && (g %in% names(ord))){ 
     if(sum(NMDS$Groups==g)>2){   
       tryCatch(df_ell <- rbind(df_ell, 
cbind(as.data.frame(with(NMDS[NMDS$Groups==g,],  
veganCovEllipse(ord[[g]]$cov,ord[[g]]$center,ord[[g]]$scale))),Groups=g)),e
rror=function(e) NULL)}}} 
  colnames(df_ell)<-c("x","y","Groups") 
  #Generate mean values from NMDS plot grouped on 
  NMDS.mean=aggregate(NMDS[,1:2],list(group=NMDS$Groups),mean) 
  cols=gg_color_hue(length(unique(NMDS$Groups))) 
  p<-ggplot(data=NMDS,aes(x,y,colour=Groups)) 
  p<-p + geom_point(alpha=0.5,size = 2) 
  p<-p+theme_bw() 
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  p<-p+ 
annotate("text",x=NMDS.mean$x,y=NMDS.mean$y,label=NMDS.mean$group,size=6,c
olour=cols,family="Courier",fontface="bold",alpha=0.8,vjust=0.3) 
  p<-p+ geom_path(data=df_ell, aes(x=x, y=y), size=1, linetype=1,alpha=0.3) 
  p<-p+xlab("NMDS1")+ylab("NMDS2") 
  pdf(paste("NMDS_",which_distance,"_",which_level,"_Grouping1",".pdf",sep=
""),width=7,height=6) 
  print(p) 
  dev.off() 
  dist<-phyloseq::distance(physeq,which_distance) 
  capture.output(adonis(dist ~ Groups, 
data=meta_table[rownames(otu_table(physeq)),]),file=paste("ADONIS_",which_
distance,"_",which_level,"_Grouping1",".txt",sep=""))   
} 
 
15.5 R Script for Differential and Random Forest Analysis of Taxa 
library(phyloseq) 
library(vegan) 
library(ggplot2) 
library(plyr) 
library(DESeq2) 
library(extrafont) 
font_import() 
loadfonts(device="win") 
library(reshape) 
fonts() 
library(phangorn) 
library(randomForest) 
which_level<-"Species" #Phylum Class Order Family Genus Otus 
which_distance<-"bray" #bray unifrac wunifrac 
sig = 0.05 
fold = 2 
physeq<-import_biom("20_sorted_otu_table.biom") 
abund_table<-otu_table(physeq) 
abund_table<-t(abund_table) 
OTU_taxonomy<-as.data.frame(tax_table(physeq)) 
colnames(OTU_taxonomy)<-
c("Kingdom","Phylum","Class","Order","Family","Genus","Species") 
#Ensure that all columns of OTU_taxonomy are character and not factors 
OTU_taxonomy[] <- lapply(OTU_taxonomy, function(x) as.character(x)) 
OTU_taxonomy[is.na(OTU_taxonomy)]<-"" 
OTU_taxonomy[]<-lapply(OTU_taxonomy,function(x) 
gsub("k__|p__|c__|o__|f__|g__|s__","",x)) 
OTU_tree <- read.tree("16_pfiltered_pynast_aligned_rep_set_tree.txt") 
meta_table<-read.csv("meta_data.csv", row.names=1, header=T) 
# attach(meta_table) # Subsetting if necessary 
# meta_table<-meta_table[ which (Delivery =='Caesarean' & Feeds 
=="Mixed"),] 
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# detach(meta_table) 
abund_table<-abund_table[rownames(meta_table),] 
abund_table<-abund_table[,colSums(abund_table)>0] 
OTU_taxonomy<-OTU_taxonomy[colnames(abund_table),] 
#CHANGE THE GROUPING COLUMN AS YOU DESIRE################################# 
#Hypothesis 1: Taxonomic abundances are significantly different between NEC 
and controls 
meta_table$Groups<-as.factor(as.character(meta_table$NEC.status)) 
new_abund_table<-NULL if(which_level=="Otus"){new_abund_table<-abund_table 
} else {list<-unique(OTU_taxonomy[,which_level]) new_abund_table<-NULL 
for(i in list){ tmp<-data.frame (rowSums (abund_table [,rownames 
(OTU_taxonomy) [OTU_taxonomy[,which_level]==i],drop=F])) 
if(i==""){colnames(tmp)<-c("__Unknowns__")} else {colnames(tmp)<-
paste("",i,sep="")} if(is.null(new_abund_table)){new_abund_table<-tmp} 
else {new_abund_table<-cbind(tmp,new_abund_table)}}} 
new_abund_table<-as.data.frame(as(new_abund_table,"matrix")) 
abund_table<-new_abund_table 
#We will convert our table to DESeqDataSet object 
countData = round(as(abund_table, "matrix"), digits = 0) 
countData<-(t(countData+1))  
dds <- DESeqDataSetFromMatrix(countData, meta_table, as.formula(~ Groups)) 
data_deseq_test = DESeq(dds) 
 
## Extract the results 
res = results(data_deseq_test, cooksCutoff = FALSE) 
res_tax = cbind(as.data.frame(res), as.matrix(countData[rownames(res), ]), 
OTU = rownames(res)) 
plot.point.size = 2 
label=F 
tax.display = NULL 
tax.aggregate = "OTU" 
res_tax_sig = subset(res_tax, padj < sig & fold < abs(log2FoldChange)) 
res_tax_sig <- res_tax_sig[order(res_tax_sig$padj),] 
res_tax$Significant <- ifelse(rownames(res_tax) %in% rownames(res_tax_sig) 
, "Yes", "No") 
res_tax$Significant[is.na(res_tax$Significant)] <- "No" 
res_tax_sig_abund = cbind(as.data.frame(countData[rownames(res_tax_sig), 
]), OTU = rownames(res_tax_sig), padj = 
res_tax[rownames(res_tax_sig),"padj"])  
 
#Apply normalisation (either use relative or log-relative transformation) 
data<-log((abund_table+1)/(rowSums(abund_table)+dim(abund_table)[2])) 
data<-as.data.frame(data) 
normalised_counts<-data 
 
## Log Fold Differences in Taxa 
### MA plot 
res_tax$Significant <- ifelse(rownames(res_tax) %in% rownames(res_tax_sig) 
, "Yes", "No") 
res_tax$Significant[is.na(res_tax$Significant)] <- "No" 
temp<-res_tax[res_tax$Significant == "Yes",] 
dim(temp) 
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### Table assocaited with NB_MA and NB_significant graphs 
temp<-temp[,c(1,2,6),] 
temp[with(temp, order(-baseMean)), ] 
p1 <- ggplot(data = res_tax, aes(x = baseMean, y = log2FoldChange, color = 
Significant)) + geom_point(size = plot.point.size) + scale_x_log10() +  
scale_color_manual(values=c("black", "red")) + labs(x = "Mean abundance", 
y = "Log2 fold change")+theme_bw()+theme(text=element_text(family="Times 
New Roman", face="bold", size=12)) if(label == T){ if 
(!is.null(tax.display)){rlab <- data.frame(res_tax, Display = 
apply(res_tax[,c(tax.display, tax.aggregate)], 1, paste, collapse="; "))} 
else { rlab <- data.frame(res_tax, Display = res_tax[,tax.aggregate])} 
  p1 <- p1 + geom_text(data = subset(rlab, Significant == "Yes"), aes(label 
= Display), size = 4, vjust = 1)} 
 
#### Log 2-Fold Summary, scatter 
png(paste("NB_MA_",paste(levels(meta_table$Groups),collapse="_"),"_",which_
level,".png",sep=""), width=4.2, height=3.2, units="in", pointsize=1, 
res=1200) 
print(p1) 
dev.off() 
res_tax_sig_abund = cbind(as.data.frame(countData[rownames(res_tax_sig), 
]), OTU = rownames(res_tax_sig), padj = 
res_tax[rownames(res_tax_sig),"padj"])  
 
#Apply normalisation 
data<-log((abund_table+1)/(rowSums(abund_table)+dim(abund_table)[2])) 
data<-as.data.frame(data) 
df<-NULL #Now we plot taxa significantly different between the categories 
sig_otus<-res_tax[rownames(res_tax_sig),"OTU"] 
for(i in sig_otus){ tmp<-NULL if(which_level=="Otus"){ tmp<-
data.frame(data[,i],meta_table$Groups,rep(paste(paste(i,gsub(".*;","",gsub
(";+$","",paste(sapply(OTU_taxonomy[i,],as.character),collapse=";"))))," 
padj = ",sprintf("%.5g",res_tax[i,"padj"]),sep=""),dim(data)[1])) 
  } else { tmp<-data.frame(data[,i],meta_table$Groups,rep(paste(i," padj = 
",sprintf("%.5g",res_tax[i,"padj"]),sep=""),dim(data)[1]))} 
  if(is.null(df)){df<-tmp} else { df<-rbind(df,tmp)}} 
colnames(df)<-c("Value","Type","Taxa") 
summary(df$Taxa) 
 
#### Log 2-Fold Significant Taxa, barplot 
p<-ggplot(df,aes(Type,Value,colour=Type))+ylab("Log-relative normalised") 
p<-p+geom_boxplot(outlier.size = 0)+geom_jitter(position = 
position_jitter(height = 0, width=0),alpha=0.5,outlier.colour = 
NULL)+theme_bw()+ 
 facet_wrap( ~ Taxa , scales="free_x",nrow=1) 
p<-p + theme (axis.text.x=element_text (angle=90,hjust=1,vjust=0.5)) + 
theme(strip.text.x = element_text(size = 16, colour = "black", angle = 
90))+theme(text=element_text( face="bold", size=12, family="Times New 
Roman")) 
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pdf(paste("NB_significant_",paste(levels(meta_table$Groups),collapse="_"),"
_",which_level,".pdf",sep=""),width=ceiling((length(sig_otus)*60/200)+2.6)
,height=8) 
print(p) 
dev.off() 
 
# #Now we will use Breiman's random forest algorithm that can be used in 
unsupervised mode for assessing proximities 
# #among data points 
# #Apply normalisation (log-relative transformation) 
abund_table_2<-abund_table 
names(abund_table_2) <- gsub(x = names(abund_table_2), pattern = "\\[|\\]", 
replacement = "")   
res_tax_sig_2<-res_tax_sig 
rownames(res_tax_sig_2)<- gsub(x = rownames(res_tax_sig_2), pattern = 
"\\[|\\]", replacement = "")   
 
data<-log((abund_table_2+1)/(rowSums(abund_table_2)+dim(abund_table_2)[2])) 
data<-as.data.frame(data) 
subset.data<-data[,as.character(res_tax[rownames(res_tax_sig_2),"OTU"])] 
 
############ Linear Graphs for Significant Taxa 
#### Log Normalised Abundance for Genus of Interest over time relative to 
NEC status 
normalised_meta<-merge(normalised_counts, meta_table, by=0) 
names(normalised_meta) 
p<-ggplot(normalised_meta, aes(x=Age.Days, y= butyricum, colour=Study_No, 
shape=NEC.status))+geom_point()+geom_smooth(method="loess")+labs(x="Age / 
Days", y="Log Normalised Abundance", colour="NEC 
Status")+theme_bw()+theme(text=element_text(family="Times New Roman", 
face="bold", size=11))+geom_text(aes(label=Study_No),hjust=0, vjust=0) 
png(filename="4_Regression_Norm_Abund_bray_butyricum.png", width=6.4, 
height=4, units="in", pointsize=1, res=1200) 
p 
dev.off() 
 
### Random Forest Analaysis 
#Now we plot taxa significantly different between the categories 
res_tax_sig_abund = cbind(as.data.frame(countData[rownames(res_tax_sig), 
]), OTU = rownames(res_tax_sig), padj = 
res_tax[rownames(res_tax_sig),"padj"])  
#Apply normalisation (either use relative or log-relative transformation) 
data<-log((abund_table+1)/(rowSums(abund_table)+dim(abund_table)[2])) 
data<-as.data.frame(data) 
df<-NULL 
sig_otus<-res_tax[rownames(res_tax_sig),"OTU"] 
for(i in sig_otus){tmp<-NULL if(which_level=="Otus"){ tmp<-
data.frame(data[,i],meta_table$Groups,rep(paste(paste(i,gsub(".*;","",gsub
(";+$","",paste(sapply(OTU_taxonomy[i,],as.character),collapse=";"))))," 
padj = ",sprintf("%.5g",res_tax[i,"padj"]),sep=""),dim(data)[1]))} else { 
tmp<-data.frame(data[,i],meta_table$Groups,rep(paste(i," padj = 
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",sprintf("%.5g",res_tax[i,"padj"]),sep=""),dim(data)[1]))} 
if(is.null(df)){df<-tmp} else { df<-rbind(df,tmp)}} 
colnames(df)<-c("Value","Type","Taxa") 
 
subset.data<-data[,as.character(res_tax[rownames(res_tax_sig),"OTU"])] 
names(subset.data) <-gsub("\\[","",colnames(subset.data)) 
names(subset.data) <-gsub("\\]","",colnames(subset.data)) 
IDs_map<-data.frame (row.names=gsub (";.*$","",colnames(subset.data)), 
To=colnames(subset.data)) 
names(subset.data)<-paste("X",names(subset.data),sep="") 
 
val<-randomForest(meta_table$Groups ~ ., data=subset.data, importance=T, 
proximity=T, ntree=1500, keep.forest=F) 
rownames(val$importance)<-gsub("^X","",rownames(val$importance)) 
imp<-importance(val) 
df_accuracy<-data.frame (row.names=NULL, Sample=rownames(imp), 
Value=abs(as.numeric(imp[,"MeanDecreaseAccuracy"])),Index=rep("Mean 
Decrease Accuracy",dim(imp)[1])) 
 
r<-ggplot(data=df_accuracy, aes(x= reorder(Sample, -Value),Value)) 
r<-r+geom_bar(fill=I("red"),stat="identity")+theme_bw() 
r<-r+theme(axis.text.x=element_text(angle=90,hjust=1,vjust=0.5))+ylab("Mean 
Decrease Accuracy") 
r<-r+theme(axis.title.x=element_blank(),text=element_text(family="Times New 
Roman", face="bold", size=11)) 
pdf(paste("RF_MDA_",paste(levels(meta_table$Groups),collapse="_"),"_",which
_level,".pdf",sep=""),width=5,height=5) 
print(r) 
dev.off() 
 
df_gini<-data.frame (row.names=NULL, Sample=rownames(imp), Value=as.numeric 
(imp[,"MeanDecreaseGini"]),Index=rep("Mean Decrease Gini",dim(imp)[1])) 
 
 
s<-ggplot(data=df_gini,aes(x= reorder(Sample, -Value),Value)) 
s<-s+geom_bar(fill=I("red"),stat="identity")+theme_bw() 
s<-s+theme(axis.text.x=element_text(angle=90,hjust=1,vjust=0.5))+ylab("Mean 
Decrease Gini") 
s<-s+theme(axis.title.x=element_blank(),text=element_text(family="Times New 
Roman", face="bold", size=11)) 
 
pdf(paste("RF_MDG_",paste(levels(meta_table$Groups),collapse="_"),"_",which
_level,".pdf",sep=""),width=5,height=5) 
print(s) 
dev.off() 
 
######### Visualising Random Forest Output 
options(repos='http://cran.rstudio.org') 
have.packages <- installed.packages() 
cran.packages <- c('devtools','plotrix','randomForest','tree') 
to.install <- setdiff(cran.packages, have.packages[,1]) 
if(length(to.install)>0) install.packages(to.install) 
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library(devtools) 
if(!('reprtree' %in% installed.packages())){ 
install_github('araastat/reprtree')} for(p in c(cran.packages, 
'reprtree')) eval(substitute(library(pkg), list(pkg=p))) 
library(reprtree) 
tree<-randomForest(meta_table$Groups ~ ., data=subset.data, importance=T, 
proximity=T,ntree=1500,keep.forest=T)  
subset.data.tree<-signif(subset.data, 4) 
reptree <- ReprTree(tree, subset.data.tree, metric="d2") 
temp<-getTree(tree, k=1, labelVar=TRUE) 
realtree<-reprtree:::as.tree(temp, tree) 
pdf("4_RF_Natural_Vag_Annotated.pdf",width=100,height=100, fonts='Times New 
Roman') 
plot(T, cex=0.25, cex.lab=0.5) 
dev.off() 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[ END ] 
